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Abstract 
 
Malaria is the most serious tropical infectious disease in humans, caused by parasites of the 
Plasmodium genus and transmitted by anopheline mosquitoes. The interaction between the 
parasites and vectors has become a focus for malaria research as it may present an alternative 
disease control method by enhancing anti-plasmodial factors within the mosquito to impede 
parasite development and transmission. Anopheles gambiae is the best studied African malaria 
vector and is often used with the murine malaria parasite, Plasmodium berghei, for 
investigating parasite-vector interactions in the laboratory setting. Anopheles funestus has not 
been studied and its interactions with Plasmodium were unknown, until now. Although the 
Vector Control Reference Laboratory routinely maintains An. funestus and a number of An. 
gambiae colonies, none have been infected with Plasmodium since their establishment. This 
study aimed to use P. berghei to determine the vectorial capacity of these colonies and to 
examine the involvement of the 2La paracentric chromosomal inversion and antimicrobial 
peptides during Plasmodium infection in An. gambiae and An. funestus, respectively. 
 
Most of the An. gambiae complex colonies were susceptible to P. berghei, but the range of 
feeding and infection rates varied considerably. The infection rates for some of the older 
colonies were lower than previously documented. Anopheles funestus colonies were all viable 
xix 
 
vectors and there was an inverse correlation between the insecticide resistance profile and 
parasite susceptibility. Increased detoxification enzyme activities may have been contributing 
to a greater degree of parasite elimination. 
 
In An. gambiae, molecular karyotyping of the 2La inversion using PCR was validated against 
traditional cytogenetic techniques. The PCR was shown to be a reliable substitute for 
identifying the inversion. Using molecular karyotyping on 2La polymorphic colonies infected 
with P. berghei, it was found that infected females were more likely to carry the 2La 
inversion, indicating possible correlation between the inversion and susceptibility to parasites. 
 
In An. funestus, the expression of antimicrobial pepetide genes during P. berghei infection 
was examined using real-time PCR. Although all three genes showed increased activity at 
certain points of the infection, none displayed significant anti-plasmodial properties. 
However, in the less parasite susceptible strain, expression of two genes was higher towards 
the end of the infection, which was not observed in the other strains. It is possible that the co-
expression of both peptides has led to a decrease in parasite load in late infection, but given 
the multi-factorial nature of the parasite-vector interaction, further investigation is required. 
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Chapter 1: General introduction 
 
1.1 Introduction 
Malaria, caused by parasitic protozoans of the Plasmodium genus and transmitted by 
mosquitoes belonging to the Anopheles genus, is the most important vector-borne infectious 
disease in humans. The disease affects up to 40% of the world‟s population, and kills up to 
700,000 people a year, most of which are children below the age of five (WHO, 2011). 
Interventions via anti-malaria drugs and vector control are feasible means to reduce, or 
possibly even eliminate malaria, particularly if multiple deterrents are utilized.  
 
The term malaria is derived from the Italian “mal‟aria”, as the disease was originally 
associated with the “bad air”, “evil air” or “corrupted air” of the marshy areas. The final form 
of the word currently used to describe the disease was only first seen in 1838 (Neghina et al., 
2010). It is a disease that has plagued humans since antiquity under various names, with 
records from Ancient Egypt intimating its presence (Garnham, 1966; Neghina et al., 2010). 
The disease was prevalent not only in the tropics and sub-tropical regions worldwide, but was 
also found in temperate areas, including parts of North America, Europe and Asia. There are 
records of malaria cases as far north as Netherlands, Siberia and Manchuria (Faust et al., 
1970). Little was known about the disease or how to treat it effectively for centuries. The first 
viable anti-malarial in the form of cinchona bark was found in South America and brought to 
Europe in the 1600s; the active compound acting against malaria in the bark, quinine, was 
isolated in 1820 by French chemists (Garnham, 1966).  
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The real breakthrough with the characterization of the disease came in the late 19
th
 century. 
First, the malaria parasite was discovered by Laveran in Algeria in 1880, although this wasn‟t 
generally accepted until 1885 (Belding, 1965). During the next five years, Italian researchers 
identified a number of parasite species. The mosquito was eventually confirmed as the vector 
for malaria parasites by Ross in India in 1897. Using avian malaria, he proved that 
transmission of the parasite occurred through the bite of infected mosquitoes. Around the 
same time, and independently of Ross, Grassi and Bignami in Italy were able to successfully 
infect a human volunteer with malaria parasites by allowing mosquitoes to feed on the person, 
demonstrating the mosquitoes‟ involvement in malaria transmission (Garnham, 1966). In 
1907, Ross further confirmed that only anopheline mosquitoes are human malarial vectors, 
and that the parasites are injected into the host as the mosquito is feeding.  
 
Understanding the mosquitoes‟ participation in the spread of malaria led to increased public 
health and sanitation awareness, which reduced malaria transmission in many areas, but did 
not eliminate the disease. The first ever documented use of insecticides as a control agent 
against malaria was in South Africa, by Park-Ross (1936) and de Meillon (1936). Pyrethrum, 
a botanical insecticide extracted from chrysanthemum flowers, first tested by Giemsa 
(Harrison, 1978) was used to great effect in the field. Park-Ross was primarily concerned with 
monitoring the decline of malaria cases, while de Meillon demonstrated the viability of indoor 
spraying to eliminate endophilic (preferring to rest indoors) malarial vectors. Around the same 
time, the first effective artificial anti-malaria drug, chloroquine, was synthesized in Germany, 
but its true effectiveness was only realized towards the end of World War II (Harrison, 1978). 
There was a dramatic upswing in development of viable insecticides during and after World 
War II (Asa & Clarke, 1961). The most important of these was dichloro-diphenyl-
trichloroethane, more popularly known as DDT, which is a chlorinated hydrocarbon. Two 
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other classes of insecticides also arose during this period, the first was organophosphates 
(OPs), discovered in the 1930s, and methylcarbamates (MCs) in the 1940s (Casida & Quistad, 
1998).  
 
With DDT as a highly effective insecticide, comprehensive indoor house-spraying programs 
were put in place during World War II by various countries in the Mediterranean region and 
on islands in the Pacific to try and reduce, if not eliminate malaria. In 1955, the World Health 
Organization (WHO) launched the Global Malaria Eradication Programme, which aimed to 
interrupt malaria transmission by using DDT as the sole indoor residual spray (IRS) 
component (International Development Advisory Board, 1956). The initiative was immensely 
successful in Latin America, the Caribbean, the Balkans, and parts of the Pacific Rim region 
(Trigg & Kondrachine, 1998; WHO, 2009). By this point, the search for effective anti-
malarial compounds to replace quinine had finally led to the testing and proof of chloroquine 
(initially called Resochin by its creator) as being an effective drug, and it was approved as the 
anti-malarial for general public consumption (Coatney, 1963). The combination of the new 
anti-malarial drug, insecticides and better understanding of the mosquitoes, more or less 
brought about the current malarial distribution: The United States of America has been free of 
malaria since the late 1950s; Europe eliminated the last vestige of the disease in the 1960s; 
parts of Asia, typically islands or archipelagos (Singapore and Taiwan in South-east/East Asia, 
for example) were also successful in eliminating it (TAMRI & WHO malaria team in Taiwan, 
1958; WHO, 2009). While isolated landmasses can be an advantage for the elimination of 
malaria, it is not an automatic guarantee that this will happen, as islands like Sri Lanka and 
Madagascar have returned to being stable transmission areas after initial successes. Malaria 
prevalences on Zanzibar and Pemba islands were greatly reduced for at least 10 years from 
the late 1950s, with no malaria related deaths reported (WHO, 1976), but when vector control 
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stopped, the disease reappeared and has persisted to this day. The islands of Mauritius and 
Reunion, on the other hand, managed to eliminate most of the vector species and this has in 
effect eliminated malaria from the islands (WHO, 1976). The last class of effective 
insecticides, the pyrethroids, were introduced in the 1980s. This is the synthetic analogue for 
pyrethrin, the active component in pyrethrum, thus providing similar benefits and 
disadvantages as the natural compound, but can now be mass produced with an effective 
residual life of up to six months (WHO, 2009).  
 
The bulk of malaria transmission was, and still remains, in the Afrotropical Region, where it 
is considered to be endemic, and in many parts holo- or hyper-endemic (WHO, 2009, 2012). 
The endemicity of a region is defined by the combined results of 1) the resistance of the 
human population to malaria (taking into account spleen rate, parasite rate), 2) the capacity of 
the vector/s to infect (including bloodmeal preference, sporozoite rate, longevity, adult 
population density), and 3) the capacity of the terrain and climate to provide a vector 
population above critical density (WHO, 1963). The continent was actually excluded from the 
Global Malaria Eradication program in 1955 because it was thought that very little success 
would be achieved in interrupting malaria transmission - Africa was “too difficult” (WHO, 
1976). The only successes in control via insecticide spraying were at the edges of tropical 
Africa where malaria was unstable (South Africa, Swaziland, Zimbabwe and the islands of 
Madagascar, Mauritius, Reunion; WHO, 1976). 
 
South Africa is one of the few African countries where malaria is not stably transmitted but 
still has transmission hotspots, particularly on the north-eastern borders (South African 
Department of Health, unpublished data). Malaria transmission also remains stable in forested 
areas of Latin America, South and South-east Asia (WHO, 2009). Areas where malaria has 
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been eliminated, but are still climatically hospitable to the vector mosquitoes, may be exposed 
to sporadic outbreaks primarily due to infected individuals or infective mosquitoes coming in 
from endemic regions (Signorelli et al., 1990; Marty et al., 1992; Layton et al., 1993; 
Muentener et al., 1999).  
 
Currently, the elimination of malaria from the Afrotropical Region is not possible for several 
reasons. Implementation of control programs in Africa is often difficult due politico-social 
instabilities, a lack of will to sustain the policies correctly and for a sufficiently long period, 
or simply the wrong control strategy being used (WHO, 2007). The situation is exacerbated if 
control programs are initiated and then abandoned, as the exposure of the parasites or 
mosquitoes to drugs and insecticides without continuance can easily lead to resistance, which 
will leave future control programs worse off (Bruce-Chwatt, 1978). The resistance problem is 
further hampered by the lack of new, effective insecticide and anti-malarial drugs. Since the 
1960s, field collections in various parts of Africa have shown that insecticide resistance in 
anopheline mosquitoes is prevalent throughout the continent, and has increased in more recent 
times (WHO technical report 655, 1980; Ranson et al., 2009) making it a challenging task to 
control the vectors using insecticides alone (Hargreaves et al., 2000; Okoye et al., 2008a; 
Morgan et al., 2010 and Djouka et al., 2011 are just a few examples detailing insecticide 
resistance in Africa).  
 
1.2 The malaria parasite 
Plasmodium parasites require two hosts in order to complete their lifecycle – a vertebrate host 
and a mosquito vector. In the first instance, there is a wide range of vertebrates that different 
Plasmodium species have adapted to, ranging from reptiles and birds, to mammals (Garnham, 
1966). Despite the diverse evolutionary paths that the parasites have taken in their choices of 
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vertebrate hosts, the infection process remains remarkably similar throughout the genus. Of 
the more than 100 known Plasmodium species, four are commonly found to infect humans 
under natural conditions: P. falciparum, P. vivax, P. ovale, and P. malariae (Garnham, 1966). 
Plasmodium vivax, P. ovale, and P. malariae, are in the subgenus Plasmodium, while P. 
falciparum is in the subgenus Laverania together with a few malaria species for non-human 
primates (Kreier & Baker 1987). A number of primate and monkey malaria parasites have also 
been shown to be able to infect humans experimentally (Garnham, 1966), but in most 
instances, no naturally occurring cases have been found. The one exception is P. knowlesi, a 
primate parasite in South-East Asia, which seems to be evolving through zoonosis and has 
become the fifth human malaria parasite (Singh et al., 2004; White, 2008).  
 
Of the four human Plasmodium species present in Africa, P. falciparum is the most dangerous. 
Infected erythrocytes can block capillaries and if this occurs in the brain, it leads to cerebral 
malaria which is often fatal, particularly in infants and pregnant women (WHO, 2012). Severe 
dysfunction of other vital organs including lungs, kidneys and liver is also possible (Carter & 
Mendi, 2005). In addition, P. falciparum infection can often lead to severe anaemia which can 
also be lethal. The species accounts for the vast majority (86%) of malaria-related deaths in 
children below the age of five in Africa (WHO, 2012). Plasmodium vivax, the most globally 
widespread of the four species, is found in the tropics as well as temperate regions of the 
world (Carter & Mendis, 2005). It can cause severe anaemia, but mild anaemia is the more 
common symptom, so fatalities are rare compared with P. falciparum. Plasmodium ovale is 
the rarest of the four, mainly found in Central and West Africa as well as some islands of the 
Western Pacific (Lysenko & Beljaev, 1969; Collins & Jeffrey, 2005), as opposed to 
Plasmodium malariae, which also has a world-wide distribution in the tropics and sub-tropics, 
albeit at lower frequencies than P. vivax. Deaths from P. ovale and P. malariae infections are 
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also rare (Collins & Paskewitz, 1995). Although fatalities are typically associated with P. 
falciparum, the other three species have the ability to cause long bouts of infection, or 
recurring relapses in the long term. Plasmodium malariae has been known to have long-
lasting blood stage infections, which can persist asymptomatically for decades (Carter & 
Mendis, 2005; Tuteja, 2007), while P. vivax and P. ovale have dormant liver stages that can 
last for weeks, up to years, before re-emerging and causing a relapse of infection (Chin & 
Coatney, 1971; Collins & Paskewitz, 1995). In such instances, if the appropriate vector is in 
the vicinity and feeds on the relapsing individual, it can lead to unexpected minor outbreaks 
of malaria in areas otherwise no longer associated with the disease (Garnham, 1966; Carter & 
Mendis, 2005).  
 
1.3 The Plasmodium lifecycle 
It is essential for the Plasmodium species‟ survival to have access to both the vector and host, 
not only because the vector is needed to transmit the parasite to new hosts, but important life 
stages occur in both vector and host, which cannot be bypassed. In the vertebrates, the 
parasite has an emphasis on asexual reproduction, with precursor cells for sexual reproduction; 
all the life stages here are haploid (Burkot & Graves, 2000). In the mosquito, sexual 
reproduction takes place, which then switches back to asexual reproduction to increase the 
number of parasites. Interestingly, the mosquito is actually considered the definitive host for 
the parasite, as sexual reproduction occurs in the insect (Garnham, 1966). Alternatively, the 
lifecycle can be divided into three stages of cell division and development: 
merogony/schizogony (asexual), gametogony (sexual), and sporogony (asexual) (Burkot & 
Graves, 2000).  
 
An infected adult female mosquito releases sporozoites from her salivary glands into the 
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bloodstream of the vertebrate host upon taking a bloodmeal. The sporozoites use the host‟s 
circulatory system to get to the liver, which can happen within a space of a few minutes (Shin 
et al., 1982). On reaching the liver, the sporozoites may migrate through several hepatocytes 
before finding the optimal host cell (Mota & Rodriguez, 2001), where they undergo asexual 
replication known as exo-erythrocytic schizogony, or in certain species, enter a dormant stage. 
The replication takes 9 - 16 days, whereupon merozoites are produced and released into the 
bloodstream. The merozoites invade the erythrocytes, and undergo asexual reproduction once 
more, going through distinct stages of development in the red blood cells (RBCs) that can be 
observed using light microscopy. At the end of intra-erythrocytic replication, mature schizonts 
containing around 20 merozoites are produced, and they are released into the bloodstream 
with the lysis of the original RBCs, to infect more erythrocytes. This mass, synchronized 
release of the merozoites is what leads to the chills and fever associated with malaria, and can 
also lead to severe anaemia. Depending on the species, the erythrocytic infection cycle repeats 
every 48 hours (P. falciparum, P. ovale and P. vivax) or 72 hours (P. malariae), which gave 
rise to the terms tertian and quartan malaria, respectively (Garnham, 1966). At some point in 
this invasive stage, typically when the reproduction has slowed, gametocytes, the precursor to 
the sexual gametes, are produced (Brey, 2003). The male and female gametocytes are 
morphologically different; they are inert in the bloodstream and remain so until taken up by 
an anopheline mosquito female during feeding. 
 
When the gametocytes are taken up by the mosquito during feeding, the sexual stage of the 
parasite development occurs very quickly in the mosquito midgut. This is triggered by 
changes in temperature, pH (Billker et al., 1997) and presence of xanthurenic acid (Billker et 
al., 1998). The male gametocytes exflagellate, releasing 8 flagellated male microgametes that 
will seek out the sessile female macrogametes to undergo sexual reproduction. The production 
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of the microgamete occurs within a space of less than 10 minutes, where three endomitotic 
cycles are completed along with the assembly of the axoneme (Billker et al., 2004). 
Successful fertilization of the macrogametes by the exflagellated microgametes results in 
another transformation of the parasite, producing motile ookinetes.  
 
The ookinete has to cross the physical barriers posed by the chitinous peritrophic membrane 
and the midgut epithelium in the mosquito. Once the ookinete is able to lodge itself in the 
basal lamina of the midgut, it develops into a sessile oocyst. In the case of human malaria, 
oocysts can be detected three to four days after the ingestion of the bloodmeal (the Malaria 
Research and Reference Reagent Resource Centre (MR4) methods in Anopheles 
research laboratory manual, 2007). The oocyst is now safe from elimination and begins to 
undergo multiple asexual replication processes to produce sporozoites. The number of oocysts 
at this stage can vary significantly even in natural vector-parasite pairing, ranging from single 
digits to over 60 oocysts in one individual female (Shute et al., 1965). Each oocyst is capable 
of releasing thousands of sporozoites upon maturation. The number of sporozoites released 
per oocyst was initially estimated at around 1,000 by Ross (1910) but higher numbers have 
been reported, typically around 10,000 per oocyst (Pringle, 1965). Therefore, even if only a 
single oocyst survives development through the midgut wall, the mosquito can become 
infective, as the amplification factor in oocyst-sporozoite transition is 2,000 - 8,000 fold 
(Christophides et al., 2004). The length of time taken to complete sporozoite development is 
dependent on the species of mosquito as well as the climate. Sporozoites may be released into 
the haemolymph as early as one week, or any time up to two weeks, post-infected bloodmeal 
(Collins & Paskewitz, 1995) 
 
Upon release from the oocysts, the sporozoites have to make their way into the salivary 
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glands of the mosquito. The mosquito salivary glands are paired organs located in the anterior 
end of the thorax. In anophelines, each gland is formed by two similarly constructed lateral 
lobes, with a shorter, wider medial lobe. The medial lobe‟s cul-de-sac is made up of large 
secretory cells, and a narrow channel of non-secretory cells connects it to the other lobes 
(Wright, 1969). The lateral lobes have a proximal and distal region, where the distal region is 
made up of secretory cells similar to those of the medial lobe, and it is in here where the 
sporozoites congregate. It still needs to be fully elucidated whether the sporozoites actively 
move toward the salivary glands by chemotaxis (Akaki & Dvorak, 2005) or are passively 
carried by the haemolymph circulation (Rodriguez & Hernández-Hernández, 2004), but there 
is evidence supporting both mechanisms. Upon arrival at the salivary glands, the sporozoites 
gain a parasitophorous vacuole by hijacking part of the host cell plasmalemma. The 
sporozoites then penetrate the gland cells. Once inside, they lose the vacuole, and create 
another one to break out of the cells and into the secretory cavity. Inside the cavity, the second 
vacuole disintegrates, and the sporozoites accumulate as tightly packed bundles (Rodriguez & 
Hernández-Hernández, 2004). The salivary glands typically carry anywhere between 10
2 
- 10
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sporozoites, depending on the species, although sporozoites numbering in the hundreds of 
thousands have been found (Shute, 1945; Beier et al., 1991a) Although in most feeding events 
less than 25 sporozoites pass into the host, the mosquito can release up to 300 sporozoites 
(Rosenberg et al., 1990; Beier et al., 1991; Li et al., 1992). The number of sporozoites 
released has been suggested to be an indication of the severity of the impending infection 
(Mcgregor, 1965), but there is evidence contrary to this (Sinden et al., 2007). In addition, 
infected mosquitoes have been shown to be infective more than 70 days post-infected 
bloodmeal (James, 1926; Shute, 1945), which is already considerably beyond the average 
lifespan of the adult female. Therefore the mosquito can be considered to be permanently 
infective should the parasite make its way into the salivary glands.  
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While the various life stages of the parasites were fairly well established soon after Ross‟ 
discovery – guides for malarial study noting the lifecycle have been in print since the early 
20
th
 century (Stephens & Christophers, 1908) – actual molecular mechanisms remain largely 
unclear. For example, details of the invasion mechanisms in both vector (the midgut and 
salivary gland invasion) and the host (the hepatocytes and erythrocytes) are not fully 
elucidated. Better understanding of interactions at these stages may provide possible points of 
intervention for novel strategies to disrupt malaria transmission.  
 
1.4 The murine malaria parasite, P. berghei and others 
The rodent infection system is important in malaria research for a number of reasons. The 
progression of the murine Plasmodium is comparable to the human malaria and uses the same 
genus of mosquitoes as vectors, which makes them favourable comparative models. Although 
one could argue that in vivo primate malaria models may provide more suitable comparisons, 
the practicalities of cost, time, space and expertise needed to maintain primates, as well as the 
ethical considerations, makes them far less attractive. In contrast, rodent malaria maintainance 
is relatively easy and techniques for synchronising and enhancing infection are well described 
(Mons & Sinden, 1990). When compared to using human malaria species for experimentation, 
rodent Plasmodium is safer as it cannot be transmitted to any other mammals (Brey, 1999), 
thus alleviating significant biosafety concerns. It also provides a complete infection system, 
where it is possible to take the parasite through both host and vector in vivo. This is obviously 
not possible using human malaria parasites. Such apparent obstacles have led to innovative 
infection systems such as using in vitro hepatocyte models (Sacci et al., 1992), or using SCID 
or recombinant mice to develop humanized mouse models (Morosan et al., 2006). These 
systems would be useful to test the efficacy of vaccines and anti-malarials, but still cannot 
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compare to a complete in vivo system in other respects.  
 
The first rodent malaria parasite, P. berghei, was surprisingly only described some decades 
after the discovery of the human and avian parasites (Vincke & Lips, 1948). Three other 
murine parasites were found subsequently: P. vinckei (Rodhain, 1952), P. chabaudi (Landau, 
1965) and P. yoelii (Landau & Chaubaud, 1965). A number of strains and sub-species have 
also been isolated for these species (for review of this, see Garnham 1966; Landau & Boulard, 
1978). Prior to the discovery of murine parasites, avian Plasmodium parasites were used 
extensively to study the parasite biology and for anti-malarial treatments. However, the avian 
Plasmodium species infection process is somewhat dissimilar to those of mammalian malarias, 
as they have prominent exo-erythocytic development stages in macrophages and endothelial 
cells of organs, whereas in mammal Plasmodium species, exo-erythrocytic forms are less 
obvious (Garnham, 1966). This is particularly true in P. falciparum, and is the main reason 
that it is in a separate subgenus, Laverania, and not the subgenus Plasmodium. The vectors of 
avian malaria are also different (Aedes and Culex mosquitoes), while it is the same genus for 
all mammalian malarias (Anopheles species) (Garnham, 1966). 
  
Plasmodium berghei was discovered in the Congo, although Vincke may have already 
observed the parasite in its natural vector a few years earlier (van den Berghe, 1954; Bruce-
Chwatt, 1978). Plasmodium berghei‟s natural habitat is highly localized, restricted to the 
gallery forests in Katanga between 1,000 - 1,700 m above sea level. Different strains have 
been isolated from nearby localities with similar biotopes, but the parasite has never been 
found to occur naturally outside of Central Africa (Landau & Boulard, 1978). The parasite‟s 
natural host is a number of sylvatic rodents that live in the forest, primarily tree rats of the 
Thamnomys genus. It is transmitted solely by Anopheles dureni in nature, even though there 
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are a number of other anopheline species in sympatry (Garnham, 1966; Killick-Kendrick, 
1978). There has been no success in colonizing An. dureni but fortunately, the rodent parasite 
has been found to be compatible with other mosquito species (Yoeli, 1965).  
 
Early attempts to infect other mosquito species aside from An. dureni consistently ended in 
failure. While oocysts were often detected, the sporozoites were not. When sporozoites were 
seen, these were often few in number and highly sporadic in the infected cohort (Box et al., 
1953; Bray, 1954). The inability to breed both the natural vector (which is still the case) and 
vertebrate host in captivity led to an impasse in establishing rodent malaria as a viable 
laboratory model for over a decade despite its promise. This was eventually resolved when 
Yoeli discovered it is essential to maintain the infected mosquitoes at 19 - 21°C, which is the 
ambient temperature in the gallery forests (Yoeli et al., 1964; Vanderberg & Yoeli, 1965, 
1966). The revelation led to successful infection of An. quadrimaculatus and other 
anophelines, thus bypassing the need for An. dureni (Yoeli, 1965). The parasite was also 
tested on a large variety of rodent species as possible hosts, and attained successful cyclical 
transmission in a number of species (Bruce-Chwatt, 1978). To date, almost all common 
laboratory mouse strains are susceptible to P. berghei and the infection is typically fatal. 
Hamsters are viable options as well, particularly for gametocytes (Sinden et al., 2002). Some 
rat strains are susceptible and usually survive the infection, while guinea pigs will fight the 
infection off and rarely show symptoms of infection. Voles, adult rabbits and North American 
gerbils are also resistant to the parasites (Belding, 1965). There is a proviso for successful 
infection of the rats and mice – the rodents need to be young adolescents whose immune 
system hasn‟t fully developed (Sinden, 2002). While the adult mice will eventually succumb 
to the infection if the initial parasitaemia is high enough, the initial time to first detection of 
parasite can vary, which would make it difficult to plan for experiments.  
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Although all four murine parasites have been used in research, P. berghei is the most popular 
choice by far and research using P. chabaudi, P. vinckei and P. yoelii are greatly in the 
minority (Sinden, 2002). The infection in rodents proceeds very similarly to that observed in 
human malaria, just a little faster as observed by Yoeli (1965). The mice are infective to 
mosquitoes three to five days after initial exposure to the parasite, and depending on the 
strains used, as well as the initial level of parasitaemia used for infection, the mice will 
succumb to the parasites any time between a week to 15 days after infection.   
 
Compared to the four human malaria parasites, P. berghei pathogenesis is most similar to that 
of P. vivax. However, mice typically do not survive the infection, while humans rarely 
succumb to vivax infections, so such comparisons are not precise. With regard to the genetic 
makeup, the Plasmodium genus has fairly conserved genomes, with approximately 3,900 
orthologous genes (accounting for around 26% of the Plasmodium genome) (Aguilar et al., 
2005). Therefore, alternative Plasmodium species infections are still viable and can produce 
results that, to some degree, reflect the processes in P. falciparum infection. There are also 
differences in the physiological response of An. gambiae to P. berghei and P. falciparum. 
Development of P. berghei ookinetes can involve a large number (~50), whereas rarely more 
than a handful of P. falciparum ookinetes survive in the An. gambiae midgut (Aguilar et al., 
2005). The midgut invasion pathways also seem to differ, with P. falciparum using an 
intercellular route, as opposed to P. berghei‟s intracellular approach (Tahar et al., 2002). 
Expression of the mosquito genes during parasite infection also varies, with P. berghei 
triggering three times as many An. gambiae midgut genes compared to P. falciparum (Dong et 
al., 2006).  
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Taking these points into consideration, it may be easy to disregard the P. berghei-anopheline 
model, but the similarities and differences in responses provide an excellent gateway for 
preliminary studies. The use of unnatural vector-parasite pairing is useful for observing 
response mechanisms otherwise not seen in normal interactions, such as melanotic 
encapsulation (Collins et al., 1986), and parasite lysis (Vernick et al., 1995). By comparing 
these results to field studies and data from natural pairings, it would provide a better picture of 
the infection and may provide alternative options for eliminating the parasite-vector 
interaction (Brey, 1999). 
 
1.5 The vectors - anopheline mosquitoes 
Mosquitoes are invertebrate arthropods classified under the Order Diptera, Family Culicidae. 
They are efficient vectors of etiological agents for a number of diseases including malaria, 
filariasis, yellow fever, dengue and other arboviruses (Gillies & de Meillon, 1968; Kettle, 
1984). Female mosquitoes are haematophagous and most species are anautogenous, requiring 
nutrients from vertebrate blood for successful egg development.  
 
Human malaria can only be spread by mosquitoes belonging to the Genus Anopheles. There 
are over 420 Anopheles species known worldwide, of which about 60 are natural malaria 
vectors but only half of these are considered to be medically important (Service, 1993). In the 
Afrotropical Region, malaria vectors are dominated by four species: An. gambiae sensu 
stricto (s.s.), An. coluzzii, An. arabiensis and An. funestus. Anopheles gambiae s.s. (hereafter 
referred to as An. gambiae), An. coluzzii and An. arabiensis belong to the An. gambiae 
complex, a group of eight recognized sibling species that are morphologically identical to 
each other (Gillies & Coetzee, 1987; Coetzee et al., 2013). Anopheles funestus belongs to, and 
is the nominal member of another sibling group, which is not quite as morphologically 
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obscure as the An. gambiae complex (Gillies & de Meillon, 1968). 
 
1.5.1 The An. gambiae complex 
The eight currently recognized species of the An. gambiae complex are widespread in Africa 
and the adjacent islands as well as nearby regions of the Arabian Peninsula. These species 
were initially considered to be a single species, Anopheles gambiae, when it was first 
described in 1902, with ecological salt-water variants (Gillies & de Meillon, 1968). 
Subsequent studies of the species showed highly varied biology and behaviour in larval and 
adult stages. The larvae can be found in different water bodies ranging from shallow, open 
sun-lit pools to edges of swamps and brackisk water (de Meillon, 1937; Vincke & Parent, 
1944; Muirhead-Thompson, 1951). The extent of the adults' endophily and anthropophily was 
also highly varied depending on regions where collections were performed (for review, see 
Gillies & de Meillon, 1968).  
 
The saltwater variant in West Africa was the first to be separated from An. gambiae, as it is 
distinctly different at all life stages. This species was named Anopheles melas. Anopheles 
gambiae remained as a single species for over six decades until 1962, when three individual 
publications detailed the separation of the East African saltwater-breeding form from the 
freshwater form (Paterson, 1962; Kuhlow, 1962), and that the freshwater form itself consisted 
of two mating groups (forms A and B) (Davidson & Jackson, 1962). Cross-mating of these 
forms produced sterile males, demonstrating reproductive isolation between them. The East 
African saltwater form was named An. merus, form A remained An. gambiae, while form B 
became An. arabiensis (Mattingly, 1977). A third mating form (form C) was found in southern 
Africa (Paterson, 1964), which is a non-vector for human malaria (White, 1974). This species 
was named Anopheles quadriannulatus (Mattingly, 1977). An Ethiopian variant of An. 
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quadriannulatus was found to be distinctly different cytogenetically from those in southern 
Africa (Hunt et al., 1998) and was recently named Anopheles amharicus (Coetzee et al., 
2013). A seventh species (form D) was confirmed in Uganda, through cross-mating 
experiments and cytogenetic characterization (Davidson & White, 1972; Hunt, 1972). It is a 
highly localized species, and was named Anopheles bwambae, after the region where it was 
found.  
 
The evolution of An. gambiae is still in progress, however, with genetical data showing that 
the species is currently undergoing incipient speciation (Coluzzi, 1984; della Torre et al., 2001; 
Gentile et al., 2001). Although hybrid male sterility from cross-mating was an early key 
feature for separating the cryptic species of the An. gambiae complex, identification by 
analysis of polytene chromosome banding patterns was more practical. Consequently, a large 
volume of data has accumulated with respect to the chromosomal variation in many An. 
gambiae populations across Africa. The changes in banding patterns are the results of fixed 
paracentric inversions, and An. gambiae has the highest complexity of the seven species 
(Coluzzi, 1984). A number of the paracentric inversion polymorphisms on the second 
chromosome have been associated with ecotypic differences in populations. Furthermore, the 
observed frequency of these inversions often deviate significantly from Hardy-Weinberg 
equilibrium and has been linked to incipient speciation within An. gambiae (Coluzzi et al., 
1984). Anopheles gambiae has been divided into five chromosomal forms, based on non-
Linnean nomenclature: Forest, Savanna, Mopti, Bamako and Bissau (Coluzzi et al., 1985). 
Non-random distribution of inversions was observed in these chromosomal forms, particularly 
those on chromosome 2R, and often with significant deviation from Hardy-Weinberg 
equilibrium (della Torre et al., 2001). Although there are no morphological differences nor 
reproductive barriers (under laboratory conditions) between the chromosomal forms, 
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cytogenetic analysis showed little or no intergradation between some of the forms in nature 
(Bryan et al., 1982; Coluzzi et al., 1985; Touré et al., 1983, 1994, 1998). This genetic 
discontinuity is strongest in Mali and Burkina Faso, where Savanna, Mopti and Bamako occur 
in sympatry and no, or very few, heterokaryotypes exist. Analyses of intergenic spacer (IGS) 
and internal transcription spacer (ITS) regions of the ribosomal DNA (rDNA) showed no 
difference between Savanna and Bamako forms, but Mopti is distinctively different from the 
other two (Favia et al., 1997; Gentile et al., 2001). More recent evidence has shown the 
presence of two distinct molecular forms, M and S, that only loosely correlate with the 
chromosomal forms (della Torre et al., 2005). Recently, the M form has been named 
Anopheles coluzzii, making it the eighth named species in the complex, while S form remains 
An. gambiae (Coetzee et al., 2013).  
 
Of the eight species in the complex, An. gambiae, An. coluzzii and An. arabiensis are the 
major malaria vectors, while An. merus, An. melas, and An. bwambae are only considered 
important in certain regions due to their restricted distribution. Anopheles quadriannulatus 
and An. amharicus are non-vector, cattle-feeding species restricted to southern Africa and 
Ethiopia respectively (Gillies & Coetzee, 1987; Sinka et al., 2010). Anopheles gambiae and 
An. arabiensis are the most widespread across the continent while An. coluzzii is found in 
West and Central Africa (Sinka et al., 2010; Coetzee et al., 2013). All three species utilize 
freshwater breeding habitats with An. gambiae and An. arabiensis found in almost any 
temporary water source, ranging from natural depressions where flood or rain water has 
collected, to hoof prints on the edge of ponds, water-filled road ruts and car-tracks. On the 
other hand, An. coluzzii prefers more permanent breeding sites such as flooded rice paddies 
(Gillies & de Meillon, 1968; Sinka et al., 2010; Coetzee et al., 2013). All three species are 
endophilic and anthropophilic (somewhat less so for An. arabiensis), and their evolution 
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seems to have coincided with the settling of humans from hunter-gatherers to permanent 
residency, often exploiting breeding sites made available from human agriculture activities 
(Alvarado, 1963; Powell et al., 1999). The close association of An. gambiae and An. coluzzii 
with human habitations makes them vulnerable to vector control by indoor house spraying 
while An. arabiensis can be found both indoors and outdoors and this difference in resting 
behaviour makes it more difficult to control. 
 
1.5.2  The An. funestus group 
Anopheles funestus is one of nine named (and two as yet unnamed) species in the An. funestus 
Group and is the only significant malaria vector species (Gillies & de Meillon, 1968). It is 
highly endophilic and anthropophilic and breeds in permanent, vegetated swamps or slow-
moving streams. It can become the dominant vector in a region, especially in the dry season, 
when the temporary water sources favoured by the An. gambiae complex species become 
limited (Gillies & de Meillon, 1968). The other members of the group, An. vaneedeni, An. 
leesoni, An. rivulorum, An. parensis, An. fuscivenosus, An. aruni, An. brucei and An. confusus 
are all mostly zoophilic (Gillies & de Meillon, 1968). However, An. rivulorum has been 
implicated as a minor vector in Tanzania (Wilkes et al., 1996; Coetzee & Koekemoer, 2013) 
and An. vaneedeni has demonstrated vectorial capacity in the laboratory but not in nature (de 
Meillon et al., 1977).   
 
Anopheles funestus also possesses paracentric chromosomal inversions like An. gambiae, and 
can also be divided into chromosomal forms based on karyotypes. Populations sampled from 
Burkino Faso showed two chromosomal forms: Kiribina with the standard chromosomal 
arrangement, and Folonzo, which is highly polymorphic for several alternative arrangements 
(Costantini et al., 1999). Sympatric populations of the chromosomal forms deviate 
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significantly from Hardy-Weinberg equilibrium with a marked lack of heterozygotes, 
suggesting that the forms are undergoing incipient speciation similar to the An. gambiae 
situation (Costantini et al., 1999; Guelbeogo et al., 2005). Further investigation will be 
necessary to determine whether these chromosomal forms can be considered good species.  
 
Anopheles funestus is widespread in tropical regions, especially savanna areas, and can thrive 
in closed canopy forests. It is also present on some islands off the African continent (Sinka et 
al., 2010). Due to the high degree of anthropophily and endophily, the species is very 
susceptible to IRS. In most regions, An. funestus has a lower infection rate (2 - 5%) compared 
with An. gambiae, but this is not always the case and infection rates may be over 10% (de 
Meillon, 1933). Its preference for breeding in permanent water bodies also leads to more 
stable An. funestus populations, allowing for year-round endemic transmission of malaria.  
 
Anopheles funestus has a longer generation time compared to members of the An. gambiae 
complex, taking on average two to three weeks from egg to adult and up to a month or longer 
in cooler conditions. The adult is also longer-lived, able to survive up to 40 days. Due to the 
long development time, An. funestus populations usually only start to increase in the middle 
of the wet season and reach a peak at the end of it and into the early part of the dry season 
(Fontenille et al., 1997). This is in contrast to An. gambiae, which undergoes a population 
explosion soon after the first rain and the numbers peak in the middle of the wet season 
(Gillies & De Meillon, 1968). This separation in seasonal abundance is unfortunate, as it 
results in large numbers of vectors throughout large parts of the year in many localities across 
Africa.  
1.6 Vector-parasite interactions 
The complete reliance of Plasmodium species on mosquitoes for a large part of their lifecycle 
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provides opportunities in terms of novel disruption strategies. Even though Huff (1927) 
proposed that mosquito immune responses may be an important determinant for parasite 
infectivity, for the most part it was thought that the mosquito is a passive carrier of the 
parasite. However, new and improved molecular techniques have provided data in recent 
years showing that this is not the case at all.  
 
As mentioned previously, the Plasmodium lifecycle in the mosquito involves both sexual and 
asexual reproduction, and undergoes multiple transformations in order to complete the cycle 
(for review of this, see Ghosh et al., 2000; Sinden, 2002). The parasite must not only first 
survive in the midgut, but also has to traverse two epithelial barriers, and finally successfully 
navigate the haemolymph to arrive at the salivary glands (Abraham & Jacob-Lorena, 2004; 
Siden-Kiamos & Louis, 2004; Vlachou et al., 2004; Michel & Kafatos, 2005). These are 
obvious points where the mosquito‟s immune system can attack the parasite.  
 
Mosquitoes, like all other insects, rely on a well-conserved innate immune system to fend off 
pathogens and foreign microbes. The innate immune system exists in all eukaryotes and is the 
only line of defense for invertebrates against pathogens (Christophides et al., 2002, 2004). 
Two categories of reactions are generated against infections in innate immunity: 
tissue/cellular and humoral responses (Christophides et al., 2004). The first category involves 
what can be considered macroscopic responses, such as phagocytosis, cellular encapsulation 
and induction of apoptosis. It can also include physical barriers like the peritrophic matrix and 
midgut epithelium that the invading organisms have to traverse. The humoral, or molecular 
responses are much more sophisticated, involving multiple steps and elicit a variety of 
responses to deal with pathogens. Potential pathogens are identified through conserved 
pathogen-associated molecular patterns (PAMPs), which are capable of non-self recognition. 
22 
 
These then interact with host pattern recognition receptors (PRRs) which may be cell-bound 
or circulating in the haemolymph. These receptors are able to activate a diverse range of 
responses including antimicrobial peptides (AMPs) and proteolytic cascades (of which 
melanization is a part). Signal transduction pathways are also engaged in immune responses, 
two of which – Toll and Imd (Immunodeficient) pathways – are nuclear factor kappa B (NF-
κB) related, and the third, the JAK/STAT pathway acts through kinase and proteins of its 
namesake (for reviews of these pathways, see Christophides et al., 2004; Lehan et al., 2004; 
Cirimotich et al., 2010).  
 
In anophelines, the PRRs that have been shown to be involved in Plasmodium infection 
include peptidoglycan recognition proteins (PGRPs), thioester containing proteins (TEPs), C-
type lectins (CTLs), and Gram-negative binding proteins (GNBPs). PGRPs are the most well 
known insect PRRs; they participate in AMP synthesis, melanization cascade, and 
phagocytosis of Gram-negative bacteria. In Anopheles, knockdown of PGRPLC (a member of 
PGRP) not only increases oocyst numbers, but also infection prevalence and percentage of 
melanized oocysts (Meister et al., 2009; Michel & Kafatos, 2005). Fifteen TEPs have been 
identified in the An. gambiae genome thus far and are typically active during bacterial 
infection. Several of them have also been shown to be upregulated after Plasmodium infection 
(Blandin et al., 2004; Christophides et al., 2002). Among these, TEP1 has been shown to 
interact with P. berghei ookinetes, leading to parasite killing by lysis in the basal labyrinth of 
the midgut epithelium (Blandin et al., 2004). CTLs are involved in bacterial responses by 
promoting phagocytosis, haemocyte nodule formation, and activation of prophenoloxidase 
(PPO), which leads to melanization. RNA silencing of two CTL genes, CTL4 and CTLMA2, 
showed significant increase in melanization of P. berghei ookinetes in An. gambiae (97% and 
48% respectively) (Osta et al., 2004). Although GNBPs are induced in the midgut and 
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salivary glands at the different parasite stages (Dimopoulos et al., 1998), there has been little 
evidence to show that they have significant impact on parasite development. 
 
The Toll and Imd pathways are highly conserved in insects (Hoffmann, 2003). Intracellular 
components of both pathways have been identified in An. gambiae (Christophides et al., 
2002), and are primarily involved in immune responses (Toll is also responsible for 
embryogenesis in Drosophila). The Toll pathway is induced by Gram-positive bacteria and 
fungal infections, whereas Imd is involved in Gram-negative bacteria infections. Activation of 
either pathway triggers movement of the REL (a NF-κB-like protein)/NF-κB transcription 
factor families into the nucleus, which recruit other proteins into the nucleus and degrade 
inhibitor proteins of the pathway to allow the signal cascade to continue. This leads to the 
production of antimicrobial peptides that are primarily effective against bacteria, but recent 
research has shown that certain AMPs are able to interact with Plasmodium parasites as well. 
The JAK/STAT pathway acts through a separate set of proteins and receptors – the janus 
kinase (JAK) and signal-transducer and activator of transcription protein (STAT) – to respond 
to bacterial infection (Agaisse & Perrimon, 2004). This pathway‟s participation in insect 
immunity was first demonstrated in An. gambiae (Barillas-Mury et al., 1999).   
 
Antimicrobial peptides are small, positively charged peptides, produced in fat bodies, 
haemocytes and epithelia. They are released in high concentration into the haemolymph upon 
bacterial or fungal infection (Hoffmann et al., 1996). The AMPs bind to the cell walls of 
micro-organisms and are thought to kill by causing lethal damage to the membrane. Four 
classes of AMPs have been discovered in An. gambiae so far: defensins, cecropins, gambicins 
and attacins. In vitro experiments where infected mosquitoes were directly injected with 
synthesized or non-anopheline AMPs showed these molecules can affect oocyst development 
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(Gwadz et al., 1989; Shahabuddin et al., 1998). Subsequent experiments have shown that this 
is usually the case in vivo. Transgenic An. gambiae expressing cecropin A (or cecropin 1) 24 
hours after a bloodmeal reduces oocyst number by 60% (Kim et al., 2003). Gambicin, a novel 
AMP discovered in An. gambiae is able to act on both Gram-positive and Gram-negative 
bacteria and has marginal lethality against P. berghei (Vizioli et al., 2001). The one peptide 
that has not shown any inherent anti-plasmodial property is defensin 1 (defA) (Blandin et al., 
2001), even though exogenous infusion of the peptide indicated otherwise (Shahabuddin et al., 
1998).  
 
Proteolytic cascades, which involve serial activation of serine proteases, are also able to 
initiate the Toll pathway and can cleave PPO zymogen to trigger melanotic encapsulation, 
which immobilizes and kills the pathogen with free radicals and toxic intermediates that are 
generated during the encapsulation process (Osta et al., 2004; Michel et al., 2005). Inhibitors 
for these serine proteases thus have significant impact on the mosquito‟s immunity. There are 
at least 27 known families of serine protease inhibitor (Patston, 2000); in anophelines, the 
most important is the serpin family. Serpins 1 - 3 are orthologous to Drosophila 
melanogaster‟s Spn27A, and silencing Serpin 2, the functional ortholog, reduces P. berghei 
oocysts (Michel et al., 2005). Encapsulation can also occur through aggregation of 
haemocytes around the pathogen, but this has not been reported with Plasmodium oocysts. 
Lastly, phagocytosis may play a role in eliminating the parasite, but the only evidence for this 
thus far is in an unnatural pairing of Ae. aegypti and P. gallinaceum, where phagocytosis of 
the sporozoites by the granulocyte subpopulation of the mosquito was the primary immune 
mechanism (Hillyer et al., 2003).  
 
The immune responses are a critical factor in determining the viability of vector-parasite 
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pairing in both nature and laboratory setting. Such a response is obvious in the L3-5 mosquito 
strain, bred from a normally parasite-friendly An. gambiae strain, which melanizes P. berghei 
and allopatric strains of P. falciparum ookinetes (Collins et al., 1986), or the lysis of P. 
gallinaceum ookinetes in the An. gambiae SUAF2 strain (Vernick et al., 1995).  
 
Aside from the more obvious interactions between the mosquito immune mechanism and 
parasite invasion, there are also genetic components of the mosquito's resistance to the 
Plasmodium parasite, and natural resistance alleles seem to occur at high frequency in some 
areas (Niare et al., 2002). As mentioned earlier, the An. gambiae genome is littered with a 
large number of paracentric chromosomal inversions. One such inversion, 2La, not only has a 
role in ecotypic adaptation for the species (Powell et al., 1999), is associated with insecticide 
resistance (Brooke et al., 2000), but also contains genes and loci that influence immune 
responses to Plasmodium infection. Four Plasmodium-resistance loci influencing 
melanization or infection intensity have been found within or near the inversion, and this 
region is considered a major Plasmodium-resistance island (PRI) of the An. gambiae genome 
(Riehle et al., 2006). Furthermore, the PRI was also found to include two novel leucine-rich 
repeat (LRR) proteins, named Anopheles-Plasmodium-responsive leucine-rich repeat 1 (APL1) 
and 2 (APL2). The APL1 protein was shown to have anti-oocyst activity, further implicating 
the PRI's role in the immune response against Plasmodium infection (Riehle et al., 2006).  
 
1.7 Rationale 
There is no doubt that malaria remains one of the deadliest infectious diseases in the world, 
but current efforts in reducing the burden are severely limited by resistance from the parasite 
and the vector to drugs and insecticides, respectively. Better understanding of the biological 
interactions between the vectors and parasites is necessary to discover new avenues for 
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disrupting transmission. Of the two primary African malaria vector species, An. gambiae and 
An. funestus, the former has been studied in great detail, even though much remains unknown, 
particularly with respect to molecular mechanisms in presence of the Plasmodium. The lack 
of data is even greater with An. funestus, primarily due to the lack of success in colonizing 
this species.  
 
Numerous mosquito species have been tested to determine whether they are viable vectors for 
P. berghei. There are a number of human malaria vectors that can carry P. berghei 
successfully (An. gambiae, An. quadrimaculatus and An. stephensi), but An. funestus was 
classified as a non-vector in an experimental situation (van den Berghe, 1954; Vincke, 1954). 
However, there have been no other recorded attempts after these early studies to show that the 
species is indeed a vector/non-vector (but see below). This is particularly important if one 
considers the advances that have been made in the re-classification of the Afrotropical 
mosquito species in the last five decades. With the separation of both An. gambiae and An. 
funestus into distinct species complexes or groups, revision of what is considered vectors and 
non-vectors would be essential to further research. It is likely that An. funestus is actually a 
viable vector for P. berghei, as other human malaria vectors are often compatible with non-
human malaria parasites, albeit not at an efficient level (Alavi et al., 2003) and indeed, this 
has been demonstrated in An. funestus twice this year (Xu et al., 2013; Lo & Coetzee, 2013), 
the latter paper being a product of research for this thesis. 
 
It has been mentioned previously that there are discrepancies between data from P. falciparum 
and P. berghei infections in the same vectors. Furthermore, given the view that each vector-
parasite pairing would generate a unique pattern of interaction between the two organisms 
(Sinden et al., 2004), it would be illogical to expect that P. berghei would generate the same 
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responses in An. gambiae and An. funestus. It is therefore of utmost importance to establish a 
viable and replicable infection system using An. funestus and P. berghei to enable 
investigations of the interactions between them and to compare these with similar interactions 
in An. gambiae.  
 
The establishment of two An. funestus colonies by the Department of Medical Entomology, 
South African Institute for Medical Research (now Vector Control Reference Laboratory 
(VCRL) at the National Institute for Communicable Diseases), Johannesburg, South Africa, in 
2000 (Hunt et al., 2005) has opened up new research options, one of which is the creation of 
an infection model in this important malaria vector that previously was unattainable. In 
addition, numerous strains of members of the An. gambiae complex are currently being 
maintained at the VCRL which made the research listed below a viable option.  
 
1.8 Aims and Objectives 
1. To set up an infection system using strains of An. gambiae and P. berghei. 
2. To optimize and establish an infection system using An. funestus and P. berghei, and 
characterize the infection cycle. 
3. Screen the infectivity of the colonies available in the VCRL Botha de Meillon insectary 
using the infection model. 
4. Optimize the 2La inversion molecular karyotyping technique for An. gambiae colonies 
and determine if the inversion has any association to Plasmodium infection in local strains.  
5. Determine expression profiles of selected immunity genes during P. berghei infection in 
the various An. funestus colonies.  
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Chapter 2: The Anopheles-P. berghei infection system 
 
2.1 Introduction 
The first rodent malaria parasite was found in the Congo in the region of Katanga, and 
described and named P. berghei by Vincke and Lips (1948). Its natural vector, Anopheles 
dureni was described a decade earlier, and later found to be infected with sporozoites, but the 
association between the mosquito and the parasite was only made in the early 1950s 
(Garnham, 1966; Bruce-Chwatt, 1978). In spite of knowing both the vector and the parasite, P. 
berghei only became a viable research model after another decade of intensive research, after 
obstacles to cyclical transmission were resolved (Vanderberg, 1964; Yoeli, 1965). Since then, 
the use of P. berghei in malaria research has been one of paramount importance, providing 
significant contributions to knowledge of mosquito and parasite immunology and 
chemotherapy (Bruce-Chwatt, 1978).  
 
The susceptibility of a large number of Anopheles mosquitoes to this Plasmodium species 
(Sinden et al., 2002) has allowed establishment of numerous in vivo infection systems to 
investigate vector-parasite interactions on both a physiological and molecular level. However, 
although An. funestus is a major African malaria vector, data on vector-parasite interactions 
are severely lacking, primarily due to the absence of viable laboratory colonies. Hunt et al. 
(2005) were successful in establishing colonies of An. funestus from Angola (colony 
designated FANG) and Mozambique (colony designated FUMOZ) that are currently 
maintained in the NICD insectaries in Johannesburg. The FANG strain is fully susceptible to 
all insecticides while FUMOZ was established from a wild population that is resistant to 
pyrethroids and carbamates. Through selection over successive generations, a strain 
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(FUMOZ-R) has been established that is almost 100% resistant to permethrin (a pyrethroid 
used for treating bed nets) (Hunt et al., 2005).  
 
In addition, the NICD houses over a dozen Anopheles gambiae complex colonies (see 
Appendix 1). These include An. gambiae (ranging from G3 established by the London School 
of Hygiene & Tropical Medicine in 1975 from Gambian material (Malaria research and 
reference reagent centre, http://www.mr4.org) to TONGS from Cote d‟Ivoire that was 
established just over a year ago), An. arabiensis (KGB established over 35 years ago to 
AMAL established last year), An. merus and An. quadriannulatus. A number of these strains 
(especially the older An. gambiae strains such as G3 and PALA) have been used as 
experimental vectors successfully in laboratory settings elsewhere (Al-Mashhadani et al., 
1980; Collins et al., 1985). However, successful infection of a strain reared in one laboratory 
is no guarantee that infection will occur in other laboratories as it is known that genetic 
composition of a strain will change over time (Chevillon et al., 1995; Scarpassa et al., 2008; 
o‟Donnell & Armbruster, 2010). Therefore the infectivity status of the VCRL colonies needed 
to be established in order to identify appropriate strains to be used as controls for the various 
experiments carried out in this study.  
 
Substantial information exists for setting up an infection system using P. berghei with An. 
gambiae complex colonies. The one recorded attempt at infecting An. funestus with P. berghei 
(van den Berghe, 1954) used wild caught populations and was carried out at a time when the 
critical development temperature for the parasites (19 - 20°C) was unknown. The present 
study, therefore, aimed to establish a functional P. berghei infection system and test the 
infectivity of the An. gambiae complex strains available at the NICD. The process would then 
be adapted to infecting An. funestus with P. berghei, which would provide proper clarity on 
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whether An. funestus is a viable vector for the rodent malaria parasite, and if so, how effective 
the species is in hosting parasite development.  
 
2.2 Materials and methods 
 
2.2.1 Establishment of An. funestus susceptible colony 
In order to assess any possible confounding influence of insecticide resistance on mosquito 
infectivity, the An. funestus base colony FUMOZ, which is partially resistant to pyrethroids 
but not under any selection pressure, was back-selected to establish a susceptible strain. Forty 
individual females were randomly selected from the general FUMOZ colony and placed into 
separate egg-laying vials. The vials had wet filter paper on the bottom to collect the eggs, and 
the females were provided with a bloodmeal every two to three days until their deaths. Eggs 
collected from each female were reared separately through to adulthood, at which point half 
the population from each egg batch were exposed to 0.75% permethrin for one hour, per 
WHO exposure assay protocols (WHO, 1998). The knockdown was recorded immediately 
after exposure and deaths were recorded after 24 hours. The offspring from each egg batch 
that were considered susceptible (greater than 85% mortality) were pooled together in a cage 
for mating. The new colony was designated FUMOZ-BS (Back Selection) and was 
maintained at standard insectary conditions (25 ±2°C, 80 ±10% relative humidity, and 12 
hours light/dark cycle with intermediate 30 minutes dusk/dawn cycle). The colony was given 
access to guinea pigs for bloodfeeding two to three times a week, and the females were 
allowed to lay eggs twice a week to continue the colony. A separate back selection process 
was performed when FUMOZ-BS reached the 10
th
 generation (F10) to supplement and 
increase the colony numbers.  
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2.2.2 Mice infection 
The mice infection followed established protocols (Sinden et al., 2002) with some 
modifications. Plasmodium berghei ANKA strain was obtained from Imperial College, 
London (courtesy of Prof. R. Sinden) and also from MR4 (MRA-311) and stored in liquid 
nitrogen until needed. Infected blood with parasitaemia of at least 10% or higher was used to 
initiate infection in the mice. The laboratory mouse strain C57BL/6 (C57 Black strain 6) was 
used as the vertebrate host for the parasite infection. Three to four days prior to being used for 
mosquito feeding, 0.2 - 0.3 ml of the infected blood was injected intra-peritoneally (IP) into 
six to eight weeks old female mice. On the day of feeding the mosquitoes, the mice were 
anaesthetized (Rompun [2% Xylazine HCL 20 mg/ml] + Anaket [Ketamine 
hydrochloride 100 mg/ml], 1:1 mixture; 0.2 - 0.3 ml per mouse), and placed on top of the 
cages for a minimum of 15 minutes for bloodfeeding. The infected mice were maintained at 
standard conditions for rodents (20 ±1°C, ~50% relative humidity (RH)) with constant access 
to food and water.  
 
To monitor the parasitaemia in the infected mice, thin blood smear slides were prepared at 
least every alternate day after feeding the mosquitoes. The blood smear slides were air-dried, 
fixed with absolute methanol for 10 - 20 seconds, and allowed to air dry again. The slides 
were stained with Giemsa (10% Giemsa in Giemsa buffer) for 20 - 30 minutes then washed 
with slow running water and left to air dry. The parasites were observed under 600 - 1,000X 
magnification using light microscopy. To determine the parasitaemia level, infected cells were 
counted from at least 1,000 red blood cells (RBCs) to give a percentage infection.  
 
When the parasitaemia was over 10% (typically 9 - 13 days after infection), the mice were 
anaesthetized using the same mixture as previously described, and sacrificed by cardiac 
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puncture. Blood was drawn directly out of the heart using a 22G needle and 1 ml syringe. A 
small volume of freezing solution (30% glycogen-PBS solution) was used to prevent 
coagulation during the cardiac puncture. The blood was mixed at a 2:3 volume ratio with 
freezing solution, and stored in liquid nitrogen in cryogenic vials (Corning, New York, USA). 
The blood was placed in liquid nitrogen storage within 20 minutes of removal from the mouse 
to minimize death and damage to the parasites. The infected blood stocks were stored 
indefinitely in liquid nitrogen until needed. If the blood was not needed, the mouse was 
terminated using carbon dioxide.  
 
Direct blood passage was the easiest method for infecting the mice, but cyclical transmission 
was also necessary, as it was not recommended to use direct blood passage stock for infection 
more than eight times in succession (Sinden et al., 2002). Infected mosquitoes were allowed 
to feed on healthy mice 18 - 21 days after the infected bloodmeal. The mice infected in this 
way were also monitored using blood smears, and were sacrificed five to seven days after the 
feeding. Storage of the P0 blood was in the same manner as described above.  
 
Ethical clearance for the use of mice for P. berghei infection was obtained from the NICD 
animal ethics committee (ethical clearance number: 110/07, 2007) and a copy provided on 
page iv.   
 
2.2.3 An. gambiae infection 
Anopheles gambiae infection was performed using the established protocols of Sinden et al. 
(2002). The An. gambiae G3 strain, known to carry P. berghei infection in other studies 
(Collins et al., 1986; Crews-Oyens et al., 1993; Brey et al., 1995; Abraham et al., 2005) was 
used initially to establish the infection system. Seventy to ninety newly eclosed female 
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mosquitoes were collected from the colony, maintained at standard insectary conditions, given 
sugar water (10% w:v) as sustenance, and left for three to four days before feeding. Sugar 
water was removed 18 - 24 hours prior to feeding, to starve the females and maximize the 
number of females that would feed on the mice. At the same time, the mosquitoes were 
moved to a cooler insectary room to facilitate the parasite development (20 ±1°C, 85 ±10% 
RH).  The mosquitoes were allowed to feed on the mice for a minimum of 15 minutes to 
maximize the feeding numbers and feeding to repletion. Females that had not fed were 
removed from the cages. Four to six days after the initial feed, the mosquitoes were again 
starved overnight, and allowed to feed for a second bloodmeal. Feeding rates were calculated 
based on the number of females that did feed against the total number of females offered a 
bloodmeal.  
 
The bloodfed females were kept at 20 ±1°C, 85 ±10% RH for at least 16 days, during which 
time they were provided with sugar water for sustenance. After 16 days, the salivary glands 
were dissected to screen for sporozoite presence using light microscopy (see section 2.2.5). 
Mosquitoes were considered infective if sporozoites were detected in the salivary glands. 
When necessary, infective populations were allowed to feed on a healthy mouse to initiate 
cyclical transmission as described above. The infection rates were calculated based on the 
number of females that had infected salivary glands against the number of females that took a 
bloodmeal. 
The three An. gambiae complex species that are considered malaria vectors were tested (An. 
gambiae s.s, An. arabiensis and An. merus) as well as the non-vector member An. 
quadriannulatus. The following colonies were tested: BOA, CIG, G3, GAH, IANP20, NAG, 
PALA, SUA (An. gambiae s.s.); SANGWE (An. quadriannulatus); ARER, KGB, MA, 
MALPAN, MBN-DDT (An. arabiensis); MAF and ZAM (An. merus) (see Appendix 1). 
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Infection for all colonies was performed at least three times to determine whether they were 
viable hosts. Colonies that were able to carry the parasites were infected at least three more 
times to determine their competence as vectors.  
 
2.2.4 An. funestus infection 
Anopheles funestus was tested for infection in a similar manner to An. gambiae infection. 
Newly eclosed An. funestus adult females were maintained in the same way as An. gambiae, 
but were kept for 10 - 14 days at standard insectary conditions, before being moved to the 
cooler conditions and deprived of sugar water prior to feeding on infected mice. The females 
were also given a second bloodmeal four to six days after the infected bloodmeal. Dissection 
of midguts for oocysts started 10 days after the infected bloodmeal, and salivary gland 
dissections for sporozoites from 18 days after infected bloodmeal (see section 2.2.5).  
 
Both An. funestus base colonies (FUMOZ and FANG) were initially tested. The more 
susceptible of the two, FUMOZ, was used for further infection experiments along with the 
colonies selected from FUMOZ (FUMOZ-R permethrin-resistant and FUMOZ-BS 
permethrin-susceptible). All the An. funestus colonies were infected at least three times to 
determine their vectorial capacity. Feeding and infection rates for An. funestus colonies were 
calculated in the same manner as for An. gambiae colonies. A cohort of F1 females reared 
from eggs produced by wild caught An. funestus from Ghana were also subjected to feeding 
on infected mice. The feeding experiment for this cohort was only performed once as only a 
small number of adults were available. Two-sample T-tests and one-way ANOVA using the 
Statistix 7 analysis software (Analytical Software, USA) were performed to compare the 
feeding and infection rates between the strains, as well as to compare the oocyst and 
sporozoite numbers. 
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2.2.5 Mosquito dissection 
Dissections were carried out according to the protocols set out in A practical guide for 
malaria entomologists in the African region of WHO (WHO, 1961) and MR4 methods in 
Anopheles Research Laboratory Manual (version 5.2, 2009). Bloodfed An. funestus females 
were dissected at two time points to determine the appearance of the different life stages of 
the parasite. The midguts were dissected from 10 days post-infected bloodmeal for oocysts, 
while the salivary glands were dissected from 16 days post-infected bloodmeal for sporozoites. 
Anopheles gambiae were only dissected for sporozoites to confirm infection.  
 
To dissect the midgut, the mosquito was knocked out using ether and placed on a drop of PBS 
buffer on a glass slide. The legs and wings were removed for easier access (and also to 
prevent the mosquito from escaping if it woke up prematurely). Under 25 - 50X magnification, 
the thorax and abdomen were first separated and an incision was made at the second last 
segment of the abdomen. The posterior end of the midgut was pulled out by slowly separating 
the last segments from the main sections of the abdomen. The midgut was cleaned by 
removing the attached Malphigian tubules, and then moved to a new slide and resuspended in 
a drop of PBS. A coverslip was gently placed onto the slide and the midgut observed under 
100 - 400X magnification for oocysts.  
 
In some instances, the midgut was stained in 1% mercurochrome for 20 minutes to emphasize 
the oocysts. Excess mercurochrome was then washed off with PBS, the midgut resuspended 
in PBS on a new slide, and observed under the same magnification as above.  
 
For salivary glands dissection, the mosquitoes were knocked out and treated on the slide in 
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the same manner as for the oocyst dissection. The head and the thorax were separated using 
dissecting needles under 25 - 50X magnification and the salivary glands, a pair of almost 
transparent trilobular structures, were gently teased out from the tissues. As much of the 
surrounding tissue was removed as possible, while taking care not to break the glands. The 
salivary glands were moved to a clean slide and resuspended in a drop of PBS. A coverslip 
was gently placed onto the slide and the salivary glands observed under 400 - 600X 
magnification for sporozoites. It was sometimes necessary to gently press or tap on the 
coverslip to rupture the salivary glands to detect the sporozoites.  
 
2.3 Results 
 
2.3.1 An. gambiae complex infections 
A number of An. gambiae complex colonies of different species and from different localities 
were tested to see whether they could carry the infection. In general, they required little 
incentive to feed on the mice and often fed to repletion with 15 minutes. Although previous 
infection data with other Anopheles mosquitoes (An. quadrimaculatus and An. stephensi) 
suggest the adults reared and maintained at 21°C, or moved to 21°C after eclosure feed better 
(Yoeli, 1965), the An. gambiae complex colonies at the VCRL actually fed better when they 
were first maintained at standard insectary temperature, and only moved to the cooler 
temperature at the time when the sugar water was removed. Immediate exposure to the cooler 
temperature after emerging from pupae led to a 10 - 20% decrease in feeding rates compared 
to those held at the higher temperatures. At the lower temperature, the lifespan of An. gambiae 
s.l. was extended, with individuals surviving past 40 days after eclosure. Dissections of the 
salivary glands of some these individuals showed that sporozoites were still present.   
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Comparing species, the An. gambiae s.s. colonies in general fed the best with 40 - 50% 
feeding rates, and also had the highest infection rates (above 10%) (Table 2.1). However, 
there were also two An. gambiae colonies that were resistant to P. berghei infection, both from 
Nigeria (Table 2.1). Anopheles arabiensis colonies were less successful at feeding and also 
had lower rates of infection, typically below 5%. The two An. merus colonies fed at rates 
comparable to An. gambiae, but infection was below 5%. Lastly, An. quadriannulatus had one 
of the lowest feeding rates and was completely resistant to infection (Table 2.1).  
 
The strain most frequently used for P. berghei infection (for cyclical transmission and as a 
positive control) was G3, as it had both the highest feeding and infection rates. More recently 
established colonies (SUA, GAH, COG) were also easy to infect, and showed consistently 
higher levels of infection (10 - 20%) compared to the other strains (usually below 5%), and 
the latter group often required multiple attempts to achieve successful infections. These three 
colonies were also used for cyclical transmission and as positive controls if G3 was 
unavailable for any reason.  
 
Plasmodium berghei infection in An. gambiae complex colonies was consistent with 
published data. Midguts were not examined for oocysts as the lifecycle in An. gambiae is well 
known, therefore data regarding the oocysts were not collected. The earliest time-point when 
the sporozoites were seen was 14 days post bloodmeal, in G3, but sporozoites were usually 
detected in the salivary glands around 16 days after feeding. 
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Table 2.1: An. gambiae complex colonies feeding and infection rates.  
 
Species 
 
Colony  
(sample size, n =) 
Average 
percentage fed 
(±std dev) 
Average percentage 
infected 
(±std dev) 
An. gambiae BOA (225) 35.6 (±2.9) 2.5 (±2.1) 
“ CIG (247) 48.6 (±8.5) 4.3 (±1.8) 
“ COG (270) 45.9 (±6.4) 10.7 (±4.4) 
“ G3 (265) 51.7 (±7.4) 35.1 (±12.1) 
“ GAH (244) 46.5(±8.4) 21.9 (±8.9) 
“ IANP20 (246) 45.9 (±5.1) 6.3 (±1.8) 
“ NAG (237) 36.6 (±5.7) 0.0 
“ PALA (233) 36.9 (±4.0) 0.0 
“ SUA (267) 45.4 (±10.8) 20.7 (±5.9) 
An. arabiensis ARER (229) 24.0 (±4.7) 2.2 (±3.8) 
“ KGB (247) 38.4 (±35.8) 3.8 (±2.8) 
“ MA (238) 25.8 (±9.1) 5.4 (±2.2) 
“ MALPAN (223) 24.2 (±6.4) 4.3 (±3.8) 
“ MBN-DDT (215) 27.4 (±2.7) 1.8 (±1.6) 
An. merus MAF (219) 37.8 (±2.3) 2.5 (±2.4) 
“ ZAM (213) 31.4 (±8.3) 3.8 (±3.1) 
An. quadriannulatus SANGWE (235) 27.7 (±2.1) 0.0 
 
 
 
2.3.2 An. funestus infections 
Based on data obtained from infection of the An. gambiae complex colonies, P. berghei 
infection was tested on the two base An. funestus colonies, FANG and FUMOZ. The initial 
results showed that FUMOZ was the better colony for infection as it not only fed better on 
mice, but was also more prone to Plasmodium infection (Table 2.2). The feeding and infection 
rates between FANG and FUMOZ were significantly different (p<0.01). The F1 progeny 
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obtained from wild caught An. funestus fed at an extremely low rate even with starving. There 
was no infection found in the bloodfed females in this cohort. Although An. funestus females 
could be persuaded to feed on mice three to four days after eclosure, those that did were in the 
vast minority (typically less than 5% of the cohort). To achieve maximum feeding rates, the 
females were left for at least 10 - 14 days before being allowed to feed on infected mice. The 
females were maintained at standard insectary conditions during this time as the feeding rate 
also decreased, like An. gambiae colonies, if they were maintained at 21°C
 
immediately after 
eclosure.  
 
Table 2.2: An. funestus base colonies and F1 progeny (Ghana) feeding and infection rates. 
Colony (n =) Average percentage fed 
(±std dev) 
Average percentage infected 
(±std dev) 
FANG (567) 30.3 (±3.7) 4.6 (±1.2) 
FUMOZ (622) 42.2 (±4.5) 10.4 (±3.9) 
Ghana F1 (195) 3.0 (±1.5) 0.0 
 
Just prior to feeding, the females were disturbed by gentle tapping on the cage and by 
exhaling into the cage. These steps were often necessary to coax An. funestus into feeding on 
the mouse even after being deprived of sugar water. Anopheles funestus took longer to feed to 
repletion compared with An. gambiae, usually requiring 15 - 20 minutes to do so. The lower 
temperature for parasite development also lengthened An. funestus lifespan, and adults living 
for more than 40 days after eclosure were common as long sugar water was provided. 
Females that lived longer than 60 days have been observed, but they were in the minority.  
 
Based on these data, subsequent infection experiments thus only utilized FUMOZ and its 
derivative colonies. The feeding rates in the FUMOZ strains were better than in the An. 
gambiae colonies, but the infection rates varied significantly, with the base colony having an 
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infection rate comparable to the best of the An. gambiae infections, and the FUMOZ-R colony 
with the lowest infection rate (Table 2.3).    
 
Table 2.3: An. funestus FUMOZ and variant colonies' feeding and infection rate 
Colony (n =) Average percentage fed 
(±std dev) 
Average percentage infected 
(±std dev) 
FUMOZ (1968) 52.1 (±4.1) 20.4 (±7.8) 
FUMOZ-R (2139) 46.6 (±3.3) 6.1 (±5.6) 
FUMOZ-BS (2023) 50.7 (±3.8) 15.4 (±6.3) 
 
To visualize the oocysts, mercurochrome staining was typically the recommended method. 
However, the staining was found not to be very useful here as the whole midgut is stained red 
and the oocysts were only stained a little more strongly than their surroundings (Figure 2.1).  
 
 
Figure 2.1: Infected midgut stained with 1% mercurochrome. The oocyst is visible as a 
doughnut shaped structure (phase contrast, 400X magnification). 
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Normal visualization was often sufficient for identifying oocysts, and it was sometimes easier 
to visualize all the oocysts by manipulating the phase contrast filters (Figures 2.2 and 2.3). 
Differential interference contrast microscopy was also used to examine the oocysts, and was 
useful in producing more definitive imaging of sporozoites within oocysts (Figure 2.4). 
Oocysts were seen on the midgut from around day 10 and persisted past day 20. Plasmodium 
berghei oocysts were 30 - 40 μm in diameter, and were not concentrated in a specific region 
of the midgut. Depending on how far the development was, immature sporozoites could be 
seen as faint lines within the oocysts (Figures 2.1, 2.3 - 2.5). By rupturing the oocysts, 
sporozoites under development could be seen attached to the blastophores (Figure 2.6), 
ranging from first stages of development to the almost mature vermicule form (Figure 2.7). 
Loose immature sporozoites that had yet to achieve the typical crescent shape were also 
released in the rupturing.  
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Figure 2.2A: Midgut dissection of An. funestus at 20 days post-infected bloodmeal (phase 
contrast, 100X magnification). 2.2B: The same midgut as the previous figure, but captured 
with the phase contrast filters out of alignment, which emphasized the oocysts as darker 
circles (ventral side) or lighter circles (dorsal side). Arrows are pointing out some of the 
oocysts. 
A 
 
B 
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Figure 2.3: Oocysts on An. funestus midgut under phase contrast microscopy. The oocysts are 
at different stages of maturation, as some can be seen containing immature sporozoites while 
others have indistinct dark contents (400X magnification). 
 
 
Figure 2.4: An unbroken oocyst detached from the midgut. Developing sporozoites can be 
seen within as short, black lines (phase contrast, 400X magnification). 
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Figure 2.5: A mature oocyst on An. funestus midgut under differential interference contrast 
microscopy. The sporozoites can be seen as short vermicules completely filling the interior 
(400X magnification). 
 
 
Figure 2.6: Immature sporozoites attached to a large blastophore in the midgut. The 
blastophore may have become distended when the midgut was ruptured. Smaller blastophores 
are also present, along with loose, immature sporozoites that have not achieved the crescent 
form (phase contrast, 400X magnification). 
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Figure 2.7: Sporozoite assembly on the blastophores from burst oocysts in a ruptured midgut. 
Sporozoites of at different stages of development can be attached to blastophores, ranging 
from nascent circular forms to short immature vermicules (phase contrast, 400X 
magnification). 
 
Interestingly, dissections of the midguts from infected females showed there were 
incongruencies in the infection rate and oocyst numbers in FUMOZ and FUMOZ-BS. The 
higher infection rate in FUMOZ was not a direct correlation with oocyst numbers, as 
FUMOZ-BS had significantly higher average number of oocysts (Table 2.4). When the data 
were broken down further, it was noted that FUMOZ typically had low numbers of oocysts, 
but had a wide range, with some individuals carrying more than 50 oocysts. On the other hand, 
FUMOZ-BS was capable of carrying a high number of oocysts with the majority supporting 
50 or more oocysts on the midgut.  
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Table 2.4: Comparison of oocyst load in FUMOZ strains. 
Colony (n = ) Average oocyst numbers 
(±std dev) 
Oocyst numbers 
1 - 10 11 - 30 31 - 50 51 - 100 
FUMOZ (59) 25 (±35) 58% 10% 0 32% 
FUMOZ-R (64) 8 (±7) 81.3% 18.7% 0 0 
FUMOZ-BS (65) 55 (±28) 0 0 38.5% 61.5% 
 
Compared to An. gambiae, An. funestus salivary glands were approximately 40 - 60% smaller 
(Figure 2.8), but were still able to carry P. berghei. While infected salivary glands were fairly 
resistant to mechanical motions during the dissection process, the application of a coverslip 
once the glands were on the slide tended to rupture them (over 90% of the time), no matter 
how gently the coverslip was placed. Whenever possible, both salivary glands were extracted 
for observation. In these instances, if one salivary gland was observed to be infected, the other 
would be as well. Plasmodium berghei sporozoites were usually 12 - 14 μm in length, and 
concentrated in the two longer lateral lobes of the salivary glands, particularly in the distal 
cul-de-sac (Figure 2.9). Sporozoites were only detected higher up the lateral lobes in FUMOZ 
and FUMOZ-BS if the sporozoite count was high. No sporozoites were observed in the 
medial lobe at any point. The earliest time when sporozoites were observed was 16 days post 
infected bloodmeal, in FUMOZ. Sporozoites were typically detected in the salivary glands 
after day 18, and sometimes as late as day 22. The sporozoites in the salivary glands had the 
classical crescent shape (Figure 2.10), and were often packed densely on top of each other 
(Figure 2.11). 
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Figure 2.8: Uninfected An. gambiae (A) and An. funestus (B) salivary glands. Anopheles 
funestus salivary glands are at least 40 - 60% smaller those of than An. gambiae 
(dissection/light microscope, 100X magnification). 
A 
 
B 
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Figure 2.9: Uninfected (A) versus infected (B) An. funestus salivary gland. The sporozoites 
are clustered in the distal end of the lateral lobes, causing opaqueness compared to the 
transparent lobes in uninfected gland. Some loose sporozoites can be seen near the lateral 
lobes, indicated by the arrows (phase contrast, 100X magnification).   
B 
 
A 
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Figure 2.10: A partially ruptured An. funestus salivary gland. The P. berghei sporozoites have 
the mature crescent form. A significant percentage of the sporozoites are at different focal 
planes, leading to the faint, unfocused crescent shapes scattered throughout the image (phase 
contrast, 400X magnification). 
 
 
Figure 2.11: Sporozoites released from a fully ruptured An. funestus salivary gland. A 
percentage of the sporozoites are seen still packed tightly on top of each other (phase contrast, 
400X magnification). 
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In terms of sporozoite counts in the salivary glands, the numbers corresponded with the 
oocyst count, with FUMOZ-BS carrying a very high number in the salivary glands, while 
FUMOZ and FUMOZ-R had much lower sporozoite counts (Table 2.5). A more detailed 
breakdown showed that FUMOZ-BS salivary glands often contained more than 10,000 
sporozoites, while majority of FUMOZ-R hosted 2,000 or less sporozoites. The base colony 
had the widest range in the number of sporozoites found in its salivary glands, but never 
carried more than 10,000 sporozoites (Table 2.5). The feeding rates between FUMOZ and its 
derivative strains were not significantly different (p>0.01) but the infection rates were 
(p<0.01).  
 
Table 2.5: Comparison of sporozoite load in FUMOZ and related sub-strains. 
 
Colony (n =) 
Average sporozoite 
numbers (±std dev) 
Sporozoite numbers 
1 - 
1 000 
1 001 - 
2 000 
2 001 - 
5 000 
5 001 - 
10 000 
10 000 - 
15 000 
FUMOZ(59) 2248 (±1173) 20% 30% 30% 20% 0 
FUMOZ-R(64) 1586 (±1044) 27% 53% 25% 0 0 
FUMOZ-BS(65) 7648 (±4986) 7.7% 15.4% 7.7% 23.1% 46.1% 
 
 
2.4 Discussion 
2.4.1 General observations 
Results of the mice infections using C57/Black strain were similar to data reported elsewhere 
(Killick-Kendrick, 1978; MacKey et al., 1980). The infection is always fatal in laboratory 
mice; the rodents typically succumb 10 - 15 days after infection, depending on the initial 
injected parasitaemia, and the number of blood passages the parasite has been through 
(Sinden et al., 2002). Infections using infected bloodstock that has undergone one or less 
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blood passage (P0 - P1) were more virulent and usually led to death within a week. With two 
to four blood passages, the mice survived up to two weeks before becoming terminally ill. 
Five or more passages increased the mice survival time to over 20 days.  
 
Although the popular laboratory mice strain for P. berghei infection is Balb/c, it was not used 
for this study as we found that the local strain was highly susceptible to the parasites when 
injected with the same dosage of P. berghei as C57BL/6. The majority of Balb/c mice had to 
be sacrificed within a week because of the severity of the infection. Due to the speedy 
progression of the infection, Balb/c often displayed symptoms of illness three to four days 
after IP infection and were unlikely to survive the anaesthetics for bloodfeeding. Ethically, 
this was also an issue as it meant prolonging the suffering of the mice.  
 
A longer survival time in C57BL/6 mice compared to Balb/c during P. berghei infection is 
consistent with published data (Contraras et al., 1980; Mackey et al., 1980). However, the 
infected mice in the current study often do not live past two weeks, which was a shorter 
period than expected. It is possible that the consistent cyclical transmission (no more than five 
direct blood passages were performed before restarting a new transmission cycle) allowed the 
parasite to remain more virulent than continuous direct blood passage transmission. A higher 
starting parasitaemia level in the IP injections may also have contributed to the shorter 
survival time. It is interesting that in wild P. berghei infections, the pathogenesis is typically 
mild and rarely leads to the tree rats‟ deaths, whereas in a laboratory setting, the infected 
rodent (if susceptible to the parasite), whether tree rats, hamsters or mice, invariably die 
(Yoeli, 1965). This pattern holds true for the mice infected in this study, and it has been 
hypothesized that in nature, young tree rats gain protective substances and antibodies from 
their mothers during suckling (Yoeli, 1965). The difference in this disease progression has not 
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been investigated in detail during the four decades the infection model has been in existence. 
 
Mice infection was also possible through cyclical transmission, whereby infected mosquitoes 
were allowed to feed on healthy mice 18 - 21 days after the infected bloodmeal. The infection 
progresses much faster in this instance, typically leading to fatality within five to seven days. 
The parasitaemia level in cyclical transmission rarely reaches 10% in the short infection time. 
Cyclical transmission is essential in maintaining infectious rodent malaria parasites in the 
laboratory setting (Sinden et al., 2002). It not only demonstrates the biological viability of the 
infection model but also helps to reduce the genetic damage or resulting from changes from 
direct passage. Direct blood passage is recommended for no more than eight direct passages, 
as the parasites seem to suffer irreparable genetic damage without passage through the 
invertebrate host (Sinden et al., 2002).  
 
There were a number of observations that applied to the mosquito infection regardless of the 
species. For each infection, 70 - 90 females were needed for feeding. This was considered the 
minimum viable number for feeding as most strains had feeding rates between 20 - 50%. 
Initial attempts at using 50 females often led to too few feeding, and not all bloodfed females 
will survive the parasite development time even under optimal conditions. Using 100 or more 
females did not significantly increase the feeding prevalence, as it merely meant there were 
more females trying to feed over the same amount of surface area, and often bloodfed females 
will not move away from the mouse until disturbed externally. It also brought up concerns 
that the mouse may be losing a significant amount of blood, especially with An. gambiae 
strains that tend to cause blood splatter when feeding to repletion.  
 
The second bloodmeal given within a week after the initial infected bloodmeal has been 
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highly recommended as it not only increases survival of the females, but also bolsters the 
parasite infection (Ponnudurai et al., 1989; Sinden et al., 2002). This had a positive effect on 
both An. gambiae and An. funestus survival, and death during the parasite development was 
reduced to 20% or less of the population. Infection rates were also boosted by 2 - 5% 
depending on the colony, with An. funestus colonies benefiting from the second bloodmeal 
more than An. gambiae.  
 
Maintainance of the bloodfed population at 21°C significantly lengthened the lifespan of the 
adult mosquitoes in all species. Most females will live at least a week longer than the average 
lifespan at standard insectary conditions. This is likely due to the lower temperature also 
lowering the base metabolism level in the adults, which allowed them survive for longer. 
Furthermore, the adults were also seen to be rarely moving except during feeding, so activity 
was minimized, further reducing the energy expenditure. The infectious status of the 
mosquitoes remained the same throughout the adult lifecycle, and successful infection of the 
mice was possible using infected An. gambiae more than 35 days old and An. funestus more 
than 50 days old.  
 
Environmental parameters also had an impact on infection. It has been shown that 
temperature is a significant factor in parasite development, where at higher temperatures (over 
24°C) complete parasite development is non-existent, and at lower temperatures (under 18°C), 
the oocyst-to-sporozoite development is reduced (Yoeli, 1965). Although the effect of 
temperature on infection was not part of the study, it was noted when the temperature deviated 
from the optimal range, infection were often adversely affected. This was consistent with 
results obtained elsewhere, where higher temperature was detrimental on the infection, 
typically terminating the parasite development (Vanderberg & Yoeli, 1965). At lower 
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temperatures, the parasite development was slower (sporozoites were usually observed two to 
three days later than usual), and infection rate was also lower. Due to this, infections in 
summer were occasionally less successful as the temperature control sometimes could not 
cope with the higher outside temperatures, and the insectary exceeded 23°C for some hours 
during the day. Low humidity was also observed to have a negative effect on the development: 
sporozoites were not observed below 65% RH. There was no obvious effect on parasite 
development when the humidity was higher than normal (≥85%).  
 
2.4.2 P. berghei infections in An. gambiae complex colonies 
Most of the An. gambiae complex colonies tested were able to carry the infection, some more 
successfully than others. Infection of old colonies (having been in existence for over a decade) 
produced highly varied results. The G3 colony, which was established in 1975, has been used 
previously as a viable P. berghei vector (Collins et al., 1986) and was the most susceptible An. 
gambiae s.s. colony. However, PALA, established in 1967, was completely resistant to P. 
berghei in this study despite being susceptible elsewhere (Al-Mashhadeni et al., 1980). 
Considering the significant time span that these two strains have been in existence, it is not 
surprising that the genetic makeup of the two is different. Collins et al. (1986) showed that 
Plasmodium refractoriness is in part linked to simple Mendelian genetics, and selection can 
create lines resistant to the parasite within three generations, creating long-lasting patterns of 
susceptibility/resistance. There is also evidence that "wild type" mosquitoes are refractory to 
the parasite (Riehle et al., 2006). It is possible that in the case of the PALA strain, the initial 
starting population for the VCRL sub-colony was biased towards Plasmodium resistance and 
selection favouring the resistance phenotype was unknowingly facilitated due to long-term 
isolation, or other unforeseen events, such as unexpected bottlenecking or adaptation to 
slightly different insectary conditions and resources. Alternatively, it may have reverted back 
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to the ancestral genotype, thus becoming refractory to Plasmodium. Even in the G3 strain, the 
infection rate obtained here compared to the data of Collins et al. (1986) are significantly 
different (below 50% versus over 90%), and the same factors mentioned above may have 
impacted on the infection rate. These differences in results reinforce the idea that long-
standing colonies may be quite different, not only to the wild populations from which they 
originated, but offshoot colonies reared in different laboratories can also be different, 
especially if significant time has passed since their creation/isolation (Black et al., 1988a, b; 
Chevillon et al., 1995; Scarpassa et al., 2008; o'Donnell & Ambruster, 2010). For all intents 
and purposes, it may be useful to consider them as distinct populations that have adapted to 
different locales, and therefore results from one strain should not be taken as applicable to the 
same colony based elsewhere. More data on the impact of Plasmodium susceptibility in An. 
gambiae with long term inbreeding may be of use in understanding the genetic differentiation 
of the species through time. 
 
In the remainder of the old colonies, all but one (NAG) were able to carry the parasite, albeit 
not as efficiently as G3, with average sporozoite indices around 5%. The average feeding rates 
in these colonies were lower even when more time was given for feeding. The newer colonies 
(COG, GAH, SUA) were more efficient vectors compared with the old colonies, but none was 
as effective as G3 in either feeding rate or infectivity. Although An. gambiae is assumed to be 
a malaria vector no matter where it comes from (there are no data to indicate otherwise), there 
will be differences in infection rates from different localities due to genetic differences, 
seasonal fluctuations and other environmental factors. Therefore, the initial starting 
population for any colony may have diminished vectorial capacity to begin with, and the 
likelihood of this increases if the starting numbers were small. Evolution and genetic drifts 
towards total Plasmodium resistance is clearly possible, but appears to be less likely than a 
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low level of susceptibility, as only two out of nine strains tested here were fully refractory to 
the parasite.  
 
Anopheles arabiensis, as the other major malaria vector, is often found in sympatry with An. 
gambiae, while An. merus is a minor vector in the coastal region of East Africa, Madagascar 
and parts of southern Africa (also in sympatry with the major vectors). To the best of my 
knowledge, the results presented here are the first infection data for both species using P. 
berghei. Colonies of both species were able to carry the parasite, albeit at a low frequency, 
and often less than the An. gambiae colonies. In An. arabiensis, most of the colonies had a 
lower average feeding rate to start with, even after starving and disturbing the cages prior to 
feeding. The lower feeding rate limited the number of possible infections, so it was 
unsurprising that the resulting infection rate was low. The infection rate with P. berghei was 
comparable to infections of human malaria sporozoites in wild caught An. arabiensis around 
human settlements that have rarely exceeded 5% (Taye et al., 2006; Abdalla et al., 2008). The 
An. arabiensis colonies have therefore maintained a baseline susceptibility to Plasmodium 
infection, and the baseline is consistent regardless of the regions that the colonies came from 
(Eritrea, Mozambique, South Africa, and Zimbabwe). 
 
In the two An. merus colonies, the average feeding rates were better than for An. arabiensis, 
but the sporozoite index was of a similar level to the An. arabiensis colonies. Anopheles 
merus is only of minor importance in malaria transmission, as it is usually found in sympatry 
with the major vectors, typically accounting for less than 10% of mosquitoes, if found at all 
(Shiff et al., 1995; Temu et al., 1998; Pock Tsy et al., 2003; Cuamba & Mendis, 2009). 
Infection rates of wild An. merus are usually low, at three to four percent (Mosha & Petrarca, 
1983; Cuamba & Mendis, 2009), but higher rates have been detected (Temu et al., 1995). The 
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P. berghei infection rate observed here was slightly lower than what is recorded in the wild 
populations with human malaria. This may be due to either long-term isolation like the An. 
gambiae colonies, or that the colonies were established from An. merus populations in South 
Africa, where it has never been incriminated in malaria transmission in nature.  
 
A single An. quadriannulatus colony, SANGWE, was also tested. Anopheles quadriannulatus 
and its sister species An. amharicus are the only medically unimportant members of the An. 
gambiae complex, as human Plasmodium parasites have never been detected in the wild 
populations, and the mosquitoes were thought to be zoophilic (Pates et al., 2001). The colony 
had a low feeding rate, but since this is also the case during routine maintenance, it is likely a 
carryover effect that influenced the infection experiments. The colony was completely 
resistant to P. berghei infection, which is in line with published data (Habteworld et al., 2008). 
However, it has also been shown elsewhere that An. quadriannulatus can be infected with P. 
falciparum, albeit at a much lower rate than An. gambiae and An. stephensi (Takken et al., 
1999). It is possible the discrepancy between the results here and previously published data 
arose from the different strains of An. quadriannulatus used. Both published papers utilized 
the SKUQUA strain from South Africa, while the SANGWE strain, used here, was from 
Mozambique.  
 
2.4.3 P. berghei infections in An. funestus 
When An. funestus was successfully colonized, two baseline colonies were established 
(FANG and FUMOZ), along with a line selected for high permethrin resistance from FUMOZ 
(FUMOZ-R) (Hunt et al., 2005). As FUMOZ was partially resistant to permethrin, it was 
thought that a third, permethrin-susceptible colony would be useful for a proper comparative 
study between insecticide susceptible versus resistant strains. Although FANG is fully 
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susceptible to permethrin, it is from the other side of the continent to FUMOZ (Angola and 
Mozambique, respectively), which means comparison between the two colonies may not be 
valid due to geographic variance. Furthermore, initial infection data showed that FANG was 
not only less prone to feed on mice, but the infection rate was also significantly lower than for 
FUMOZ. A stable susceptible colony created from FUMOZ, along with FUMOZ-R, would 
provide a more useful comparison not only for the current infection model, but also for future 
work where insecticide resistance (or lack thereof) may have an impact. The establishment of 
FUMOZ-BS showed it was possible by simple selection methods to re-establish some degree 
of insecticide susceptibility in the strain. 
 
It should be mentioned that although FUMOZ-BS was considered the susceptible variant of 
the three strains, it was not strictly in accordance with the WHO definition of insecticide 
resistance/susceptibility. The WHO defines mosquito susceptibility to an insecticide as 
mortality of 98 - 100%, and 80 - 97% mortality as "possibility of resistance that needs to be 
confirmed" (WHO CDS CPC MAL 98.12 document, 1998). As the selection process for 
FUMOZ-BS used families that had at least 85% mortality, the strain would fall into the latter 
category. However, it was impractical to try and select only families that had 98 - 100% 
mortality as this would have greatly reduced the number of families that could be retained for 
breeding. Consequently, the degree of insecticide susceptibility was set at 85% to facilitate the 
establishment of the colony. It may be possible to further select a proper permethrin-
susceptible colony in the future, but as this was not the main aim of the study, the use of a 
semi-susceptible colony was thought to be sufficient for the required purposes.  
 
The establishment of an infection system using An. funestus required much optimizing. The 
main obstacle was getting the usually highly anthropophilic An. funestus to feed on mice. 
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Even though the colonies are routinely maintained using guinea pigs as the source of the 
bloodmeal, the females were still reluctant to feed on the smaller mouse. This was particularly 
obvious when compared to most An. gambiae colonies, which required little incentive to feed 
on the mice. Starving An. funestus females prior to providing a bloodmeal became even more 
important to induce feeding, as it increased the feeding percentage quite significantly. The 
second issue was when to provide the An. funestus with the bloodmeal. Anopheles gambiae 
were usually fed three to four days after eclosure for infection or mating purposes. Although 
An. funestus of the same age will feed, it is only a small number that would feed on mice, 
even with starving. It was thought that because the An. funestus live longer than An. gambiae, 
their maturation process would take longer. The bloodmeal was therefore shifted back to at 
least a week after eclosure, and it was eventually found that bloodmeals given 10 - 14 days 
after emerging led to the greatest number of females feeding on the rodents. A small cohort of 
F1 progeny from wild An. funestus caught in Ghana was also used in the infection process and 
although subjected to the same conditions as the colonies, the females fed very poorly. The 
feeding preference of the species thus still remains an obstacle.  
 
Average oocyst number in infected FUMOZ-R females was in the single digits compared with 
the other two An. funestus colonies. The oocyst number is also the lowest ever observed 
compared to any P. berghei vectors to date (Yoeli, 1965). On the other hand, the average 
number of oocyst in FUMOZ-BS was comparable with An. dureni (60 - 80), but not as high as 
An. quadrimaculatus, which is able to carry 100 - 500 oocysts (Yoeli, 1965) – the number of 
oocysts never exceeded 100 in FUMOZ-BS. FUMOZ was the median species, covering both 
ranges, with a bias towards the lower oocyst numbers. This was logical considering that the 
base colony gave rise to the other two colonies, and as parasite refractoriness seems to be 
heavily influenced by genetic traits, the original colony should have individuals with 
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genotypes ranging from somewhat resistant to the parasites to being very susceptible. 
 
The average sporozoite numbers in the three colonies correlated with the oocyst numbers, 
with FUMOZ-R being the lowest, followed by FUMOZ and FUMOZ-BS. Sporozoite number 
in FUMOZ-R was significantly higher than observed in An. quadrimaculatus (100 - 300), 
despite carrying less oocysts. Infected FUMOZ-BS females‟ sporozoite numbers were similar 
to An. stephensi (6,000 - 8,000), but the range in the former is much greater, from about 500 
to just over 13,000. The majority of the infections exceeded 5,000 sporozoites per female, so 
the strain can be considered highly susceptible to the parasite. FUMOZ as the median colony 
displayed a low average sporozoite number. Its range was quite evenly spread, but the 
sporozoites never passed 9,000, and were not lower than 200. The persistence of sporozoites 
for the remainder of the infected females' lives is also consistent with data from other 
mosquitoes (James, 1926), and shows that the An. funestus salivary glands is a non-
threatening environment for the parasite.  
 
The combined feeding and infection data showed the base colony had the highest rate in both 
respects, followed by FUMOZ-BS and FUMOZ-R, whereas FUMOZ-BS had the highest 
oocysts and sporozoites loads. Thus there was no association between the most frequently 
infected strain (FUMOZ) and the strain most amenable to parasite development (FUMOZ-BS).  
 
This is the first known instance showing a possible link between Plasmodium parasite 
susceptibility and insecticide susceptibility in An. funestus. Existing data for other anophelines 
are somewhat contradictory, as most studies seem to support insecticide resistance being 
associated with increased parasite survival (Vontas et al., 2001, 2004; Christophides et al., 
2004), but the correlation is not consistent (Vontas et al., 2004). This difference in results has 
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been attributed to different vector and parasite species, thus more work is necessary to fully 
elucidate the association. Currently there is no known related interaction or pathway that acts 
in both insecticide and Plasmodium resistance mechanisms in malaria vectors. The most 
appropriate data regarding such interaction is found in Culex quinquefasciatus and the 
lymphatic filariasis parasite, Wuchereria bancrofti. Insecticide resistant Cx. quinquefasciatus 
based on increased esterase activity affects the development of W. bancrofti larvae in the gut 
cells (McCarroll et al., 2000). The correlation was easier to quantify in Cx. quinquefasciatus 
as the esterase amplicon duplication is the dominant resistant mechanism, found in over 80% 
of insecticide resistant Cx. quinquefasciatus (Hemingway & Karunaratne, 1998). It may be 
more difficult to correlate the two phenotypes in anophelines as the malaria vector has a 
number of insecticide resistant mechanisms which are involved depending on the type of 
insecticide the mosquitoes are exposed to.  
 
Susceptibility to insecticides is likely an ancestral phenotype for both An. gambiae complex 
and An. funestus group species as mosquitoes had never been exposed to high amounts of 
toxic chemicals until human intervention - both in public health and agriculture - began on a 
mass scale in the mid-20
th
 century (WHO, 1979). The current understanding of insecticide 
resistance is that it is primarily based on biochemical pathways, typically relying on up-
regulation of detoxification enzymes to minimize the impact of neurotoxic compounds 
(Hemingway & Ranson, 2000). Anopheline refractoriness to Plasmodium is also likely the 
ancestral phenotype (Riehel et al., 2006; Habtewold et al., 2008), but the varying degree of 
infection here showed that it is rare for strains to be fully refractory to the parasite even when 
the environment is optimal for the insect. The mosquito's susceptibility or refractoriness to 
Plasmodium could be described as a gradient (Beier, 1998), and it is very rare under wild or 
laboratory conditions to find cohorts that are either totally (i.e. 100%) susceptible or resistant 
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to the parasite. If parasite refractoriness was indeed the ancestral phenotype, it suggests that 
such a phenotype was skewed towards being highly refractory, which may be part of the 
reason why the vast majority of wild mosquitoes are not infected.  
 
To determine the development of P. berghei in An. funestus, dissections for midgut and 
salivary glands were essential. It was unknown if the parasite developed at a different rate in 
An. funestus compared with other P. berghei vectors, particularly considering the longer adult 
lifespan of An. funestus. Midgut dissections revealed oocysts consistently only 10 days after 
the infected bloodmeal, and maturation of oocysts takes at least 15 days after the bloodmeal, 
with maturing oocysts still observed at 20 days post feeding. This development time is much 
longer than in the natural vector An. dureni, which takes 8 - 11 days to oocyst maturation. It is 
also longer than the development in the experimental vectors An. quadrimaculatus and An. 
stephensi, which takes 13 - 14 days to oocyst maturation (Yoeli, 1965). Salivary glands 
dissection was initiated from 14 days post bloodmeal, and the earliest time when sporozoites 
were seen in the glands was 16 days after the infected bloodmeal, in line with the slow oocyst 
development. The average time for sporozoite invasion was around day 18 - 21, and 
sometimes as late as day 24. Compared to the recently publication by Xu et al. (2013) using 
the same vector-parasite pairing, the appearance of oocysts in this study was slower by three 
days, but the invasion of salivary glands was very similar, around day 18 - 20. The slight 
differences in development time may be due to using An. funestus from different localities, 
and it may be of interest to compare the two strains for similar genetic markers (e. g. anti-
Plasmodium gene expression) in the future.  
 
The other major difference in infecting An. funestus versus An. gambiae complex species, was 
that instead of using three-to-four days old adults, An. funestus females needed to be 10 - 14 
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days old before being given the infected bloodmeal. This is probably due to the longer adult 
lifespan of An. funestus compared to An. gambiae. Another theory is that as An. funestus is 
highly anthropophilic, they are less inclined to feed on other animals. However, as oogenesis 
in anopheline mosquitos is anautogenous and requires nutrients from vertebrate blood, 
delaying the bloodmeal may eventually force the females to feed on whatever source of blood 
is given. This could be correlated to the observation that although it is possible to get An. 
funestus females to feed on rodents three to four days after eclosure, the feeding rate is very 
low (typically less than 10%) and successful sporogony is even lower out of the bloodfed 
population (less than 5% of fed females).  
 
Although early data showed that An. funestus was not a vector for P. berghei (van den Berghe, 
1954), this has been proven not to be the case (Xu et al., 2013; Lo & Coetzee, 2013). Both 
wild and laboratory colonized An. funestus can in fact be viable vectors for rodent malaria, 
possibly as good as An. stephensi, the traditional experimental vector used for supporting P. 
berghei. The main reason for this dramatic change in results is the increased understanding of 
the conditions required for P. berghei infections. The first recorded attempt of infecting An. 
funestus was in the early 1950s, soon after its discovery when much about the parasite was 
unknown (particularly the lower temperature requirements) and infection attempts using 
unnatural vectors were often unsuccessful (Bruce-Chwatt, 1978). Successful cyclical 
transmission in the laboratory was only achieved by Yoeli in 1963, where established 
Anopheles colonies were tested. This naturally excluded An. funestus since no colony existed 
at that point. Secondly, An. funestus underwent some reclassification after the 1960s (Gillies 
& de Meilon 1968; Gillies & Coetzee; 1987). It is likely that the original infectivity test 
performed by van der Berghe (1954) was done on An. funestus s.s., as the species has a wide 
distribution in Africa, but this cannot be proven conclusively. It would have also been difficult 
64 
 
to persuade the wild An. funestus cohort to feed on infected rodents due to the species‟ highly 
anthropophilic nature, which may have also contributed to the failed infection. 
 
The data presented here have shown conclusively that An. funestus is a viable vector for P. 
berghei, albeit with slower development time compared to other known vectors of the parasite. 
In the case of FUMOZ-BS, the species was highly competent, as the highest P. berghei 
sporozoite rates ever documented were seen in individuals of this colony. Furthermore, some 
association was observed between insecticide resistance and parasite refractoriness, where 
strains with lower insecticide resistance carried more intense infections, and vice versa. The 
successful infection result will hopefully provide impetus to use An. funestus in future vector-
parasite research, and the association between insecticide resistance and parasite 
refractoriness should be further examined in An. funestus and other malaria vectors.  
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Chapter 3: Distribution of 2La in An. gambiae colonies and 
correlation with dieldrin and P. berghei exposure 
 
3.1 Introduction 
Detailed information on how to maintain Anopheles gambiae colonies in a laboratory setting 
has existed for six decades (Moores, 1953; Shute 1956). This has led to the establishment of 
numerous strains and colonies in a controlled environment. Wild populations, insecticide 
resistant variants, and genetically altered cohorts are all available for research purposes (see 
MR4 catalogues). However, their genetic profiles are often unknown, which may influence 
resistance to insecticide, malaria vectorial capacity, and the species‟ ability for ecological 
adaptation/differentiation. Furthermore, colonized populations are likely to show reduced 
genetic variation compared to the wild, ancestral cohort from which they were established. 
Local random genetic drift is known to influence genetic differentiation in a number of 
mosquito vectors, including Culex pipiens (Chevillon et al., 1995), Aedes aegypti (Scarpassa 
et al., 2008) and Aedes albopictus (O‟Donnell & Armbruster, 2010). Physiological and 
genetic characteristics may also be significantly influenced as a consequence of genetic drift 
during local population establishment due to a small starting number of individuals, or 
collection from a reduced population (Black et al., 1988a, b). Certain colonies have also been 
in captivity for decades under standard insectary conditions (e. g. the G3 and KGB strains 
have been maintained for more than 3 decades), and are likely to have diverged from the 
original populations due to long-term genetic isolation, inbreeding, or bottlenecks. It is 
therefore important to assess at least some of the genetic variation within a colony, 
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particularly those important genotypes that can influence insecticide resistance and 
adaptations. At the VCRL Botha de Meillon insectary, a large number of An. gambiae 
colonies are maintained for experimental purposes as well as controls (see Appendix 1). 
 
In An. gambiae complex mosquitoes, there are over 30 paracentric chromosomal inversions, 
and ten of these can be used to differentiate between morphologically identical sibling species 
(Coluzzi et al., 2002). Some of the paracentric inversions are also non-randomly distributed, 
suggesting that these rearrangements are present due to selection pressure on alleles trapped 
within the inversions, which may be able to confer adaptive advantages in different ecological 
niches (Coluzzi et al., 2002). Indeed, a number of these inversions have been linked to 
environmental, physiological and biological adaptations (Coluzzi et al., 1979; Petrarca & 
Beier, 1992; Brooke et al., 2000; Riehle et al., 2006; Gray et al., 2009). Although 
chromosomal inversions do not alter gene function (unless the gene sequence spans the 
breakpoint), the recombination of alleles situated in the inverted segment is suppressed in the 
heterokaryotypes (Kirkpatrick & Barton, 2006). This cross-over suppression allows for the 
maintenance of association between single or multiple alleles and particular inversion 
arrangements that can also inadvertently provide adaptive advantages in contrasting 
conditions, which in turn enable the organism to adapt to highly divergent habitats and widen 
their range (Kirkpatrick & Barton, 2006).  
 
A particularly good example of this is the 2La inversion. This is a large region on the left arm 
of chromosome 2 of the An. gambiae complex, which can be inverted during chromosomal 
recombination; it is the only inversion on 2L and is highly polymorphic (White et al., 2007). 
Inversion 2La‟s close correlation to the humidity cline was described in An. gambiae over 30 
years ago (Coluzzi et al., 1979). is almost fixed in dry regions and decreases in frequency 
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with increasing humidity. Individuals carrying the inverted arrangement are also more likely 
to be found indoors due to the nocturnal saturation deficit (Sharakhov et al., 2006). More 
recently, inversion 2La has been associated with mosquito-parasite interactions in An. 
gambiae. Two immune genes, APL1 and LRIM1, act against a number of Plasmodium species 
and are found within the 2La inversion (Osta et al., 2004; Riehle et al., 2006), along with four 
Plasmodium-resistant loci that influence the degree of parasite encapsulation and infectivity 
(Riehle et al., 2006). The 2La inversion has also been correlated with enhanced thermal 
tolerance in larvae (Rocca et al., 2009), and increased resistance to dessication in early 
adulthood of female mosquitoes (Gray et al., 2009). Lastly, the assortment of this inversion 
closely associates with dieldrin resistance/susceptibility in certain An. gambiae laboratory 
colonies (Brooke et al., 2000) because the rdl locus associated with dieldrin resistance occurs 
within inversion 2La (Holt et al., 2002). It is therefore important to determine the 2La 
inversion‟s frequency in a given An. gambiae s.s. population, be it wild or laboratory, as it can 
affect the species‟ adaptation and fitness in various ways.  
 
The traditional method of karyotyping inversions is by cytogenetics (Coluzzi, 1968; Green, 
1972; Hunt, 1972), but the technique has several restrictions which have been  limiting factors 
in advancing our understanding of 2La. There are two possible stages of mosquito 
development for obtaining viable polytene chromosomes for inversion karyotyping: 1) from 
the salivary glands of 4
th
 instar larvae (Frizzi, 1947), or 2) from the large nurse cells in the 
ovaries of half-gravid females (Coluzzi & Sabatini, 1968). The latter is the easier to obtain but 
it is still restricted by practical issues. The length of the gonotrophic cycle is dependent on 
ambient environmental conditions where warmer conditions accelerate the process (Gillies, 
1953), so it can be difficult to ascertain the best time to collect the nurse cells. This 
automatically precludes the possibility of performing cytogenetic analysis on archived 
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samples that have not been prepared properly, nor can it be done on males. In addition, 
cytogenetics is time consuming in terms of preparation and analysis of the samples, requiring 
considerable expertise to analyze the banding patterns correctly.  
 
Certain advances in the past decade have helped to alleviate dependence on cytogenetics for 
inversion 2La analyses. Sequencing of the entire An. gambiae genome (Holt et al., 2002) 
provided the means for detailed analyses of the 2La breakpoint structures (Sharakhov et al., 
2006) and allowed for the design of a Polymerase Chain Reaction (PCR-based) method for 
karyotype analysis. The primer pairs that generate the PCR products span the breakpoints, 
thus forming the basis for discrimination between inversion arrangements (White et al., 2007). 
The molecular karyotyping is not only faster and easier to analyze, but also can be used on 
males and any archived specimens, which provides significant advantages over cytogenetics. 
 
The aim of this chapter was to: a) determine if the PCR method of White et al. (2007) is an 
appropriate substitution for inversion 2La karyotyping by cytogenetic analysis using GAH, an 
An. gambiae laboratory colony known to be heterozygous for the inversion (B. Brooke, 
personal communication); b) determine the frequencies of inversion 2La in other polymorphic 
An. gambiae laboratory colonies that have not been monitored for over a decade (Brooke et 
al., 2000) or have never been examined not at all; c) compare the frequencies of 2La 
karyotypes between a base An. gambiae colony and a dieldrin-resistant selected strain in order 
to determine if there is a long-term association between the 2La inversion and dieldrin 
resistance; and d) infect samples of 2La polymorphic colonies with P. berghei in order to 
determine if the assortment of the 2La inversion associates with parasite infectivity.  
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3.2 Materials and methods 
 
3.2.1 An. gambiae colonies 
The following An. gambiae laboratory colonies, known to be polymorphic for the 2La 
inversion, were used: CIG (Cote d'Ivoire), GAH (Ghana), IANP20 (Nigeria), COG and COG-
EXP (Republic of Congo). COG-EXP is an insecticide resistant selected line derived from 
COG. The selection procedure was based on adult exposures to 0.05% deltamethrin, 4% 
dieldrin and 4% DDT every generation as per WHO (1998) exposure protocols. Survivors 
from each set of exposures constituted the breeding cohort for the next generation, thus 
maintaining the colony‟s resistance profile. All colonies were maintained under standard 
insectary conditions. 
 
3.2.2  Cytogenetics for 2La karyotyping 
Cytogenetics was performed largely according to previously established protocols (Green 
1972; Hunt, 1973). Adult female An. gambiae mosquitoes less than a week old were collected 
from the GAH colony, provided with a bloodmeal, and dissected 26 - 30 hours later once they 
had reached the half-gravid stage. The females were anaesthetized with diethyl ether and their 
ovaries were dissected from the posterior region of the midgut. The ovarioles were then 
suspended in Carnoy‟s fixative solution (1:3 ratio of glacial acetic acid:absolute ethanol) for at 
least 24 hours. The ovaries were stored in Carnoy‟s solution at 4°C while the remainder of the 
carcasses were stored individually on silica gel for later use in correlated PCR assays of White 
et al. (2007). 
  
The polytene chromosomes were prepared for microscopy as follows. A small volume of 50% 
propionic acid was mixed with 2% lacto-aceto orcein dye on a slide. Ovaries with associated 
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nurse cells were removed from the Carnoy‟s solution and transferred onto the slide. It was 
important to prevent the ovaries from drying out during the transfer. The tissues were allowed 
to absorb the propionic acid and dye by osmosis for approximately three minutes whereafter 
as much of the stain as possible was removed by dabbing with filter paper. The ovarioles were 
resuspended in 50% propionic acid and a coverslip was gently lowered onto the prepared 
tissue. Pressure was firmly applied to the coverslip by tapping with a modified dissecting 
needle in order to rupture the nurse cells and release the polytene chromosomes. These 
chromosome preparations were viewed and photographed under phase-contrast microscopy. 
The banding sequences of the polytene chromosomes in question were compared to those of a 
reference cytogenetic map (Green, 1972; Coluzzi et al., 1977) in order to karyotype inversion 
2La. At least fifteen females for each genotype (2La homozygote, 2La/+
a
 heterozygote, and 
2L+
a
 homozygote) were identified and their respective carcasses were then processed for 
molecular karyotyping.  
 
3.2.3 PCR for detection of 2La inversion 
DNA was extracted from preserved carcasses using Collin‟s method (1987). All plastics 
(including pipette tips, eppendorff tubes, etc.) were autoclaved for 20 minutes at 121°C before 
the extraction. The grinding buffer was composed of 1.6 ml NaCl (1M), 1.095 g sucrose, 2.4 
ml EDTA (0.5M), 1 ml SDS (10%), and 2 ml Tris-Cl (pH 8.6, 1M). The final volume was 
made up to 20 ml using distilled water. Each specimen was placed into a 1.5 ml 
microcentrifuge tube and was ground as finely as possible using a pestle. The pestle was left 
inside while 200 μl grinding buffer was added. The specimen was ground again and the pestle 
was removed while ensuring as little as possible of the material and buffer remained on the 
pestle. The mixture was incubated at 70°C for 30 - 60 minutes, and 28 μl KAc (8M) was 
added. This was mixed by vortexing and then incubated on ice for 30 minutes. The mixture 
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was then centrifuged for 20 minutes at 13,000 rpm, and the supernatant was carefully 
transferred to a clean 1.5 ml microcentrifuge tube without disturbing the pellet which was 
then discarded. Ice cold 100% ethanol (400 μl) was added to the supernatant, mixed (by 
inverting the tube briefly) and left overnight at -20°C. The mixture was then centrifuged for 
30 minutes at 13,000 rpm. The supernatant was removed without disturbing the pellet. Ice 
cold 70% ethanol (200 μl) was added to the pellet and gently mixed. The mixture was 
centrifuged again for 30 minutes at 13,000 rpm. The supernatant was again removed, and the 
pellet was allowed to air dry. The DNA pellet was resuspended in 150 - 200 μl TE buffer (1X).  
 
The PCR assay was adapted from the protocol of White et al. (2007), with some 
modifications. The three PCR primer sequences were those designed by White et al. (2007), 
but were renamed as 2La (27A2), 2L+ (DPCross5), and universal (23A2) for easier 
identification. The PCR conditions were as follows: 94°C for two minutes; 35 cycles of 94°C 
for 45 seconds, 55°C for 60 seconds, 72°C for 90 seconds; a final extension at 72°C for 10 
minutes. For each 12.5 μl PCR reaction, the following reagents were added: 1X PCR reaction 
buffer, 0.8 mM of each primer, 2.5 mM MgCl2, 0.4 mM dNTPS, 0.5 U of Dreamtaq 
(Fermentas, USA, cat. #EP0701), 100 - 200 ng DNA, and the remaining volume made up 
with double distilled water. The PCR products were electrophoresed on a 1.5% agarose gel 
stained with ethidium bromide. The gel was run at 100 - 120 V for an hour to separate the 
products. The gel was then placed under UV light to visualize the PCR products. 
 
PCR was performed on the karyotyped samples of the GAH strain and then on CIG and 
IANP20 using 50 - 55 randomly selected individuals from each colony. Initial baseline 
sampling of COGS was performed using samples drawn from the F9 to F13 generations. 
Random sampling of COGS and COGS-EXP (35 - 40 adults) was then performed every 
72 
 
alternate generation from F15 - F25 to determine whether the inversion distribution was being 
influenced by exposure to insecticide.  At F25, both strains were subjected to exposure to 
dieldrin as per the WHO (1998) insecticide exposure protocol. DNA was extracted from both 
the surviving and dead cohort, and subjected to PCR to determine the 2La genotypes of each 
phenotypically characterised specimen.  
 
The PCR results were used to determine if the cohorts were in Hardy-Weinberg equilibrium 
(p
2
 + 2pq + q
2
 = 1) for 2La, where „p‟ is the frequency of one arrangement, and „q‟ the 
frequency of the alternate arrangement. Chi-square (Χ2) Tests were also performed to 
determine if the inversion frequencies varied significantly between generations, or between 
COGS and COGS-EXP of the same generation, or between dieldrin resistant and susceptible 
specimens. 
 
3.2.4 Molecular karyotyping of 2La in P. berghei infected mosquitoes 
Adult females from COGS, IANP20 and GAH were infected with P. berghei as described in 
chapter two (section 2.2.3). Eighteen days post bloodmeal, the salivary glands were dissected 
to determine if sporozoites were present. The female carcasses were separated according to 
their infectivity status; DNA extraction and PCR followed the same methods as described in 
3.2.2. At least 30 infected females from each colony were processed in this manner.  
 
The infected cohorts were also examined for Hardy-Weinberg equilibrium with respect to 
inversion 2La. Chi-square Tests were performed to determine if the inversion frequencies 
varied significantly from between the infected cohort and the uninfected population.  
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3.3 Results 
 
3.3.1 Comparative study of 2La karyotyping between cytogenetic analysis and PCR 
The 2La inversion was karyotyped according to banding patterns on the standard chromosome 
map (Figures 3.1 - 3.3). 2L+
a
/a heterozygotes were the easiest to identify due to the typical 
looping that occurs as a consequence of the two arrangements (Figure 3.1). Using PCR, 2L+
a
 
homozygotes gave rise to a 207 bp fragment, 2La homozygotes a 492 bp fragment, and 
2L+
a
/a heterozygotes produced both bands (Figure 3.4), as described by White et al. (2007). 
The comparative study using cytogenetics and PCR karyotyping produced a good correlation 
between the two sets of results. Out of 54 samples of mixed genotype karyotyped by 
cytogenetics, three samples (5.6%) could not be correlated due to poor PCR amplicon quality. 
All three samples were heterogygotes according to cytogenetic analysis.  
 
 
Figure 3.1: 2La/+
a
 heterozygote in GAH female showing the typical chromosome looping that 
occurs in heterozygotes (phase contrast, 60X magnification). 
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Figure 3.2: 2L+
a
 homozygote in GAH female (phase contrast, 60X magnification). 
 
 
Figure 3.3: 2La homozygote in GAH female (phase contrast, 60X magnification). 
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Figure 3.4: Inversion 2La karyotype PCR results on 1.5% agarose gel. The samples were run 
with 100 bp molecular markers in lanes 1 and 18. 2L+
a
 homokaryotypes gave rise to a single 
482 bp fragment (lanes 5, 8, 11 - 14), while 2La/a produced the smaller 207 bp band (lanes 9, 
15 - 16). Heterokaryotic samples produced both bands (2 - 4, 6, 7, 10, 17). 
 
 
 
3.3.2 Frequency of 2La in An. gambiae laboratory colonies 
PCR was used to determine the 2La inversion frequencies in GAH, CIG, IANP20 and COGS, 
by random sampling of the colonies (Figure 3.5). Each of the colonies displayed quite 
different profiles for the inversion. Allelic frequencies for all colonies were in Hardy-
Weinberg equilbrium (Table 3.1), but Chi-square analysis showed the genotype frequencies 
were rarely in equilibrium (Table 3.2). In GAH, the population (n = 55) is dominated by the 
heterozygotes (72.7%), with a minority (27%) of 2La homozygotes. On the other hand, 2La 
homozygotes were dominant (92%) in CIG, with heterozygotes (8%) making up the 
remainder of the population (n = 52). In COGS (n = 37) and IANP20 (n = 53), 2La 
homozygotes were also dominant (67.6% and 86.8%, respectively) although 2L+
a
 
   1     2     3     4    5     6     7    8    9    10   11  12   13   14   15  16   17   18  
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homozygotes and heterozygotes were both present (in COGS 16.2% for both; 5.7% and 7.5% 
in IANP20).   
 
 
 
  
Figure 3.5: Frequencies of the 2La inversion arrangements in four An. gambiae polymorphic 
laboratory colonies. 
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Table 3.1: Frequency of the 2La alleles in the PCR karyotyped cohorts and subsequent Hardy-
Weinberg equilibrium calculations. 
Colony/generation 
 
Alleles 
(2n =) 
2La 
(p) 
2L+ 
(q) p
2
 2pq q
2 
CIG 
 
104 100 4 0.925 0.074 0.001 
COGS F9 
 
76 58 18 0.582 0.362 0.056 
GAH 
 
110 70 40 0.405 0.463 0.132 
IANP20 
 
106 96 10 0.820 0.171 0.009 
COGS F9 infected 
 
28 21 7 0.5625 0.375 0.0625 
GAH infected 
 
34 31 3 0.831 0.161 0.008 
IANP20 infected 
 
10 10 0 1.000 0.000 0.000 
COGS F11 
 
70 46 24 0.432 0.451 0.117 
COGS F13 
 
72 43 29 0.357 0.481 0.162 
COGS F15 
 
80 42 38 0.276 0.499 0.225 
COGS-EXP F15 
 
76 16 60 0.044 0.332 0.624 
COGS F17 
 
78 34 44 0.190 0.492 0.318 
COGS-EXP F17 
 
74 49 25 0.438 0.447 0.115 
COGS F19 
 
72 44 28 0.374 0.475 0.151 
COGS-EXP F19 
 
78 51 27 0.428 0.453 0.119 
COGS F21 
 
78 36 42 0.213 0.497 0.290 
COGS-EXP F21 
 
80 32 48 0.16 0.48 0.36 
COGS F23 
 
70 26 44 0.138 0.467 0.395 
COGS-EXP F23 
 
76 18 58 0.056 0.362 0.582 
COGS F25 
 
74 25 49 0.114 0.447 0.439 
COGS-EXP F25 
 
76 32 44 0.177 0.488 0.335 
COGS F25 
dieldrin exposure 96 42 54 0.191 0.492 0.317 
COGS-EXP F25  
dieldrin exposure 100 62 38 0.384 0.472 0.144 
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Table 3.2: Chi-square Tests for generational 2La karyotype comparisons in An. gambiae 
colonies. 
Colonies Χ2 value p ≤ 
CIG 598.6 0.005 
COGS F9 31.28 0.005 
GAH 32.1 0.005 
IANP20 69.62 0.005 
COGS F9 infected 52.33 0.005 
GAH infected 379.5 0.005 
IANP20 infected 0 1 
COGS F11 61.27 0.005 
COGS F13 39.33 0.005 
COGS F15 10.31 0.01 
COGS-EXP F15 29.29 0.005 
COGS F17 7.075 0.1 
COGS-EXP F17 214.5 0.005 
COGS F19 173.4 0.005 
COGS-EXP F19 320.7 0.005 
COGS F21 17.54 0.005 
COGS-EXP F21 86.11 0.005 
COGS F23  8.967 0.25 
COGS-EXP F23 29.52 0.005 
COGS F25  0.704 0.9 
COGS-EXP F25  5.769 0.5 
COGS F25 dieldrin exposure survivor 11.11 0.005 
COGS F25F25 dieldrin exposure knockdown 49.27 0.005 
COGS-EXP F25 dieldrin exposure survivor 440.6 0.005 
COGS-EXP F25  dieldrin exposure knockdown 67.32 0.005 
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The COGS colony and its insecticide-exposed sub-colony (COGS-EXP), were monitored for 
2La assortment over 10 generations from F15 to F25 (Figure 3.6). In the base colony, all three 
karyotypes were present, although it was initially dominated by 2La. However, as time 
progressed, 2La began to decline in frequency, and either 2L+
a 
homozygotes or heterozygotes 
formed the majority in the population, depending on the generation examined. The COGS-
EXP line was significantly skewed towards karyotypes containing 2L+
a
, as almost no 2La 
were detected for most of the generations. Only in F25 did 2La appear in fair numbers again. 
Linear regression analysis of the 2La arrangement through the generations showed that in 
COGS there was a slight trend of 2L+
a
 slowly increasing (R
2
 = 0.7115), but it was not highly 
significant (p ≤ 0.1). In COGS-EXP there were no significant trend to speak of (R2 = 0.1994; p 
≤ 0.5) 
 
 
 
Figure 3.6: 2La frequency in COGS strain over 16 generations. 
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Figure 3.7: 2La frequency in COGS-EXP strain over 10 generations. 
 
Dieldrin exposure at F25 in COGS (n = 48) and COGS-EXP (n = 50) lines showed that all 
survivors carried either the 2L+
a
 or 2La/+
a
 arrangements (Figure 3.7). In COGS, the dieldrin 
susceptible specimens covered all three karyotypes, with close to half of the knockdowns 
being heterozygotes (45.7%) and the remainder fairly evenly split between the two 
homozygotes (32.6% for 2L+
a
/+
a
 and 22.9% for 2La/a). In contrast, the majority of dead 
individuals in COGS-EXP were 2La homokaryotypes (70.0%). The remainder of the 
knockdowns were slightly biased towards the heterokaryotypes than 2L+
a
 homokaryotype 
(18.0% versus 12.0%). None of the cohorts exposed were in Hard-Weinberg equilibrium with 
regard to the genotype distribution (Table 3.2).  Comparison of COGS and COGS-EXP of the 
same generation showed significant difference in 2La genotype distribution (Table 3.4). 
Although there was already a significant difference between F25 genotype distributions of 
COGS and COGS-EXP, the difference was even greater when comparing mosquitoes of the 
two strains following dieldrin exposure (Table 3.2). 
 
0
10
20
30
40
50
60
70
80
90
F9 
(38)
F11 
(35)
F13 
(36)
F15 
exp 
(38)
F17 
exp 
(37)
F19 
exp 
(39)
F21 
exp 
(40)
F23 
exp 
(38)
F25 
exp 
(38)
%
 o
f 
co
h
o
rt
Generations (n =)
2L+
2La
2La/+
81 
 
 
Figure 3.8: 2La distribution in COGS and COGS-EXP line at F25 after dieldrin-exposure 
assays. 
 
3.3.3 Frequency of 2La in P. berghei-infected An. gambiae colonies 
The frequency of sporozoite infection in the three 2La polymorphic An. gambiae colonies 
ranged from 4.3% (IANP20; n = 113) to 15.0% (GAH; n = 114). COGS (n = 124) was the 
median, with 11.3% infection rate. The values were within expected range as reported in the 
previous chapter. PCR showed that in all three colonies, 2La was present in the vast majority 
of the infected females, with all infected IANP20 homozygous for the 2La arrangement 
(Figure 3.9). Only in COGS was 2L+
a
 homozygotes infected, which accounted for a minority 
(17.6%) of the infection. Heterokaryotype infections accounted for a low percent of the 
infection in both COGS and GAH (21.4% and 14.3%, respectively). Both cohorts were not in 
Hardy-Weinberg equilibrium (Table 3.2), and the 2La genotype frequency of the infected 
cohort was significantly different to the infected cohort (Table 3.5).  
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Table 3.3: Chi-square Tests for generational 2La karyotype comparisons in Anopheles 
gambiae COGS and COGS-EXP laboratory colonies. 
Colonies Χ2 value p ≤ 
F9 vs. F11 21.66 0.005 
F11 vs. F13 2.46 0.1 
F13 vs. F15 10.86 0.005 
F13 vs. F15 EXP 100.09 0.005 
F15 vs. F17 17.488 0.005 
F15 EXP vs. F17 EXP 12.043 0.005 
F17 vs. F19 33.58 0.001 
F17 EXP vs. F19 EXP 9.49 0.01 
F19 vs. F21 66.5 0.001 
F19 EXP vs. F21 EXP 5.42 0.05 
F21 vs. F23 16.99 0.005 
F21 EXP vs. F23 EXP 111.29 0.001 
F23 vs. F25 12.35 0.005 
F23 EXP vs. F25 EXP 34.83 0.001 
 
 
Table 3.4: Chi-square tests for 2La karyotype comparisons between COGS and COGS-EXP 
strains of the same generations. 
Colonies Χ2 value p ≤ 
F15 vs. F15 EXP  66.68 0.001 
F17 vs. F17 EXP 19.581 0.005 
F19 vs. F19 EXP 91.674 0.001 
F21 vs. F21 EXP 51.52 0.001 
F23 vs. F23 EXP 12.94 0.005 
F25 vs. F25 EXP 4.514 0.1 
F25 vs. F25 EXP (dieldrin exposure assay) 53.6 0.001 
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Table 3.5: Chi-square tests for 2La karyotype comparisons between uninfected and P. berghei 
infected An. gambiae laboratory colony. 
Colonies Χ2 value p ≤ 
COGS F9 vs. infected 2.633 0.1 
GAH vs. infected 155.71 0.001 
IANP20 vs. infected 16.14 0.005 
 
 
 
 
 
 
Figure 3.9: Distribution of inversion 2La karyotypes in P. berghei-infected females of three 
An. gambiae colonies. 
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3.4 Discussion 
 
 
3.4.1 Comparison of cytogenetic and molecular karyotyping 
Molecular karyotyping of the 2La inversion was shown to be suitably reliable when compared 
to the cytogenetic method (White et al., 2007). However, unexpected non-specific amplicons 
in addition to the expected fragments were produced when used elsewhere. These additional 
fragments have previously been detected and do not appear to be PCR artefacts or derived 
from another unlinked locus (Obbard et al., 2007; Ng‟habi et al., 2008). Due to these 
unexpected PCR products, it was necessary to validate the PCR with traditional cytogenetics. 
Furthermore, even though PCR is widely accepted as a robust technique, adapting protocols 
from other laboratories sometimes require re-optimization, caused by variations in starting 
materials, reagents and PCR machines. These nuances further necessitated a comparative 
study of results between molecular and cytogenetic karyotyping.  
 
All three possible karyotypes were observed in the GAH colony by cytogenetic analysis and 
were then subjected to the PCR assay. Along with the two expected fragments, additional 
fragments were also amplified (around 400 bp and 600 bp), but these were subsequently 
eliminated after optimization of the PCR. The PCR at the original conditions was tested on 
COG and IANP20, and a 400 bp non-specific band also appeared in the former. In some of the 
IANP20 samples, a non-specific band of approximately 780 bp was present, which is similar 
in size to one of the derivative fragments detected by Obbard et al., (2007). However, the re-
optimized PCR eliminated all of these fragments, indicating that these were all non-specific 
amplifications, and not fragments derived due to polymorphisms in the amplicon region. 
These results caution against adopting the PCR assays blindly as a substitute for cytogenetic 
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analysis in determining 2La status.  
 
Almost all 2La-related publications since the establishment of the molecular karyotyping 
method have utilized the PCR technique to quantify the inversion‟s distribution in wild 
populations (Obbard et al., 2007; Stump et al., 2007; Ng‟habi et al., 2008; Gray et al., 2009; 
Rocca et al., 2009; Fouet et al., 2012). This indicates the general acceptance that PCR is a 
suitable substitute for cytogenetic karyotyping. However, due to the ambiguities brought on 
by derivative fragments, cytogenetics ought to be used in conjunction with PCR to validate 
the results (Ng‟habi et al., 2008). In summary, although polymorphisms in the amplified 
region of 2La may lead to distortion of results, the lower level of expertise required for 
molecular karyotyping makes profiling of the inversion in any given population much easier. 
It is also less time-consuming and can be performed on individuals of either sex. It is thus a 
good technique for quick karyotyping of the inversion, and useful for population genetics 
where large sample numbers may need to be processed. However, cytogenetic karyotyping 
cannot be totally disregarded, as it can provide details within the inversion where the PCR is 
unable to do so. 
 
3.4.2 Distribution of 2La in An. gambiae colonies 
A number of the An. gambiae colonies maintained in the VCRL insectary are known to be 
polymorphic for 2La but the frequency of the inversion has not been quantified in recent times 
(and in the case of newer colonies, not at all). The CIG and IANP20 colonies were previously 
karyotyped for 2la with evidence of positive heterosis in both (Brooke et al., 2000). The 
frequencies have changed after a decade with both colonies now heavily dominated by 2La 
homozygotes (91.5% for CIG, and 86.1% for IANP20). There was no selective pressure 
applied by insecticides, where dieldrin resistance has been being linked to the inversion 
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(Brooke et al., 2000). It is possible that due to the lack of selective pressure over time, in 
addition to long-term genetic isolation, bottlenecking and genetic drift, both populations have 
shifted back to 2La, now considered the ancestral arrangement (Sharakhov et al., 2006). More 
investigations would be required to understand the pattern of 2La selection in long-term 
insectary colonies.  
 
With respect to the new colonies, GAH and COG (both less than 5 years old), their 2La 
frequency has never been monitored. The GAH strain was dominated by heterozygotes with 
some 2La homozygotes. It was the only colony tested that is dominated by the 
heterokaryotype (73%). No 2L+
a
 homokaryotypes were found during the process, although 
they should exist considering the presence of the heterokaryotype. The absence of 2L+
a
 
homokaryotypes from the IANP20 cohort may have been due to the slightly small sample size 
(n = 55). 2L+
a
 homozygous mosquitoes have been observed previously as being less fit than 
other genotypes, as they were usually smaller, less prone to take bloodmeals, and showed 
slow ovarian development (R. Hunt, MSc dissertation, University of the Witwatersrand, 1984), 
which may have also contributed to its absence in GAH, and the low frequency in other 
colonies. This may be due to the presence of lethal genes within the inversion, but the 
hypothesis has yet to be tested.   
 
The COGS colony, along with its derivative colony, COGS-EXP, underwent more extensive 
profiling. The initial baseline data over seven generations (from F9 - F15) showed that 
although 2La began as the dominant arrangement, homozygous individuals steadily declined 
in numbers (Figure 3.6). Although it never fully disappeared, 2La/a became the minority, and 
the strain was dominated by 2L+
a
/+
a
 or heterozygous individuals. Both colonies were 
typically not in Hardy-Weinberg equilibrium, but the 2La genotype frequencies at any given 
87 
 
generation were significantly different when compared to generations two previous or after it, 
except for between F11 and F13, where the X
2
 value was fairly small compared to the others. 
Given the fact that these laboratory colonies are not infinitely large, it is not surprising that 
2La and related genotype is not in equilibrium as time passes. What sort of effect (if any) the 
disequilibrium will have on the colonies is unknown, and perhaps should be explored further.  
 
Linear regression of the inversion showed no significant pattern of selection in either COGS 
or COG-EXP, but the former was somewhat tending towards higher frequencies for 2L+
a
. 
This was surprising as 2L+
a
 is supposed to offer some resistance to dieldrin, yet it was not 
selected for in the dieldrin exposed colony. However, the data have been somewhat 
misleading as for most of the generations monitored, the 2La frequency was decreasing, and 
only in F23 and F25 was there an increase of the arrangement. It is unknown what could have 
led to this increase, and without further data, it is difficult to hypothesize. The COGS colony 
maintained all three karyotypes throughout the profiling, with the pattern of 2La/a being in the 
minority continuing through the generations. In contrast, the COGS-EXP population only 
showed low frequencies of the homokaryotype in some generations. The selection pressure 
for 2L+
a
 by the insecticide was fairly evident, despite the results of the linear regression 
analysis. To show that the 2La inversion was linked to dieldrin resistance, individuals from 
F25 of both colonies were exposed to dieldrin. The results clearly showed 2La homokaryotype 
individuals are fully susceptible to dieldrin, and the 2L+
a
 arrangement, whether present as a 
single or double copy, confers some resistance to the insecticide. The correlation was 
particularly obvious in the COGS-EXP strain, as the vast majority of knockdowns were 2La 
homokaryotypes. Correlation between dieldrin resistance and 2L+
a
 was not as conclusive in 
the COGS colony. Although the survivors carried 2L+
a
, the presence of 2L+
a
 was not a 
guarantee that the mosquito would survive dieldrin exposure, as all three karyotypes were 
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found in the knocked down individuals, and close to half of the deaths were heterokaryotypes. 
The results reinforce the idea that insecticide resistance is multifactorial and that there are 
likely to be metabolic detoxification mechanisms acting in parallel to the resistance locus 
(Hemingway et al., 2004). In general, the results were consistent with previous data obtained 
from CIG and IANP20 (Brooke et al., 2000). The main difference was that in the earlier study, 
there were survivors carrying 2La/a, and no 2L+
a
 homokaryotes were knocked down, whereas 
in COGS and COGS-EXP there were no 2La/a survivors, and some 2L+
a
 homokaryotes did 
not survive. As the colonies were not from the same locations and have been maintained as 
insectary colonies for different lengths of time, inherent genetic and resistance profiles were 
likely different as well, leading to variations in results.  
 
3.4.3 Distribution of 2La in P. berghei infected females 
Of the four An. gambiae colonies initially tested for 2La frequency, only three were used for P. 
berghei infection. The CIG colony was omitted as infection rates for the strain were very low 
compared with the other three colonies (see Chapter Two). In the three An. gambiae 
populations tested, all infected females were skewed towards the 2La arrangement, 
particularly 2La homokaryotic individuals. Infection rates of 2La homokaryotes were at least 
three times higher compared to the other arrangements. For COGS, the 2La frequency of 
infected females was of a similar percentage to what was detected in the randomized sampling 
of the colony at the same generation, where 2La homozygotes were dominant and the other 
two karyotypes in more or less equal distribution. In IANP20, it was only the 2La 
homokaryotes that showed infections, which was perhaps not surprising as the base 
population was already heavily dominated by 2La/a. The cohort that were successfully 
infected may have been too small (n = 5) to detect infected heterokaryotype or 2L+
a
/+
a
 
individuals, as GAH has showed that females carrying 2L+
a
 can be infected. The most 
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unexpected distribution of the 2La inversion was in infected GAH females. The base 
population was dominated by heterokaryotes with 2La homokaryotes in the minority, yet in 
the infected cohort the proportion was inverted, with the homozygotes dominant, and present 
at over four times the number compare with 2La/+
a
 females. All cohorts barring IANP20 were 
not in Hardy-Weinberg equilibrium, but this is not surprising given the very small number of 
infected females in IANP20. The 2La genotype frequencies of the GAH and IANP20 were 
significantly different compared to their respective uninfected cohorts when subjected to Chi-
square Test. COGS F9 was not as significantly different compared to the other two strains. The 
smaller sample size of the infected cohorts may be a slight concern, but the fact that in all 
three strains 2La homozygotes were more likely to be infected, indicates that there is a trend 
there.  
 
The results presented here are in contrast to data collected on wild populations from the 
Kisumu region, where it was found that the 2L+
a
 homozygotes were more likely to be 
infected with Plasmodium than the 2La homozygotes (Petrarca & Beier, 1992). However, a 
cautious approach to interpreting data should always be taken when making comparison 
between wild-caught populations infected with P. falciparum and insectary-based cohorts 
infected with P. berghei as it is known that P. falciparum and P. berghei can trigger different 
immune responses in mosquitoes (Tahar et al., 2002; Riehle et al., 2006). More detailed 
research on the 2La region also revealed such differences, where paralogs of the APL1 family 
exhibit mutually exclusive protection against different Plasmodium species, and the protection 
is mediated by different signalling pathways (Mitri et al., 2009).  
 
Variations in mosquito physiology between wild and laboratory-reared populations, as well as 
those brought on by spatial and temporal separation, temperature and other environmental 
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variables, are well acknowledged (Carey, 2001; Huho et al., 2007). Consequently, it would be 
more useful to take both sets of results into consideration given the different circumstances, 
rather than eliminate one data set altogether, especially considering that each vector-parasite 
pairing, whether natural or unnatural, tends to have its own unique pattern of interaction 
(Sinden et al., 2002). It is also important to not assume the data obtained from one vector-
parasite pairing is not necessarily applicable to another, particularly as laboratory models 
often have not been systematically validated against natural host-pathogen interactions (Mitri 
& Vernick, 2012).   
 
The prevalence of 2La in P. berghei infected females in the present study seems to indicate a 
greater degree of susceptibility to Plasmodium linked to the inversion. A number of immune 
genes that affect Plasmodium infection and transmission are found within or near the 2La 
region (Osta et al., 2004; Cohuet et al., 2006; Riehle et al., 2006). While none of these 
immune genes occur at the inversion break points with their functions and expression directly 
affected by the rearrangement, it is unknown what effect the inversion has on these genes. 
There may be cis- or trans-acting mechanisms targeting these genes that become less effective 
(or even non-operational) once the locations of the genes have shifted, but there are no 
molecular data available for this hypothesis with regard to the 2La inversion. Conversely, 
genes outside of the inversion may be influenced due to displacement of loci that previously 
interacted with them. More research is thus necessary to elucidate the interactions and effects 
the 2La inversion may have on Plasmodium infection.  
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Chapter 4: Expression of immune genes in An. funestus during P. 
berghei infection 
 
4.1 Introduction 
The malaria parasite is completely reliant on anopheline mosquitoes as both the obligatory 
host, and as a vector to transmit it to the vertebrate host. The traditional view of the mosquito-
parasite relationship maintains that the vector is a passive carrier of the parasite, and does not 
act against the parasite‟s presence, nor does it suffer from adverse effects. However, studies in 
recent decades have shown this to be untrue. Ookinetes passing through the midgut leads to 
tissue damage (Ramasamy et al., 1997); amino acids level in haemocoelomic fluid are altered 
(Mack et al., 1979) and physiological modifications such as egg production and feeding 
behaviour are also likely (Hogg & Hurd, 1995; Koella et al., 1998; Rossignol, et al., 1984). 
Selection based on basic Mendelian genetics has also shown it is possible to create an An. 
gambiae strain that is refractory to the parasites (Collins et al., 1986). The Plasmodium 
resistance mechanisms have been further elucidated through the An. gambiae genome (Holt et 
al., 2002), and advances in molecular techniques, such as gene silencing by RNA interference 
(RNAi) in the same species (Blandin et al., 2002). This has led to discovery of a number of 
genes and associated regulatory pathways mediating mosquito susceptibility to Plasmodium, 
which are all involved in the mosquito‟s innate immunity (Abraham et al., 2005; Michel et al., 
2005; Meister et al., 2005; Vlachou et al., 2005; Dong et al., 2006).  
 
Much of anopheline innate immunity has been resolved by comparative studies with the 
Drosophila melanogaster immune system, coupled with some descriptions from orthologous 
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pathways in mammals (Cirimotich et al., 2010). Innate immunity involves both humoral and 
cellular factors, typically responding to microbial challenges within the haemolymph. 
Circulating haemocytes can phagocytose or encapsulate microbes; serine protease cascades 
can lead to melanization or release of free radicals to kill the pathogens (Meister et al., 2004; 
Osta et al., 2004). PRRs binding to PAMPs of pathogens will lead to production of 
antimicrobial effector molecules (Meister et al., 2004; Osta et al., 2004). On a cellular level, 
intracellular immune responses detect pathogens using PGRPs, which activate one of three 
immune signaling pathways (Toll, IMD or JAK/STAT). Activation of these pathways usually 
results in up-regulation of immune-related genes, including AMPs (Choe et al., 2002; Yassine 
& Osta, 2010).  
 
Of the multitude of immune responses the mosquito can mount, the most diverse is perhaps 
the AMPs. These peptides have been well studied in other insects (Hoffmann, 1995; 
Hoffmann et al., 1996), and were amongst the first group of immune-related molecules to be 
studied in mosquitoes (Richman et al., 1996; Dimopoulos et al., 1997, 1998; Vizioli et al., 
2000, 2001) Insects mount potent anti-bacterial/anti-fungal responses through production of 
AMPs in the fat body (Hoffmann et al., 1996). Molecular studies have also revealed that some 
of the AMPs also have anti-parasitic properties when mosquitoes are exposed to malaria 
parasites (Richman et al., 1996; Dimopoulos et al., 1997, 1998; Vizioli et al., 2000, 2001). 
Insect AMP can be divided into four major classes according to sequence similarity: cecropins, 
cysteine-rich peptides, glycine-rich polypeptides and proline-rich peptides (Meister et al., 
1997). Defensins are cysteine-rich peptides that were first discovered in Drosophila, 
expressed by fat bodies and some haemocytes during bacterial infection and mechanical 
injuries (Hoffmann & Hetru, 1992). Defensin 1/defensin A (AgDfn1) was subsequently 
isolated in An. gambiae (Richman et al., 1996), and three more defensins were found in the 
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annotated genome (Christophides et al., 2002). Defensins primarily act against Gram
+
 
bacteria and some filamentous fungi (Vizioli et al., 2001) but the anti-Plasmodium effect of 
defensin is still ambiguous at this point. Exogenous defensin or up-regulation of defensin 
through bacterial challenge affected P. gallinaceum oocysts and sporozoites in Ae. aegypti 
(Shahabuddin et al., 1998; Lowenberger et al., 1999), as does co-overexpression of 
endogenous defensin A with cecropin A (Kokoza et al., 2010). However, knockout of defensin 
in An. gambiae during P. berghei infection showed no significant changes in the parasite‟s 
midgut developmental stages (Blandin et al., 2002).  
 
Cecropins are found in both insects and mammals (Boman, 1994). In An. gambiae, three 
cecropins were initially isolated (Vizioli et al., 2000; Zheng & Zhang, 2002) followed by a 
fourth in the genome sequence (Christophides et al., 2002). Cecropins have a broad spectrum 
of antimicrobial activity in mosquitoes. The peptides usually act against Gram
-
 bacteria but 
have been found to act against a number of species of Gram
+
 bacteria, yeasts and fungi 
(Vizioli et al., 2000). Cecropin 1/cecropin A (cec1/cecA) expression is induced during 
Plasmodium infection (Vizioli et al., 2000), and expression beginning 24 hours post-infected 
bloodmeal causes significant reduction in the number of P. berghei oocysts in An. gambiae 
(Kim et al., 2004). 
 
Gambicin is a novel AMP that was first isolated in An. gambiae (Vizioli et al., 2001) and later 
found in other dipteran vectors such as Cx. pipiens pipiens (Bartholomay et al., 2003), Cx. 
quinquefasciatus (Ribeiro et al., 2004) and Ae. aegypti (Hillyer et al., 2005). It is a unique 
AMP with no sequence homology to other known insect AMPs. The peptide works against 
both Gram
+
 and Gram
-
 bacteria, with some lethality to P. berghei ookinetes (Vizoli et al., 
2001). Attacin was the only novel class of AMP discovered in the An. gambiae genome 
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(Christophides et al., 2002), with the other peptides having being isolated earlier. Although it 
is known to have antimicrobial activities in other insects (Hultmark et al., 1983; Sugiyama et 
al., 1995), only recently have there been data showing some activity during Plasmodium 
infection in An. albimanus (Herrera-Ortiz  et al., 2011).  
 
It is likely that An. funestus uses similar mechanisms in response to Plasmodium invasion, but 
without a functional infection model, it was not feasible to validate the immune responses in 
An. funestus. However, having established the An. funestus-P. berghei infection model, this 
chapter aimed to examine the immune response in the mosquito during Plasmodium invasion 
and development. Three AMP genes – cecropin 1, defensin 1 and gambicin – were amongst 
the first AMPS to be studied in An. gambiae, and were chosen for that reason. Assessment of 
their expression during P. berghei infection at various time points, in three An. funestus strains 
with varying insecticide susceptibility, will provide new information for An. funestus infection, 
and also allow a comparison with results obtained previously from An. gambiae.  
 
4.2 Materials and methods 
 
4.2.1 An. funestus infection  
Adult female An. funestus were infected with P. berghei as described in chapter two (section 
2.2.3). The three FUMOZ colonies were all infected and maintained as for normal P. berghei 
development until the time points required for RNA extraction. The infection status of the 
females was determined retroactively, that is, females were collected from the fed cohort at 
various time points, and only used for gene expression analyses if the females of the same 
cohort had infected salivary glands when dissections were performed. The mosquitoes were 
knocked down with ether, their abdomen removed and kept on ice. RNA was extracted 
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immediately following the dissection. Alternatively, the dissected abdomens were stored at -
70ºC and RNA extraction took place within 48 hours of the dissection.  
 
4.2.2 RNA extraction  
Total RNA was extracted from all three colonies at the following time points: 24 hours post 
infection (pi), 7 days pi, 14 days pi and 21 days pi. Three biological replicates for each strain 
were obtained for each time point. Each replicate contained 10 - 12 mosquito abdomens. RNA 
was also extracted from adult females that were given uninfected bloodmeals at the same time 
as 24 hours pi cohorts. These uninfected females were used as baseline material in real-time 
PCR.  
 
RNA was extracted using a modified TRIzol method. The dissected mosquito abdomens were 
placed in 100 μl TRI reagent (Sigma-aldrich) and homogenized in a microcentrifuge tube, the 
suspension incubated at room temperature for five minutes and then centrifuged at 12,000 g 
for 10 minutes at 4ºC. The liquid was transferred into a new microcentrifuge tube and 
homogenized for 15 seconds with 20 μl chloroform. It was again incubated at room 
temperature for 15 minutes, and then centrifuged again at 12,000 g for 15 minutes at 4ºC. The 
top aqueous phase of the three layers was transferred into a fresh tube; 50 μl isopropanol was 
added and gently mixed to precipitate the RNA. This was incubated at room temperature for 
10 minutes and then centrifuged at 12,000 g for 10 minutes at 4ºC. The supernatant was 
removed and the precipitated RNA was washed in 100 μl 70% ethanol, vortexed briefly, then 
centrifuged at 7,500 g for 5 minutes at 4ºC. The ethanol was removed and the RNA pellet 
allowed to air dry before being suspended in 35 μl DEPC water.  
 
To eliminate DNA that may have carried over during the extraction, the resuspended RNA 
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was treated with DNase I. For each sample, 1 μl DNase I and 4 μl 5X RT buffer was added, 
and incubated at 37ºC for 15 minutes. The DNase was then heat inactivated at 70ºC for 10 
minutes, and then immediately placed on ice, or into the freezer for storage.  
 
4.2.3 RNA quality assessment 
To determine the quality of the total RNA extracted, two methods were used: the traditional 
formaldehyde gel and Bioanalyzer (Agilent, USA). 
 
4.2.3.1 RNA formaldehyde gel  
To verify the RNA quality, RNA samples were electrophoresed on a 1.2% formaldehyde gel. 
RNase-free water (44 ml) was mixed with 0.6 g agarose in an RNase free container, brought 
to the boil and swirled until the agarose had dissolved. The mixture was moved to the fume 
hood, allowed to cool to 55 - 60ºC, before 5 ml 10X 3-(N-morpholino)-propanesulfonic acid 
(MOPS) formaldehyde gel running buffer was added under the fume hood, followed by 1.5 
ml 37% formaldehyde solution. Air bubbles were avoided (or removed after) while adding 
and mixing the two formaldehyde-based solutions. Ethidium bromide (2 μl; 10mg/ml) was 
also added and mixed. The liquid was then poured into a gel template and allowed to set for at 
least 30 minutes before use.  
 
To prepare the RNA samples for electrophoresis, the following reagents were mixed together: 
2.5 μl 10X MOPS running buffer, 4.4 μl 37% formaldehyde solution and 12.5 μl formamide. 
The RNA sample was then added (2 - 10 μg) and DEPC water was added to make up a final 
volume of 25 μl. The mixture was incubated at 55ºC for 15 minutes, and 5 μl orange loading 
buffer added to each sample.  
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The formaldehyde gel had to sit in 1X MOPS gel running buffer for at least 30 minutes to 
equilibrate before electrophoresis. The RNA samples were loaded onto the gel and 
electrophoresed with RNA molecular weight markers (Fermentas, EU; cat # SM1821) at 5 
V/cm for at least 45 minutes. The RNA products were visualized under ultraviolet (UV) 
illumination.  
 
4.2.3.2 Bioanalyzer  
The Agilent (California, USA) 2100 Bioanalyzer is an alternative to RNA formaldehyde gels, 
requiring less input material and can provide more information about the RNA sample than 
the traditional gel. The RNA and reagents were prepared as the manual described from the 
Agilent RNA 6000 Nano Kit (Agilent Technologies, USA). In brief, gel matrix was spin-
filtered at 1,500 g ±20% for 10 minutes, and mixed with an aliquot of the dye concentrate. 
The mix was spun at 13,000 g for 10 minutes before loading onto the RNA Nano chip using a 
special syringe and chip priming station. This was followed by 5 µl marker into each of the 
samples wells and the ladder well. RNA samples were heat denatured at 70ºC for 2 minutes, 
and 1 µl of each sample along with 1 µl of the RNA ladder were loaded onto the chip. The 
chip was then vortexed and placed into the Bioanalyzer for analysis. The software generates a 
gel and electropherogram for each samples, as well as analyzes the amount of intact and 
degraded RNA. By comparing the data to the RNA ladder, the RNA Integrity Numbers (RIN) 
for the samples were calculated, where on a scale of 1 to 10, samples with intact RNA would 
score more highly than degraded samples.  
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4.2.4 cDNA synthesis 
cDNA synthesis was performed using the SuperScript
™
 III First-Strand Synthesis System for 
RT-PCR (Invitrogen, USA). The process was performed exactly as described in the kit manual. 
Up to 5 µg of total RNA was first primed with Oligo (dT)20, incubated at 65ºC and placed on 
ice. The cDNA synthesis mix was then added and incubated at 25ºC for 50 minutes. The 
synthesis was terminated by incubation at 85ºC for 5 minutes and then chilled on ice. The 
residual RNA was removed by addition of RNase H and incubation at 37ºC for 20 minutes. 
The Nanodrop
®
 ND-1000 Spectrophotometer (Thermo Scientific, Massachusetts, USA) was 
used to assess the quantity of cDNA produced. The cDNA was stored at -20ºC or used 
immediately for other downstream applications.  
 
4.2.5 Primer design 
PCR primers for the three An. funestus immune genes were obtained and tested using several 
approaches: 1) primers designed for amplifying the immune genes in An. gambiae were tested 
on An. funestus; 2) degenerate primers based on the degeneracy of the amino acid sequence in 
the region where the An. gambiae-specific primers were located were designed and tested 
(only defensin); and 3) primers based on known amino acid and nucleotide sequences of 
homologous genes from other mosquito species, including Ae. aegypti, An. stephensi, and 
members of the An. gambiae complex were tested. Primers for cecropin were designed using 
An. stephensi, An. gambiae and An. arabiensis. Defensin primers were designed using the 
same species plus Ae. aegypti. Gambicin primers were designed using consensus sequences 
from all members of the An. gambiae complex (see Appendix 2 for all three versions of 
primer sequences).  
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A number of housekeeping/reference genes were also designed by locating conserved 
sequences across multiple mosquito species. These were needed for real-time PCR to 
establish baseline gene expression. The reference genes designed included the following: 
GAPDH, ND5, rpS7, rpL8, rpL19, 18S, rpS26, CO1 (see Appendix 2).  
 
All designed primers were subjected to NetPrimer to validate their functionality and stability 
(e.g. no hairpin, palindrome, or significant primer dimer formation). Primer sequences with 
potential to adversely affect amplification were redesigned. The primers used for PCR (both 
conventional and real-time) are listed in Appendix 2.  
 
4.2.6 PCR 
Conventional PCR was performed on the Bio-Rad C1000™ series thermal cycler (Bio-Rad 
Laboratories, California, USA). Optimal amplification of the genes was achieved using 
DreamTaq DNA polymerase (Fermentas, EU), using primers designed for targeting conserved 
regions across mosquito species. The mastermix used and conditions for each of the PCRs 
were as follows.  
 
Cecropin: 0.5mM final concentration for both primers, 1X PCR buffer, 2.5mM MgCl2, 
0.5mM of each dNTP, 200 - 300 ng DNA, 0.5U of DreamTaq DNA polymerase and made up 
to a final volume of 20 µl with double distilled water. The reactions were amplified using the 
following parameters: initial denaturation at 95ºC for 3 minutes; 40 cycles of 94ºC for 30 
seconds, 58ºC for 30 seconds, and 72ºC for 45 seconds; final extension at 72ºC for 10 minutes, 
and hold at 4ºC indefinitely.   
 
Defensin: 1mM final concentration for both primers, 1X PCR buffer, 2.5mM MgCl2, 0.5mM 
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of each dNTP, 0.5U DNA polymerase, 200 - 300 ng DNA, and made up to a final volume of 
20 µl. The reactions were amplified using the following parameters: initial denaturation at 
95ºC for 3 minutes; 40 cycles of 95ºC for 30 seconds, 55ºC for 45 seconds, and 72ºC for 45 
seconds; final extension at 72ºC for 10 minutes, and hold at 4ºC indefinitely.   
 
Gambicin: 0.5mM for both primers, 1X PCR buffer, 2.5mM MgCl2, 0.5mM of each dNTP, 
200 - 300 ng DNA, 0.5U of DNA polymerase and made up to a final volume of 20 µl with 
double distilled water. The reactions were amplified using the following parameters: initial 
denaturation at 95ºC for 3 minutes; 40 cycles of 94ºC for 30 seconds, 58ºC for 30 seconds, 
and 72ºC for 45 seconds; final extension at 72ºC for 10 minutes, and hold at 4ºC indefinitely.   
 
To determine the size of the fragments, the products were electrophoresed on 1% agarose gels 
stained with ethidium bromide (0.5 µl in 80 ml). The samples were mixed with a marker dye, 
loaded on the gel with a DNA molecular weight marker (Fermentas, EU, cat. #SM0321), and 
electrophoresed at 100 - 120 V for 60 minutes. The products were visualized under UV 
illumination.  
 
4.2.7 Cloning 
PCR products for defensin and gambicin were cloned. Prior to cloning, the PCR product was 
electrophoresed as described previously. The DNA fragments of interest were then excised 
from the gel and extracted from the agarose using the QIAquick Gel Extraction Kit (Qiagen 
Inc, California, USA, cat. #28704), as stated in the kit manual. The piece of gel containing the 
DNA fragment was weighed, and 3 volumes of Buffer QG were added to 1 volume of the gel 
(every 100 mg ≈ 100 µl) excised. The mixture was incubated at 50ºC for 10 minutes with 
intermittent vortexing. To maximize the DNA yield, 1 gel volume of isopropanol was then 
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added and mixed. The solute was added to the QIAquick spin column/collection tube and 
centrifuged for 1 minute at 17,900 x g (13,000 rpm). The flow-through was discarded, and 0.5 
ml buffer GQ was added to the column and centrifuged for 1 minute at 17,900 x g. The DNA 
was washed by adding 0.75 ml buffer PE to the spin column and centrifuged for one minute at 
the same speed. The column was spun for another minute to remove excess buffer and then 
placed into a clean 1.5 ml microcentrifuge tube. To elute the DNA, 50 µl of buffer EB was 
added to the centre of the column, allowed to stand for a minute, and then centrifuged for a 
minute. The purified DNA's concentration was determined using the Nanodrop
® 
ND-1000 
spectrophotometer (Thermo Scientific, Massachusetts, USA), and stored at -20ºC for storage 
or processed for sequencing.  
 
The Promega pGEM
®
 -T Easy Vector Systems (Wisconsin, USA, cat. #A1360) was used for 
the cloning. For optimal cloning, the insert:vector ratio was calculated to be 8:1 for all three 
genes, and the total volume of DNA per reaction was adjusted accordingly. The rest of the 
reaction consisted of 1X rapid ligation buffer T4 DNA ligase, 50 ng pGEM
®
-T Easy Vector, 3 
Weiss Unit of T4 DNA ligase, and made up to a final volume of 10 µl with nuclease free 
water. The reaction was gently mixed and incubated at room temperature for 1 hour, or at 4ºC 
overnight to maximize the number of transformants.  
 
Transformation of the ligation reaction and selection of successfully transformed colonies was 
performed using the E. cloni
®
 10G Chemically Competent Cells (Lucigen Corp, New York, 
USA, cat. #60106-1), a derivative of Escherichia coli (E. coli) that has high transformation 
efficiency by heat shock. The E. cloni
®
 cells were taken from the -70ºC freezer and thawed 
completely on ice. Sterile culture tubes were chilled on ice (one tube for each transformation 
reaction) and 40 µl of the thawed cells were added per tube. The ligation reaction was heat-
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inactivated (70ºC for five minute) and 1 - 4 µl was added and gently stirred while on ice. The 
cells were incubated on ice for 30 minutes, followed by heat shocking at 42ºC for 45 seconds. 
The mixture was then chilled on ice for another two minutes and 960 µl recovery medium 
(warmed to room temperature) was added. The cells were placed in a shaking incubator at 250 
rpm for one hour at 37ºC.  
 
 The nutrient agar plates were made up of LB medium (10 g Baco-tryptone , 5 g Bacto-yeast, 
5 g NaCl mixed in 1 L distilled water and adjusted to pH 7.0 with NaOH). Agar (15 g) was 
then added and the medium autoclaved. Once the medium had cooled to approximately 50ºC, 
ampicillin was added (final concentration of 100 µg/ml). It was further supplemented with 
IPTG (0.5mM), and X-Gal (final concentration of 80 µg/ml). The agar was poured into 
culture plates to set. The plates were used immediately, or stored at 4ºC for up to a month. Up 
to 100 µl of the transformed cell was plated per nutrient agar plate and incubated overnight at 
37ºC.  Successfully transformed cells would have the LacZ gene function disrupted and would 
appear white as they were unable to process X-Gal (untransformed colonies were blue). 
Individual colonies were picked off the plate using a sterile pipette tip and resuspended in 20 
µl double sterile water. The selected colonies were amplified using the Bio-Rad C1000™ 
series thermal cycler using the standard SP6 and T7 primers. Each reaction contained 0.2mM 
for both primers, 1X PCR buffer, 1.0mM MgCl2, 1.0mM of each dNTP, 0.5 µl resuspended 
cells, 0.5U of DNA polymerase and made up to a final volume of 20 µl with double distilled 
water. The amplification conditions were as follows: initial denaturation at 95ºC for 3 minutes; 
35 cycles of 95ºC for 30 seconds, 50ºC for 30 seconds, 72ºC for 45 seconds; final extension at 
72ºC for 10 minutes and hold indefinitely at 4ºC. The PCR products were electrophoresed on 
a 1.0% agarose gel stained with ethidium bromide, and visualized under UV illumination.  
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4.2.8 DNA sequencing 
To verify the cloning (for defensin and gambicin) and PCR (cecropin) amplicons, the products 
were sequenced using an automated sequencer. Prior to sequencing, the DNA was purified 
using either the QIAquick Gel Extraction kit, as described earlier, or the QIAquick PCR 
purification Kit (Qiagen Inc., cat. #28104). For purification of PCR products, each sample 
that was to be sequenced was mixed with 5 volumes of buffer PB. This was added to the 
QIAquick spin column/collection tube assembly and centrifuged at 17,900 x g for 1 minute. 
The bound DNA was washed with 0.75 ml buffer PE and centrifuged again at the same speed 
for a minute. The spin column was centrifuged one more time to get rid of any excess liquid. 
The QIAquick column was then placed in a clean microcentrifuge tube and 30 µl buffer EB 
was added to elute the DNA. The column was allowed to stand for a minute and centrifuged 
for a minute at the same speed. The concentration of the purified DNA was determined using 
the Nanodrop ND-1000 spectrophotometer.   
 
Sequencing was initially performed in-house using the Applied Biosystems (California, USA) 
3130 automated DNA sequencer. For each sequencing sample, two sequencing reactions (one 
for forward primer, the other for reverse primer) were prepared using the BigDye Terminator 
Cycle Sequencing kit (Applied Biosystem, cat. #4337455). Each reaction contained 1 μl 
terminator ready reaction mix, 1.5 μl 5X sequencing buffer, 50 - 100 ng of cleaned PCR 
product, 5μM of either forward or reverse primer for the target gene, and made up to 10 μl 
with Sabax water. The reactions were amplified using the following conditions: 94ºC for 1 
minute, followed by 25 cycles of 95ºC for 30 seconds, 50ºC for 20 seconds, and 60ºC for 4 
minutes. The sequencing products were then cleaned using the DyeEx 2.0 Spin kit (Qiagen, 
cat. #63204) as per kit manual. The dried sample was resuspended in 10 μl hi-di formamide 
(Applied Biosystem, cat. #4311320), vortexed and spun briefly. It was heated at 95ºC for 2 
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minutes and then placed on ice for 1 minute. The sample was vortexed and spun down again 
and pipetted onto the 96-well sequencing plate. The plate was sealed with a septum cover and 
placed into the sequencer. The resulting sequences were viewed/analyzed using the Lasergene 
DNASTAR software, or were viewed using the FinchTV software (Geospiza Inc., Washington, 
USA).  
 
Later, sequences were sent to Inqaba Biotech (Pretoria, South Africa), utilizing a similar 
automated sequencer setup.  
 
4.2.9 Semi-quantitative real-time PCR 
Real-time PCR was performed on the Bio-Rad CFX96™ Real-Time PCR detection system. 
All three genes (cecropin, defensin and gambicin) were amplified along with two reference 
genes (S26 and CO1) in accordance to the Minimum Information for Publication of 
Quantitative Real-Time PCR Experiments (MIQE) guideline to calculate relative expression 
of the immune genes. The eight reference genes initially designed were narrowed down to two 
by examining the Cq or raw data values between uninfected and infected cohort. The 
BestKeeper
©
 (Pfaffl et al., 2004) and NormFinder software (Andersen et al., 2004) were then 
used to determine the best reference genes. 
 
Cecropin and gambicin amplification were performed using the Bio-Rad iQ™ Master SYBR® 
Green Supermix (cat. #170-8880). Each reaction contained the following: 0.5 mM of both 
primers, 1X SYBR master mix, 50 - 60 ng DNA, and made up to a final volume of 20 µl with 
double distilled water. Amplification was as follows: initial denaturation at 95ºC for 5 minutes; 
40 cycles of 95ºC for 10 seconds, 55ºC for 15 seconds, and 72ºC for 15 seconds; final 
extension at 72ºC for 5 minutes, and melt curve capture from 60 - 95ºC with increments of 
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0.5ºC for 5 seconds and fluorescence capture for SYBR Green (510 - 530 nm) at every 
increment. 
 
Defensin was amplified using the Applied Biosystem SYBR kit (cat. #4304886). Each 
reaction contained the following: 0.4mM of both primers, 1X SYBR master mix, 0.5mM of 
each dNTP, 2.5mM MgCl2, 50 - 60 ng DNA, and made up to a final volume of 20 µl with 
double distilled water. Amplification was as follows: initial denaturation at 95ºC for 5 minutes; 
40 cycles of 95ºC for 10 seconds, 56ºC for 15 seconds, and 72ºC for 15 seconds; final 
extension at 72ºC for 5 minutes, and melt curve capture from 60 - 95ºC with increment of 
0.5ºC for 5 seconds and fluorescence capture for SYBR Green (510 - 530 nm) at every 
increment. 
 
Relative expression levels of the immune genes were all performed in triplicate runs, and 
calculated using Cq values obtained for the target gene and accompanying housekeeping 
genes (Pfaffl et al., 2001). The formula used is as provided below. 
 
Relative expression ratio = (Efficiency of target)
ΔCq Target (treated - untreated)
 
                    (Efficiency of HKG)
 ΔCq Target (treated - untreated) 
 
4.3 Results 
 
4.3.1 An. funestus infection 
Infection rates for the cohorts used for RNA extraction and subsequent AMP expression 
analysis varied between 5 - 20% (Table 4.1), which were within the expected range for the 
strains.   
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Table 4.1: Infection rate for the cohorts used for RNA extraction. 
Colony (total no. for three replicates) Infection rate (±std dev) (%) 
FUMOZ (n = 32) 15.5 (± 6.0) 
FUMOZ-R (n = 33) 16.3 (± 2.9) 
FUMOZ-BS (n = 35) 5.2 (± 0.3) 
 
4.3.2 RNA quality assessment 
All samples were initially subjected to formaldehyde gel electrophoresis or Agilent RNA 
Nano chip analysis to determine the integrity of the RNA. Gel electrophoresis typically 
showed strong 18S bands and weak 28S, 5.8S and 5S bands (Figure 4.1). The bioanalyzer 
calculated the integrity of the RNA based on the amount of 28S and 18S RNA as well as other 
smaller fractions (Figure 4.2). RNA samples used had at least a value of 5.5 (out of 10) before 
proceeding to the next steps.  
 
 
Figure 4.1: Extracted RNA on a formaldehyde gel. Lanes 1 - 2: FUMOZ; 3 - 4: FUMOZ-
BS; 5: FUMOZ-R; 6: negative control; 7: molecular weight marker (Fermentas High 
Range RNA ladder; cat. #SM1821). 
200 bps 
500 bps 
1 000 bps 
1 500 bps 
2 000 bps 
3 000 bps 
4 000 bps 
6 000 bps 
1         2         3          4          5         6           7 
28S 
18S 
5.8S 
5S 
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Figure 4.1: A bioanalyzer electropherogram of a RNA sample. 
 
 
 
4.3.3 Immune genes PCR  
PCR for the three immune genes using the An. gambiae primers produced zero amplification 
or highly non-specific results (Figure 4.3). The primers were designed to produce fragments 
of 400 - 600 bps depending on the gene targeted, but a number of varying size products were 
seen, along with streaks showing non-specific amplifications. Degenerate primers for defensin 
were designed to amplify shorter fragments of 300 - 400 bps, but again highly non-specific 
results were obtained producing streaks as opposed to short segments of DNA (Figure 4.4). 
Furthermore, in both sets of primers, the target fragments (where present) were either 
extremely weak compared to the non-specific products or non-existent. Optimizations on both 
sets of PCRs included varying temperature, primer concentration, starting material 
concentration, MgCl2 concentration, and using different types of Taq polymerase, but none of 
these optimization produced satisfactory results. It was difficult to isolate and clone the 
expected products due to the constant streaks often seen in the PCRs.  
 
 1   2    3    4   5    6    7 
Combined 
28S & 18S 
peaks 
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Figure 4.2: A and B: Defensin, gambicin and cecropin PCR on An. funestus samples using An. 
gambiae specific primers. A: lanes 1 – 3, defensin; lane 4, molecular marker (100 bps); lanes 
5 – 7, gambicin. B: lanes 1 – 4, cecropin; lane 5, molecular marker (100 bps). 
  
Figure 4.3: Defensin PCR using An. funestus with degenerate primers. Lanes 1 - 6: defensin 
amplification; lane 7: molecular marker (100 bps). 
 
PCR using primers targeting conserved regions across multiple mosquito species produced the 
best results of the three approaches. The primers were designed to produce amplicons 
between 100 - 250 bps in size. Cecropin PCR produced only one amplicon with almost no 
optimization required. Gambicin produced some non-specific products along with the 
theoretical target. All fragments produced were less than 300 bps, which was a significant 
improvement, as this was closer to the expected product size. The defensin PCR had more 
1     2     3    4    5   
B A 
     1     2     3    4     5     6    7    
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non-specific products, but was also an improvement as all the amplicons were below 300 bps 
and there were less non-specific fragments compared to the An. gambiae and degenerate 
primer sets (Figure 4.5).  
 
 
Figure 4.5: Defensin, gambicin and cecropin PCR using cross-species conserved region 
primers on An. funestus. Lanes 1 and 14: molecular marker (100 bp); lanes 2 - 5: defensin; 
lanes 6 - 9: gambicin; lanes 10 - 13: cecropin. 
 
 
Verification of the PCR was subsequently based on using the primers designed using multiple 
mosquito species. As defensin and gambicin PCRs produced multiple amplicons which were 
close to the expected product, all the amplicons were cloned prior to sequencing. For each 
product, 20 - 30 clones were selected and further amplified using the SP6T7 PCR (Figure 4.6). 
Three to five clones were then selected and processed for sequencing. As cecropin PCR only 
produced a single product, it was directly processed for sequencing.  
 
The contigs produced by the clones were subjected to the Basic Local Alignment Search Tool 
(BLAST) which matched them to sequences in the National Centre of Biological information 
 1        2        3        4       5        6        7        8       9       10     11      12      13     14    
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(NCBI) Genbank nucleotide database. For all three genes, the amplicon of the expected size 
was able to align with homologous genes in other mosquito species. The amplicons were all 
within 20 bps of the originally designed size, and were 95 - 99% similar to the genes in other 
mosquito species (see Appendix 3). The products did not align with any other known genes in 
the mosquito, indicating the primers' specificity. Once products from the gambicin and 
defensin PCR were confirmed to be correct, the PCR were optimized to produce only the 
single amplicon (Figure 4.7) 
 
Reference genes were designed in a similar manner, and underwent the same process to 
confirm that the correct sequences were amplified in An. funestus.  
 
 
Figure 4.6: SP6T7 PCR from gambicin cloned inserts. Lane 1: molecular marker (100 bps); 
lanes 2 - 20: PCR products from selected transformed colonies; lane 21: negative control. 
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Figure 4.7: gambicin (A) and defensin (B) PCR products using redesigned primers. A: lane 1, 
molecular marker (100bp); lanes 2 – 3, negative control; 4 – 5, gambicin. B: lane 1, molecular 
marker (100bp); lanes 2, 4, 6, negative controls; 3, 5, 7, defensin. 
 
4.3.4 Real-time PCR  
Relative quantification of expression for all three genes was carried out using real-time PCR. 
Two reference genes were selected with the target genes to obtain meaningful data. Using the 
Bestkeeper and Normfinder software, CO1 and S26 were considered two of the better 
reference genes to be used in the study (see Appendix 4). The Normfinder software 
considered ND5 and rpL8 to be the best pair of reference genes to be used in combination, but 
when the real-time PCR runs were performed, there were non-specific amplicons for these 
genes at the amplification parameters designed for the immune genes. As a result, the two 
genes with the best stability values were considered - CO1 and S26. With regard to 
Bestkeeper, both CO1 and S26 were considered viable, thus there was agreement between the 
two software packages for the reference genes used in this study.  
 
  1     2    3     4     5    6     7     1    2    3    4    5      
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Figure 4.8: Expression of AMP genes in individual An. funestus strains, plotted against both 
reference genes. 
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When the immune genes were analyzed against both reference genes, gambicin was 
consistently the lowest expressed across all three An. funestus strains. Gambicin expression 
was typically highest 24 hours pi and decreased thereafter, although there was a slight 
increase at 14 days pi in FUMOZ-BS. Cecropin expression in all three strains showed 
increased activity as the infection progressed, although the expression level at 24 hours pi 
differed with FUMOZ-R initiating a much stronger expression than FUMOZ and FUMOZ-BS. 
However, during the other time points, cecropin expression was always highest in FUMOZ-
BS, followed by FUMOZ and FUMOZ-R (Figure 4.8).  
 
Defensin was the most varied of the three, maintaining very low levels in FUMOZ throughout 
the infection. Expression of the gene was at its peak at 14 days pi in both FUMOZ-R and 
FUMOZ-BS, but in FUMOZ-R defensin expression was low while FUMOZ-BS began with 
high expression. Co-expression of the AMPs was the strongest in FUMOZ-R with defensin 
and cecropin both having similar levels of increased expression through most of the time 
points (Figure 4.8). Combined results from triplicate experiments showed large variations 
between each discrete run.  
 
4.4 Discussion 
In order to isolate and analyze expression of the AMP genes in An. funestus, some 
assumptions had to be made in light of the relative absence of genomic data (particularly 
when compared to other well studied mosquito vectors). It has been established that the 
dipteran innate immunity system is a highly conserved one, with the same pathways activated 
by the same pathogens and producing highly similar, if not identical effector molecules. This 
is further supported by the presence of AMPs across the mosquito genera (Culex, Anopheles, 
and Aedes), with largely homologous sequences and activation pathways for these peptides 
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despite divergent evolution (Holt et al., 2002; Shin et al., 2002; Bartholomay et al., 2003). 
Given these data, it was assumed that An. funestus AMPs were highly likely to have similar 
sequences to An. gambiae, especially when the genes have been conserved across different 
genera of mosquitoes. 
 
The first attempt at isolating the AMP genes in An. funestus was using the primers designed 
for An. gambiae. This was based on the assumption that An. gambiae and An. funestus 
immune genes should be extremely similar to each other so that the An. gambiae primers 
would be able to bind to the same region in An. funestus. This was not the case for any of the 
genes as the targeted fragments were often weakly amplified and a large number of non-
specific fragments were also produced. Degenerate primers based on amino acid sequences 
were then designed to target the same region as the An. gambiae primers. This design process 
was only performed on defensin as a trial attempt. When it was found that the degenerate 
primers were more problematic than using the An. gambiae primers (only non-specific 
products were produced), this approach was abandoned.  
 
In light of the inefficient degenerate primers, the third round of primer design relied on both 
amino acid and nucleotide sequences, targeting conserved regions elsewhere on the AMP 
genes. In addition, the primers were designed to amplify smaller regions (typically less than 
200 bps), which was more in line with the optimal amplicon size when using real-time PCR. 
For cecropin, this worked exceptionally well, as only one amplicon was produced, and it was 
confirmed to be the desired product using DNA sequencing. Defensin and gambicin were 
subjected to cloning due to a number of non-specific products under normal PCR conditions. 
Once the target amplicon was identified by sequencing, the PCR was optimized to produce 
only the single band. Real-time PCR protocols were then created from the optimized 
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conventional PCR to quantify the gene expression. Sequences from the amplified regions in 
all three genes showed greater than 90% similarity to other known anopheline AMP genes. As 
the primers were targeting conserved regions of the genes, the high degree of sequence 
homology was expected. Whether this homology extends to the complete sequence remains to 
be determined. 
 
The three AMP genes' expression levels were evaluated against the reference genes rpS26 and 
CO1 by examining parasite infected samples at various times during the infection, and a 
comparison made across all three An. funestus strains. Some associations have been made 
between AMPs and anti-parasitic responses in An. gambiae and other vectors, but the data are 
mostly limited to the early stages of infection and little is known about the interactions 
between the AMPs and sporozoites. It was initially hoped that the gene expression study could 
be performed on the abdomen and the salivary glands, particularly in the late stage of the 
infection, but isolation of sufficient material to perform cDNA synthesis proved to be difficult. 
The effects of P. berghei infection on AMPs expression were thus limited to the abdominal 
carcass here.  
 
AMP expression profiles in An. funestus suggested that of the three peptides, gambicin was 
least affected by P. berghei infection. In An. gambiae, gambicin is expressed throughout the 
whole organism barring the head and extremities. It was found to be significantly up-
regulated in the midgut and abdomen 24 hours post infected bloodmeal, and was also up-
regulated from 11 - 21 days when sporozoites were released into the haemolymph for salivary 
gland invasion (Vizioli et al., 2001). The level of expression detected in An. funestus was 
initially similar to that of An. gambiae, but then decreased to two-fold or less in the older 
infected An. funestus. The peptide is therefore still up-regulated in late infection, but not as 
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significantly so in An. funestus.  
 
Defensin had the most varied expression profile in An. funestus, as there were no consistent 
patterns across the strains. In FUMOZ, the peptide was constitutively expressed, except at 24 
hours pi where there was a slight increase in expression. In FUMOZ-R and FUMOZ-BS, 
however, it reached high levels at 24 hours and 14 days pi. Furthermore, defensin expression 
in FUMOZ-R peaked at 14 days, while in FUMOZ-BS it was at 24 hours. The one 
commonality was that at 24 days, the expression level was very low in both strains. This 
suggested that defensin responded to the ookinete transition at 24 hours and possibly the early 
stages of sporozoite release into the haemolymph. This is similar to the expression profile in 
An. gambiae, where defensin was detected in An. gambiae midgut and salivary glands, and 
was highly expressed in the midgut/abdomen during early stages of infection, with lower 
activity around 10 - 15 days, but was then up-regulated at the salivary glands during 
sporozoite invasion (Dimopoulos et al., 1998). 
 
Cecropin expression at 24 hours pi varied between the species. FUMOZ-R and FUMOZ-BS 
strongly expressed the peptide while the expression level was low in FUMOZ. However, 
cecropin expression in all strains reached high levels as the infection progressed. This is 
significantly different to the other two peptides that were at low levels by 24 days pi. 
Furthermore, the level of expression after 24 hours pi seemed to correlate with the parasite 
infection intensity of the strains, as FUMOZ-BS, with the highest parasite load, had the 
highest cecropin expression level, and FUMOZ-R had both low parasite load and low 
cecropin expression. It is possible that unlike the other two AMPs, cecropin is induced by the 
increase in the number of sporozoites circulating in the mosquito as the infection reaches the 
end stage. However, if this is the case, it also demonstrated that cecropin alone is not very 
117 
 
effective at reducing the number of parasites, as all three An. funestus strains remained 
infective despite increasing expression of the AMP gene. Currently there is no other data 
examining the effect of cecropin against sporozoites in vivo or in vitro, so further investigation 
may be necessary to understand the interaction between cecropin and parasite infection in the 
mosquito.  
 
When the AMPs expression levels were examined individually, only cecropin displayed a 
pattern correlating to parasite development and infection intensity. If the AMPs expression 
were examined together, however, it appeared that in the more parasite-refractory strain, 
FUMOZ-R, there was more consistent co-expression of cecropin and defensin through the 
infection. Although FUMOZ-BS also had some increased co-expression at 14 days pi, it was 
not as high as in FUMOZ-R, and the defensin expression was lower than cecropin. Therefore, 
while the stand-alone response from cecropin is clearly inadequate in dealing with the 
parasites, the co-expression of defensin and cecropin may be a viable combination to reduce 
sporozoite load as demonstrated by Kokoza et al. (2010) and may warrant further 
investigation. 
 
The large standard deviations that were typically seen throughout the gene expression results 
were likely due to individual samples, sample size and the varying infection rates. As the 
infection rate in An. funestus was low (20% at most), in any of the biological replicates 
collected, the majority of the individuals would have been uninfected. With the current state 
of technology, it was impossible to determine the infection status of each and every female 
used in the cohorts for the gene expression, particularly in the early stages of the infection, as 
the parasite would be present in the mosquito but that is no guarantee that the infection would 
have been successfully completed. Later in the infection, it is possible to determine the 
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infection status by dissections, but to do so would lead to the loss of significant amount of 
material (and contamination) that could be processed for RNA. This led to the compromise 
where the infection rate had to be determined retrospectively. There is also no way of 
determining the infection intensity without losing material, and thus the parasite load can vary 
between infected individuals, leading to further variations in the result. It may be of use to 
devise a method where it is possible to determine the early infection stages, as well as a more 
efficient molecular method to detect the presence of oocysts, as opposed to relying on 
microscopy.  
 
Although progress has been made in identifying components of the mosquito immune system, 
much of the details regarding the mechanisms and interactions remain unclear, particularly in 
the late stage of the infection. The identification of AMPs and other immune molecules like 
TEP and LRIM acting in the early stages of Plasmodium infection showed that the mosquito 
immune system has a wide array of responses at its disposal (Dimopoulos et al., 1997, 1998; 
Christophides et al., 2004). However, the typical immune responses are clearly not sufficient 
to eliminate the parasite. This is likely an effect of co-evolution between the vector and 
parasite, a balancing act for the mosquito between fitness cost and succumbing to 
Plasmodium infection, but even the true effect remains unresolved due to inconsistent data 
(Ferguson & Read, 2002). Nonetheless, research into artificially bolstering the immune 
reactions against Plasmodium in the vectors has shown some success and AMPs are possible 
candidates in such approaches (Cohuet et al., 2006; Kokoza et al., 2010). 
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Chapter 5: General discussion, future research and conclusion 
 
5.1 General discussion 
The large body of work dealing with An. funestus up to now has been concerned with 
physiological characterization and behavioural patterns (e.g. Gillies & de Meillon, 1968; 
Charlwood et al., 2003; Spillings et al., 2010; Wondji et al., 2011; Coetzee & Koekemoer, 
2013), with some focus on cytogenetic data (Sharakhov et al., 2002;  Wondji et al., 2005, 
2007). There are also some comparative analyses with other malaria vectors (Coetzee et al., 
2006; Charlwood, 2011). More recently, with the advent of molecular biology techniques, 
inroads have been made with regard to the species' insecticide resistance profile and related 
mechanisms (Amenya et al., 2008; Okoye et al., 2008a, b; Spillings et al., 2008; Coetzee & 
Koekemoer, 2013). These studies are important for understanding how best to control An. 
funestus using the available arsenal of insecticides. Efforts are now also being directed 
towards obtaining comprehensive sets of genomic/protein data, such as the sialome (Calvo et 
al., 2007), salivary gland proteome (Fontaine et al., 2012), as well as the complete genome 
sequence for the organism (Anopheles Genomes Cluster Committee, 2008). However, one 
critical issue that has not been addressed thus far is the vectorial capacity of An. funestus in 
the laboratory setting.  
 
5.1.1 An. funestus-P.  berghei infection 
Anopheles funestus is a highly competent vector of human malaria due to its extremely 
anthropophilic and endophilic nature. This, however, does not necessarily make it a useful 
vector model in the laboratory. The failure to infect the species over six decades ago using P. 
berghei (van den Berghe, 1954) may have been more due to a lack of understanding of both 
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vector and parasite biology than a true indication of the vector's permissibility towards the 
parasite. In the intervening decades, malaria vectors were often found to be susceptible to 
infection with other Plasmodium species that they would never come into contact with 
naturally (Garnham, 1966; Bruce-Chwatt, 1978). These unnatural pairings have advanced our 
understanding of vector-parasite interactions, and the question arose as to whether An. 
funestus can be a host of P. berghei under the correct conditions. The hypothesis has been 
proven correct (Xu et al., 2013; Lo et al., 2013) and in the present study all An. funestus 
colonies were shown to be viable vectors, albeit at different rates.  
 
Trends and patterns seen in other Plasmodium infection models are generally consistent with 
those observed thus far in the An. funestus-P. berghei infection system. The malaria parasite, 
for the duration of its lifecycle in the invertebrate host, seems to be constantly living on a 
knife's edge as only a small minority of the mosquitoes is ever infected, and numerous 
bottlenecks during development in the insect severely limit parasite numbers. However, this is 
possibly a false interpretation of how vulnerable the parasite is in the mosquito, as the parasite 
is consistently able to survive under these adverse conditions. This demonstrates that 
extensive co-evolution and co-adaptation has occurred between the two organisms, where 
both suffer to some extent but are still able to thrive. There is obviously no such co-evolution 
between unnatural vector-parasite pairings, but the fact that P. berghei still follows a similar 
pattern of development in An. funestus indicates that there are significant similarities between 
Plasmodium species to make An. funestus-P. berghei infection system a useful alternative in 
malaria research. The An. funestus-P. berghei infection system thus provides new research 
opportunities for studying the immune system in An. funestus and for comparative studies 
with other vector-parasite systems.  
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Perhaps the most significant result from the successful infection of An. funestus was that the 
insecticide resistant phenotype was present alongside low parasite infection intensity, and vice 
versa. There are very little data concerning the overlap between vector-parasite interactions 
and vector-insecticide interactions for anopheline mosquitoes, and some of these results are in 
conflict with one another (Christophides et al., 2004; Vontas et al., 2004). This is the first 
indication that there is a possible association between the two phenotypes in An. funestus, 
which could have significance for vector control and malaria transmission.  
  
5.1.2 2La and P. berghei infection in An. gambiae 
The association of phenotypes (e.g. insecticide resistance) with genotypes (e.g. paracentric 
inversions) has long been an important area of research for An. gambiae. A particularly 
important genotype is the 2La paracentric inversion, which has been linked to numerous 
environmental adaptations, and evolutionary divergence of the species (Coluzzi et al., 1979; 
Petrarca & Beier, 1992; Brooke et al., 2000; Riehle et al., 2006; Gray et al., 2009). 
Quantitative trait loci (QTL), co-localized with mutations in the sodium channel gene and the 
γ-aminobutyric acid (GABA) receptor associated with insecticide resistance, have also been 
shown to be in the inversion or in the vicinity thereof (Holt et al., 1996; Ranson et al., 2004; 
Zheng et al., 1996). What prevented the use of 2La as an efficient marker in routine vector 
surveillance was that the cytogenetic technique was the only means of identifying inversions 
for almost four decades. This issue was recently overcome when the 2La breakpoints were 
sequenced and a protocol designed to identify the rearrangements by PCR (Sharakhov et al., 
2006; White et al., 2007). The molecular karyotyping worked well in all the An. gambiae 
colonies tested in this study and corresponded perfectly to cytogenetic observations on the 
same individuals.  
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Further molecular karyotyping of P. berghei infected females from 2La heterozygous colonies 
showed a bias towards the 2La inversion even when the population from which the infected 
cohort were drawn were not 2La dominated. There is thus yet another possible genotype-
phenotype association for 2La with regard to P. berghei infection. This is not the first time the 
2La inversion has been associated with parasite interaction, as the PRI is located within the 
inversion along with a number of immune genes (Niare et al., 2002; Osta et al., 2004; Riehle 
et al., 2006).  
 
There appears to be a commonality between insecticide resistance and parasite refractoriness, 
and in this study, the presence of 2La in the An. gambiae colonies seems to be a marker for 
both dieldrin susceptibility as well as parasite susceptibility. It is currently unknown whether 
constant parasite infection or insecticide pressure would drive the 2La
+
 arrangement to 
dominance. Perhaps neither would apply any selection pressure on the genotype since 
previously tested colonies retained 2La
+
 at high levels despite an absence of selection pressure 
(Brooke et al., 2000). Furthermore, as the 2La inversion has an effect on the ability of An. 
gambiae to adapt to drier climates, it is possible that the xeric An. gambiae populations may 
be better hosts to Plasmodium than their mesic counterparts. The relation between the 2La 
inversion and parasite refractoriness would thus need to be investigated in more detail, since it 
also has the potential to impact on the species' insecticide resistance and climate adaptation 
profiles. If 2La does influence vectorial capacity, the chromosomal arrangement's 
involvement in malaria transmission may be even more complex than previously thought. 
 
In An. funestus, some data are available for insecticide resistance mechanisms and the 
correlating QTLs, where similar genes (GSTs, mixed function oxidase, cytochrome P450s) 
and mutations (GABA receptor) are also involved in An. gambiae (Brooke et al., 2011; Okoye 
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et al., 2008; Wondji et al., 2007). This shows that there are significant similarities between An. 
gambiae and An. funestus in terms of insecticide resistance mechanisms. Given that An. 
funestus has numerous paracentric inversions (albeit not as many as An. gambiae), it is 
possible that some of these inversions may have similar influences on the An. funestus 
phenotypes. Cytogenetic techniques thus may have an important place in An. funestus 
research, as data on how paracentric inversions influence An. funestus phenotypes remain 
largely incomplete.  
 
5.1.3 Expression of AMPs of  An. funestus during P.  berghei infection 
The successful infection of An. funestus strains presents not only the first set of laboratory 
infection data for the species, but also one of the few sets of results where both insecticide 
resistance and parasite refractory phenotypes are shown in the experimental cohorts. Infection 
in the insecticide resistant strain of An. funestus displayed the lowest oocyst and sporozoite 
counts of the three FUMOZ colonies. Conversely, the insecticide susceptible strain was the 
most heavily infected, with parasite numbers comparable to those detected in other anopheline 
vectors. Anopheles funestus thus demonstrates a positive correlation between insecticide 
resistance and parasite refractoriness. The results here are consistent with most published data 
(Vontas et al., 2001; Christophides et al., 2004), and it is generally thought that the higher 
levels of insecticide detoxification enzymes conferring resistance usually facilitate better anti-
parasite responses (Vontas et al., 2001, 2004). Nonetheless, insecticide resistance in 
anophelines is brought about by a number of different detoxification mechanisms depending 
on the class of insecticide the insect is exposed to. Further investigations are necessary, 
therefore, to determine whether resistance to other insecticides aside from permethrin would 
lead to the same results. 
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As this is the first time that laboratory colonized An. funestus has been successfully infected 
with any Plasmodium species, no data exist for parasite resistance mechanisms, or any related 
information (such as resistance QTL) in this species. In other insects, the AMP proteins were 
among the first molecules to be examined for their properties and functions, so the three best 
characterized AMPs in An. gambiae - cecropin1, defensin1, and gambicin - were targeted in 
this study of An. funestus, and their expression levels monitored over the course of the P. 
berghei infection. All three genes had increased expression 24 hours pi, and were at least 
constitutively expressed throughout the remainder of the infection, showing that they were 
active as immune responses. Although there were different patterns of AMPs expression 
between the FUMOZ strains, it was clear that the AMPs had no strong anti-malarial properties 
as all three An. funestus strains were able to sustain the infection despite the increased 
expression. 
 
Nonetheless, AMP participation in anti-Plasmodium responses should not be disregarded 
entirely. Mosquito immune responses are clearly multifactorial, with complex interactions 
between all the components. Of all the Plasmodium-killing mechanisms identified thus far, 
none has been shown to lead to total elimination of the parasite, and the molecular basis for 
these mechanisms is usually unresolved (Christophides et al., 2004). The other point that 
should be raised is that the AMPs were all previously examined in isolation to one another. 
This is obviously necessary to determine the standalone effect of the genes/proteins, but it 
cannot reliably inform us what the AMP's true effect is when acting in concert with other 
immune factors, and certainly not within a fully functional in vivo setting. A good example of 
combined factors producing more profound anti-Plasmodium responses than the standalone 
factors was demonstrated by Kokoza et al. (2010), where over-expression of defensin and 
cecropin together in Ae. aegypti was able to reduce P. gallinaceum oocyst numbers, and the 
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sporozoites were unable to make it to the salivary glands. This was not seen when the two 
AMPs were examined separately in An. gambiae. Different vector-parasite combinations may 
have led to such a difference, but the fact that higher cecropin and defensin co-expression was 
observed here in the more parasite refractory An. funestus strain, lends some credence to the 
idea that co-expression of AMPs may be an option in reducing parasite load in the mosquito.  
 
Most AMP research have been focused on the effects on ookinetes and oocysts invasion 
(Richman et al., 1997; Dimopoulos et al., 1997; Dimopoulos et al., 1998; Vizioli et al., 2000; 
Vizioli et al., 2001, 2001a;  Tahar et al., 2002). The reason for the focus is that if the early 
stages can be eliminated, the parasite cannot develop further and spread. The immune reaction 
against sporozoites in the haemolymph and salivary glands is also considered to be less 
dramatic than those launched against oocysts and ookinetes (Christophides et al., 2004). With 
the amplification factor from oocysts-to-sporozoites being an 2, 000 - 8, 000 fold increase, 
any immune responses mounted is considered to have no substantial effect on parasite 
transmission by that stage (Christophides et al., 2004). However, there have been little data 
indicating that complete elimination of the parasite in the mosquito is possible by only 
targeting the pre-sporozoite stages without selecting for enhanced melanization/encapsulation 
phenotype. Furthermore, recent data suggest that even if low number of oocysts are present, it 
is possible to prevent sporozoite invasion of the salivary glands using AMPs (Kokoza et al., 
2010). Expression of AMPs in An. funestus indicates that they are induced by the presence of 
the parasite, and even if the peptides alone are not able to reduce the parasite load, activation 
of other immune reactions in conjunction with AMPs may provide better responses to the 
infection. It would therefore be prudent to further investigate what interactions exist between 
the AMPs (and other immune factors) when sporozoites are released into the haemolymph and 
during salivary glands invasion. 
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The question of how insecticide resistance in mosquitoes affects parasite refractoriness (and 
vice versa) has largely not been addressed, not just in anophelines, but also other mosquito 
vectors such as Culex and Aedes species. One of the few investigation examining this 
interaction showed that in insecticide resistant Cx. quinquefasciatus (which has increased 
esterase activity) the development of W. bancrofti larvae in the gut cells were affected 
(McCarroll et al., 2000). Other attempts at correlating the two phenotypes has usually led to 
conflicting results that require further investigation (Yan et al., 1997; McCarroll et al., 2000; 
McCarroll & Hemingway, 2002; Vontas et al., 2004). While the aim of this study was not to 
show if there are any relationships between insecticide resistance and parasite refractoriness, 
the results indicate that there appears to be some correlation between the two. In this case, 
permethrin resistance in An. funestus is related to increased refractoriness towards the parasite. 
This would have significant repercussions for vector control and malaria management. If 
mosquitoes with pyrethroid resistance carry less sporozoites, the increased insecticide 
resistance may not be a total loss, as it may be possible to induce the mosquito immune 
system to be a little more effective at eliminating the parasite, as opposed to an extensive 
modification of the immune response. It would also be interesting to determine whether 
insecticide resistance will drive the selection of parasite resistance (or vice versa), as currently 
there is no relevant data for this.  
 
The data presented here shows in part the highly complex nature of the vector-mosquito 
interaction, whether it is purely between the two organisms, or with regard to other factors 
such as insecticide resistance. Although one of the key tenets of a good scientific experiment 
is to observe the effect of only one variable while controlling all others, this tends to dismiss 
the complexity that is inherent in an organism, or interactions between organisms. It is rare for 
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biological components to have a single interaction with one other component in vivo, thus a 
good experiment may not necessarily produce accurate results truly reflective of the real 
conditions. As mentioned above, the role of AMPs in Plasmodium infection is a good example 
of this. Characterization of the AMPs in An. gambiae showed largely weak anti-Plasmodium 
effects when examined separately, but when combined, they may generate more effective 
responses than previously thought. Similarly, parasite refractoriness has rarely been examined 
in conjunction with insecticide resistance, but the few results that are available seem to 
indicate that there are interactions between the two. The single variable experiments are also 
likely to have contributed to the unresolved question of fitness versus survival cost incurred 
by mosquitoes during Plasmodium infection, given the complexity of such an issue.  The 
resolution of these multi-factorial questions may require a combination of experiments 
simultaneously targeting various aspects of the vector and parasite biology to truly understand 
the interplay between the organisms, and the environments they inhabit.  
 
5.2 Future research 
The possible uses for the An. funestus-P. berghei infection system in the future, whether as a 
standalone infections model or to provide a comparison with existing infection systems, are 
numerous. A few possible directions that link directly to results presented in this thesis are 
given here.  
 
The infection of An. gambiae complex colonies using P. berghei at VCRL is the first set of 
infection results for these colonies since their establishment. The infection rates obtained for a 
number of the older colonies that have been used in laboratories elsewhere (e.g. G3 strain), 
are lower than previously observed. The causes of this difference are unknown and have been 
speculated upon in earlier parts of the thesis, but investigation into why there is a change in 
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infection rate may be useful if these colonies are to be used as reference or baseline controls 
in the future. Similarly, the change in 2La frequency in the heterozygous An. gambiae 
colonies should be investigated, especially considering that the inversion can influence a 
number of phenotypic expressions in the mosquito.  
 
Paracentric chromosomal inversions like 2La in An. gambiae and their effects on the species' 
evolution and adaptations are well studied. Anopheles funestus does not possess as many 
paracentric inversions as An. gambiae, and it is largely unknown if there is any association 
between An. funestus inversions and physiological adaptations. Given the similarity between 
An. gambiae and An. funestus (e.g. overlapping habitats, vectorial capacity, insecticide 
resistance mechanisms), and that An. gambiae is highly influenced by its paracentric 
inversions, the inversions in An. funestus should be examined in greater detail. While the An. 
funestus whole genome sequence will provide a wealth of data, especially if homologous and 
orthologous sequences to the An. gambiae genome can be found, it should be remembered 
that cytogenetics on An. gambiae decades earlier, revealed significant physiological and 
evolutionary correlations prior to determination of the An. gambiae genome (a few examples 
are Coluzzi et al., 1977, 1979, 1985; Davidson & Hunt, 1973; Green, 1972; Green & Hunt, 
1980; Hunt, 1972; Petrarca & Beier, 1992; Brooke et al., 2000). Although cytogenetic 
techniques require specific expertise, these skills are necessary to correlate physical traits with 
chromosomal variations that the molecular techniques are not as well suited for.  
 
The quantitative study of the parasite infection indicated there were some associations 
between insecticide resistance and parasite refractoriness in An. funestus. The data on the 
association of the two phenotypes in mosquitoes are severely limited at this point, despite the 
impact these two traits have on vectors and disease control. More attention needs to be given 
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to understanding if and how the two phenotypes affect each other and how this may lead to 
better methods for controlling malaria and other vector-borne diseases.  
 
The analysis of three AMPs in An. funestus during P. berghei infection is the first step to 
understanding the immune response in An. funestus. There remain a large number of immune-
related genes/proteins that can be examined (e.g. GNBP, LRIM, TEP), provided homologues 
are found in An. funestus. Data mining the An. funestus genome will facilitate this process. It 
would also be important to examine these immune-related genes/proteins in conjunction with 
one another, and not as standalones, as their combined effect may be more significant than 
when they are examined separately.  
 
Lastly, the infection of An. funestus using P. falciparum remains the ideal infection system to 
strive for. The caveat for using murine (or any other non-human) malaria models to 
extrapolate data regarding anopheline-P. falciparum infections remains. Multiple papers have 
addressed this issue, demonstrating discrepancies between unnatural vector-parasite pairings 
and the normal pairing found in nature (Dimopoulos, 2003; Aguilar et al., 2005; Cohuet et al., 
2006; Dong et al., 2006; Michel et al., 2006). Research using P. berghei thus may not 
necessarily provide  results relevant to P. falciparum, but can be useful in conjunction with 
other studies and more research (Cohuet et al., 2006). Until such time, the use of P. berghei 
makes a good starting point for investigating An. funestus-Plasmodium interactions, and 
infection of the species using P. berghei ookinete cultures may be the next step towards 
establishing infection with P. falciparum. 
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5.3 Conclusion 
 
Malaria research has advanced significantly in the past few decades, in part due to better 
understanding of the vector biology, physiology, and vector-parasite interactions. The use of 
unnatural vector-parasite pairing has been the mainstay to deciphering the complex relation 
between the two organisms, and results here have provided new data and options for this area 
of research. Most of the Anopheles gambiae complex species tested here were shown to be 
competent vectors and can now be used with confidence as the targets or as references in 
future infection-related experiments. The successful development of P. berghei in An. funestus 
provides a novel infection system that represents a significant step forward for An. funestus 
research.   
 
Infection of both An. gambiae and An. funestus with P. berghei produced results where the 
infection can be correlated to other phenotypes, genotypes and molecular expression. 
Understanding how the mosquitoes' genetic makeup influences its phenotypic expression is 
critical to vector control and disease management, especially if phenotypes of increased 
resistance/refractoriness are involved. Molecular mechanisms of resistant/refractory 
phenotypes have typically been studied in isolation, but there are indications that it is much 
more complex in vivo, where pathways and interactions can overlap, influencing more than 
just one trait. Furthermore, these traits often exist as a gradient, and not absolute values, thus 
further complicating the roles and effects of the factors and genes involved. 
 
The increased understanding of the genetic basis of insecticide resistance and parasite 
refractoriness in anopheline mosquitoes makes the use of genetically modified mosquito  part 
of the final solution to malaria eradication ever more promising. Such understanding 
ironically also reveals more complexities that exist within the organism and of its interactions 
131 
 
with Plasmodium. Anopheles funestus is no exception, as infection with P. berghei showed a 
possible correlation to insecticide resistance. The species also demonstrated immune 
responses similar to those seen in other mosquitoes with respect to anti-microbial peptides; 
furthermore, co-expression of AMPs may be a viable alternative in reducing parasite loads 
even though individual AMPs have little anti-plasmodial effect. More research is therefore 
required to understand the interaction of An. funestus with malaria parasites. The results 
presented herein are the first step in investigating parasite interaction in An. funestus, and 
hopefully will provide impetus for more research in this direction.   
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Appendices 
 
Appendix 1: Anopheles colonies in the Botha de Meillon insectary used in 
the study 
 
Colony 
Name 
Species Country of 
origin 
Date 
colonized 
Resistance 
status 
BOA An. gambiae Cote d‟Ivoire 1997 Dieldrin 
CIG An. gambiae Cote d‟Ivoire 1999 Dieldrin 
COGS An. gambiae Congo 2010 Susceptible 
COGS-EXP An. gambiae Congo 2010 Multiple 
G3 An. gambiae The Gambia 1970s Dieldrin 
GAH An. gambiae Ghana 2004 Multiple 
IANP20 An. gambiae Nigeria 1970s Dieldrin 
NAG An. gambiae Migeria 2001 Dieldrin 
PALA An. gambiae Burkino Faso 1970s Dieldrin 
SUA An. gambiae Liberia ? Malathion 
ARER An. arabiensis Eritria 2000 Susceptible 
KGB An. arabiensis Zimbabwe 1975 Susceptible 
MA An. arabiensis Mozambique 1990 Susceptible 
MALPAN An. arabiensis South Africa ? Susceptible 
MBN-DDT An. arabiensis South Africa 2003 Multiple  
MAF An. merus South Africa 1988 Susceptible 
ZAM An. merus South Africa 1980 Susceptible 
SANGWE An. quadriannulatus Zimbabwe 1998 Susceptible 
FANG An. funestus Angola 2002 Susceptible 
FUMOZ An. funestus Mozambique 2002 Partial 
FUMOZ-R An. funestus Mozambique 2002 Permethrin 
FUMOZ-BS An. funestus Mozambique 2008 Susceptible 
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Appendix 2: PCR primer sequences 
 
Table A2.1: Primers for antimicrobial peptide genes. 
 
Primer Sequence Amplicon size 
Cec F 5' - CAT CTT ATC AAC CCA GA - 3' 287 bps 
Cec R 5' - GCC ATA TCA TGT TAG CA - 3' 
CecRD F 5' - AAC TTC ACA AAA CTG TTC ATT - 3' 175 bps 
CecRD R 5' - CCA AGG GCT TTA TAG CCG GCA - 3' 
Dfn F 5' - CTG TGC CTT CCT AGA GCA T - 3' 403 bps 
Dfn R 5' - CAC AAC CTC TTC CCA GGA T - 3' 
Dfn degen F 5' - ATR ACR CGN AAR RAN CTY GT - 3' ~400 bps 
Dfn degen R 5' - CGN TCN CTY CTY CCN CAN GG - 3' 
DfnRD F 5' - GAC GAA CTG CCC GAG GAA ACG - 3' 253 bps 
DfnRD R 5' - GTT GCG GCA AAC ACA CAC - 3' 
DfnRD2 F 5' - GAG AAC TAT CGG GCC AAA CGG - 3' 127 bps 
DfnRD2 R 5' - CCT TAC TGT TGC AGT AAC CAC CGC - 3' 
Gmb F 5' - AAC CGG AAG GGC GTT TCG TG - 3' 265 bps 
Gmb R 5' - CGT CTG GCA CTG ATT AAA CC - 3' 
GmbRD F 5' - GAA GCA AGT GTG CAT TCT TCT - 3' 150 bps 
GmbRD R 5' - TAG CCA CAC TAG CGA GCA CCG - 3' 
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Table A2.2: Primers for candidate reference genes. 
Primer Sequence Amplicon size 
CO1 F 5' - TAG GAG CCC CTG ATA TAG CTT TC - 3' 123 bps 
 CO1 R 5' - ACT GTT CAT CCT GTT CCT GCT C - 3' 
GAPDH F 5' - GAC TGC CAC TCG TCC ATC - 3' 139 bps 
GAPDH R 5' - CCT TGG TCT GCA TGT ACT TG - 3' 
ND5 F 5' - TAG AAT TTT ATT AGG GTG GGA TGG - 3' 122 bps 
ND5 R 5' - ATC TCC AAT TCG ATT TGA TAA TGC - 3' 
rpL8 F 5' - CAT CAG CAC ATT GGT AAG - 3' 305 bps 
rpL8 R 5' - GTT TTC GCT TCC CGT TTT TC - 3' 
rpL19 F 5' - GAA ACA CCA ACT CCC GAG A - 3' 223 bps 
rpL19 R 5' - TCA ACA GGC GAC GCA ACA C - 3' 
rpS7 F 5' - GTG CCG GTG CCG AAA CAG AA - 3' 134 bps 
rpS7 R 5' - AGC ACA AAC ACT CCA ATA ATC AAG - 3' 
rpS26 F 5' - GAT AAG GCA ATC AAG AAG TTC G - 3' 160 bps 
rpS26 R 5' - TAC GGA CAA CCT TCG AGT GG - 3' 
18S F 5' - TAC CTG GGC GTT CTA CTC - 3' 116 bps 
18S R 5' - CTT TGA GCA CTC TAA TTT GTT C - 3' 
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Appendix 3: Gene sequences for An. funestus antimicrobial peptide genes 
 
 
 
 
 
 
 
 
 
 
 
 
Cecropin 
Defensin 
Gambicin 
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Cecropin 
Anopheles stephensi salivary cecropin mRNA, partial cds  
Sequence ID: gb|EU071705.1| 
97% similarity 
Query  119  GGAAAAACTTGGACGTAATGTGTTCCGGGCGGCTAAGAAAGCGCTGCCAGTCATTGCCGG  178 
            |||||||||||||||||||||||||||||| ||||||||||||||||| ||| ||||||| 
Sbjct  46   GGAAAAACTTGGACGTAATGTGTTCCGGGCTGCTAAGAAAGCGCTGCCGGTCGTTGCCGG  105 
 
Query  179  CTATAAAGCCCTTGGA  194 
             || ||||| |||||| 
Sbjct  106  ATACAAAGCACTTGGA  121 
 
Query  7   GATGGTGCTCCCCGTTGGAAGTTTGGCAAGCGGTTGG  43 
           |||||||| |||||||||||||||||||||||||||| 
Sbjct  11  GATGGTGCGCCCCGTTGGAAGTTTGGCAAGCGGTTGG  47 
 
 
Defensin 
Anopheles gambiae defensin (Def) gene, complete cds  
Sequence ID: gb|AF063402.1|AF063402 
98% similarity  
Query  1     CCCACACCGAACCCGCTGGCCAAATCGCAGGTCGCCCGCTTGGCCCGATAGTTCTCCAGC  60 
             |||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct  2439  CCCACACCGAACCCGCTGGCCAGATCGCAGGTCGCCCGCTTGGCCCGATAGTTCTCCAGC  2380 
 
Query  61    GCGGCATGGTGCGTTTCCTCGGGCAGTTCGTCCACTAATGGGAGGGGGGAAA-CAACCGA  119 
             |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct  2379  GCGGCATGGTGCGTTTCCTCGGGCAGTTCGTCCACTAATGGGAGGGGGGAAAACAACCGA  2320 
 
Query  120   GCACACAGGATACGTTAGTGGACAACGGCAAAAAGGGATGCGAACGGAAGGATCAAAGCG  179 
             |||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||| 
Sbjct  2319  GCACACAGGATACGTTAGTGGACAACGGGAAAAAGGGATGCGAACGGAAGGATCAAAGCG  2260 
 
Gambicin 
Anopheles gambiae M isolate GamM957_A gambicin (AGAP008645) gene, complete cds. 
Sequence ID: gb|GU990117.1| 
98% similarity  
Query  1    GAGTGCTTTTGCAAAGGAACGCAACGGGAAGTAAACATGGGTGGGCGTTCATCTTTTGCA  60 
            |||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||| 
Sbjct  434  GAGTGCTTTTGCAAAGGAACGCAACGGGAAGTAAACATGGCTGGGCGTTCATCTTTTGCA  493 
 
Query  61   GACCACCATCAATAGCTGTGAGGACTGCAAGCGAAGGTTGGGCCGCTGTTCAGACGGCTT  120 
            ||| ||||||||||||||||||||||||||||||| ||| |||||||||||||||||||| 
Sbjct  494  GACGACCATCAATAGCTGTGAGGACTGCAAGCGAAAGTTTGGCCGCTGTTCAGACGGCTT  553 
 
Query  121  TATTACAGAATGTTTCTTGTGAGTGGAGCTCTGCTGGAACCATGATCGGCAGGACCGCCG  180 
            ||||||||||||||||||||||||||||||||||||||||||| |||||||||||||||| 
Sbjct  554  TATTACAGAATGTTTCTTGTGAGTGGAGCTCTGCTGGAACCATCATCGGCAGGACCGCCG  613 
 
Query  181  GTGCGTCTTGTGCAGGGTGT  200 
            |||||||||||||||||||| 
Sbjct  614  GTGCGTCTTGTGCAGGGTGT  633 
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Appendix 4: Real-time PCR 
 
Reference gene calculation results 
Data from the Normfinder software indicating the best reference gene and best possible 
pairing of reference genes. Genes with the lowest stability values would be the optimal choice. 
 
Gene name Stability value 
rpS7 0.223 
rpS26 0.178 
rpL19 0.312 
ND5 0.355 
rpL18 0.403 
GAPDH 0.256 
CO1 0.148 
18S 0.801 
 
Best gene CO1 
Stability value 0.148 
  
Best combination of two genes ND5 and rpL18 
Stability value for best combination of two genes 0.062 
 
 
 
Bestkeeper software also calculates the best reference genes as the ones with the lowest score. 
 rpS7 rpS26 rpL19 ND5 rpL18 GAPDH CO1 18S 
p-value 0.243 0.001 0.005 0.016 0.001 0.001 0.001 0.001 
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Figure: Sample of real-time PCR runs of the immune genes with standard curves (in blue). 
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